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Abstract
Cardiovascular disease risk communication in NHS Health
Checks using QRISK®2 and JBS3 risk calculators:
the RICO qualitative and quantitative study
Christopher J Gidlow ,1* Naomi J Ellis ,1 Lisa Cowap ,2
Victoria Riley ,1 Diane Crone ,3 Elizabeth Cottrell ,4
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3Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK
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5Department of Psychology, Manchester Metropolitan University, Manchester, UK
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Background: The NHS Health Check is a national cardiovascular disease prevention programme.
There is a lack of evidence on how health checks are conducted, how cardiovascular disease risk is
communicated to foster risk-reducing intentions or behaviour, and the impact on communication of
using different cardiovascular disease risk calculators.
Objectives: RIsk COmmunication in Health Check (RICO) study aimed to explore practitioner and
patient understanding of cardiovascular disease risk, the associated advice or treatment offered by the
practitioner, and the response of the patients in health checks supported by either the QRISK®2 or the
JBS3 lifetime risk calculator.
Design: This was a qualitative study with quantitative process evaluation.
Setting: Twelve general practices in the West Midlands of England, stratified on deprivation of the
local area (bottom 50% vs. top 50%), and with matched pairs randomly allocated to use QRISK2 or
JBS3 during health checks.
Participants: A total of 173 patients eligible for NHS Health Check and 15 practitioners.
Interventions: The health check was delivered using either the QRISK2 10-year risk calculator
(usual practice) or the JBS3 lifetime risk calculator, with heart age, event-free survival age and risk
score manipulation (intervention).
Results: Video-recorded health checks were analysed quantitatively (n = 173; JBS3, n = 100; QRISK2,
n = 73) and qualitatively (n = 128; n = 64 per group), and video-stimulated recall interviews were
undertaken with 40 patients and 15 practitioners, with 10 in-depth case studies. The duration of the
health check varied (6.8–38 minutes), but most health checks were short (60% lasting < 20 minutes),
with little cardiovascular disease risk discussion (average < 2 minutes). The use of JBS3 was associated
with more cardiovascular disease risk discussion and fewer practitioner-dominated consultations than
the use of QRISK2. Heart age and visual representations of risk, as used in JBS3, appeared to be
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better understood by patients than 10-year risk (QRISK2) and, as a result, the use of JBS3 was more
likely to lead to discussion of risk factors and their management. Event-free survival age was not
well understood by practitioners or patients. However, a lack of effective cardiovascular disease
risk discussion in both groups increased the likelihood of a maladaptive coping response (i.e. no
risk-reducing behaviour change). In both groups, practitioners often missed opportunities to check
patient understanding and to tailor information on cardiovascular disease risk and its management
during health checks, confirming apparent practitioner verbal dominance.
Limitations: The main limitations were under-recruitment in some general practices and the resulting
imbalance between groups.
Conclusions: Communication of cardiovascular disease risk during health checks was brief, particularly
when using QRISK2. Patient understanding of and responses to cardiovascular disease risk information
were limited. Practitioners need to better engage patients in discussion of and action-planning for their
cardiovascular disease risk to reduce misunderstandings. The use of heart age, visual representation
of risk and risk score manipulation was generally seen to be a useful way of doing this. Future work
could focus on more fundamental issues of practitioner training and time allocation within health
check consultations.
Trial registration: Current Controlled Trials ISRCTN10443908.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 25, No. 50. See the NIHR Journals Library website for further project information.
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Informatica Software addition that offers some JBS3 functionalities.
JBS3 risk calculator Lifetime cardiovascular disease risk calculator.
Point-of-care testing Blood test during health check.
QRISK®2 Cardiovascular disease risk calculator for estimating the 10-year risk of having a
cardiovascular event in people who do not already have heart disease.
QRISK®2+ Used to denote health checks in which QRISK2 and Informatica are used.
DOI: 10.3310/hta25500 Health Technology Assessment 2021 Vol. 25 No. 50
Copyright © 2021 Gidlow et al. This work was produced by Gidlow et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social
Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution,
reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the




BMI body mass index
CI confidence interval




ICC intraclass correlation coefficient
IMD Index of Multiple Deprivation
JBS Joint British Societies for
cardiovascular disease prevention
NHSHC NHS Health Check
PHE Public Health England
PMT protection motivation theory
PN practice nurse
PoC point of care
PPG Patient Participation Group
PPI patient and public involvement
QOF Quality and Outcomes Framework
RICO RIsk COmmunication in NHS
Health Check
VSR video-stimulated recall
DOI: 10.3310/hta25500 Health Technology Assessment 2021 Vol. 25 No. 50
Copyright © 2021 Gidlow et al. This work was produced by Gidlow et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social
Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution,
reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the




In England, NHS Health Checks aim to prevent cardiovascular diseases, such as heart attack andstroke. Health checks are conducted in primary care by a health-care assistant or practice nurse, who
should measure the patient’s risk of cardiovascular disease before advising them on how to reduce their
risk. Cardiovascular disease risk is measured using a cardiovascular disease risk calculator. These calculators
use various patient characteristics (e.g. age, sex, blood pressure and cholesterol) to predict how likely
patients are to have a heart attack or stroke in the future.
The aim of this study was to compare how practitioners explain cardiovascular disease risk to patients
during health checks when using two risk calculators: QRISK®2, which measures the risk of heart
attack or stroke over the next 10 years (current usual practice), and JBS3 (a newer risk calculator),
which gives this risk across the lifetime, is more interactive and has various visual displays of risk. We
were interested to see if using JBS3 in health checks would lead to better practitioner and patient
understanding of cardiovascular disease risk and result in patients intending to change, or actually
changing, their behaviour to reduce their cardiovascular disease risk (compared with QRISK2).
Health checks were video-recorded: 73 using QRISK2 and 100 using JBS3. Patients and members of the
public advised on the study design, methods and management. Most consultations lasted < 20 minutes,
with most time spent discussing the causes of cardiovascular disease. There was evidence that, compared
with health checks using JBS3, those using QRISK2 led to less discussion of risk and practitioners speaking
far more than patients. Sixty-four health checks from each risk calculator group were examined in depth.
Opportunities to check whether or not patients understood the cardiovascular disease risk information
and to encourage ways to lower risk were missed, making it less likely that patients would change their
behaviour. The way that risk is presented by JBS3 seems to be more easily understood by patients than
that presented by QRISK2.
Nineteen patients in the QRISK2 group and 21 patients in the JBS3 group were interviewed 4 weeks
after the consultation, and the practitioners were interviewed after they had completed all of their
health checks. Patients found it difficult to understand and remember what they had been told about
their cardiovascular disease risk during their health check. Their understanding and motivation to
change behaviour appeared to be higher when they were visually shown how behaviour changes could
lower their risk. Practitioners sometimes misunderstood risk and used patients’ reactions to judge
whether or not they understood, rather than asking them.
Our findings should help to improve how cardiovascular disease risk is communicated during health
checks in future, through simple changes to the consultations (e.g. using aspects of JBS3) and by
highlighting a gap in practitioners’ training.
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NHS Health Check is a national programme with a focus on cardiovascular disease prevention in those
aged 40–74 years in England. Consultations are usually delivered in primary care by a health-care
assistant or practice nurse. They involve assessing the patient’s cardiovascular disease risk, communicating
this to them and making recommendations for risk management. At present, there is a lack of evidence on
how health checks are conducted, the nature and adequacy of cardiovascular disease risk communication
to foster risk-reducing intentions or behaviour, and the potential benefit of using different cardiovascular
disease risk calculators.
Aim
The overarching aim of the RIsk COmmunication in Health Check (RICO) study was to explore
practitioner and patient perceptions and understanding of cardiovascular disease risk, the associated
advice or treatment offered, and the response of the patients who attend a health check conducted
using either the QRISK®2 10-year risk calculator or the JBS3 lifetime risk calculator.
Methods
RICO was a qualitative study with quantitative process evaluation in 12 general practices in the West
Midlands of England. Six practice pairs, which were approximately matched on level of deprivation,
were randomly assigned to one of two groups: the QRISK2 (usual practice) group, in which practitioners
delivered the health check using QRISK2, which presents cardiovascular disease risk as a percentage
risk of a cardiac event in the next 10 years; or the JBS3 (intervention) group, in which practitioners
delivered the health check using the JBS3 cardiovascular disease risk calculator, using heart age,
event-free survival age and risk score manipulation (to demonstrate the risk-reducing effects of
intervention). The study comprised several components:
l Video-recorded health check consultations. Each practice was asked to video-record 20 health
checks conducted using the allocated cardiovascular disease risk calculator (the number of health
checks actually recorded by practices ranged from 3 to 29 checks). Patient recruitment was stratified
by age, sex and ethnicity. Video-recordings were quantitatively coded (second by second) to explore
content and the relative contributions of practitioner and patient. Transcripts from a subsample of
health checks (n = 128, 64 in each group) were subject to deductive thematic analysis, using a
framework adapted from protection motivation theory.
l Video-stimulated recall interviews. Video-stimulated recall interviews were undertaken with a
subsample of 40 patients (within 2 weeks of their health check) and all 15 practitioners (after
completing all video-recorded health checks). Video-stimulated recall interviews used excerpts
from recorded health checks to facilitate recall and reflection. Interviews were audio-recorded,
transcribed and analysed using inductive thematic analysis.
l Medical record reviews. Data were extracted from all patients’ medical records (n = 173), 12 weeks
post health check, to identify resulting activities, prescriptions or diagnoses.
l Case studies. Within-case analysis was completed for 10 patients who expressed positive intentions
and/or implemented behaviours to reduce cardiovascular disease risk following the health check.
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A total of 173 video-recorded health checks were included in the analysis (QRISK2, n = 73; JBS3,
n = 100). The sample comprised approximately equal proportions of male (49.7%) and female (50.3%)
participants, and was 83% white British. The average age was 58.2 ± 9.7 years and 60% of the sample
classified as low risk (10-year risk < 10%). Practitioners were health-care assistants (n = 9) or practice
nurses (n = 6), who had varying experience of delivering health checks (mean 4.7 ± 2.4 years) and had
received either no formal health check training or training focused on processes (rather than risk
communication or behaviour change).
Quantitative analysis of health checks and medical record review
The duration of the health check ranged from 6.8 to 38.0 minutes. Most health checks (60%) lasted
< 20 minutes. On average, cardiovascular disease risk was discussed for < 2 minutes (9.1% ± 4.3% of
consultation time). There were indications that, compared with health checks using QRISK2, those
health checks that used JBS3 involved more cardiovascular disease risk discussion (JBS3, mean 10.24%,
95% confidence interval 8.01% to 12.48% of consultation time; QRISK2, mean 7.44%, 95% confidence
interval 5.29% to 9.58% of consultation time) and were less practitioner dominated (as determined by
the ratio of practitioner talking time to patient talking time: JBS3, mean 2.35, 95% confidence interval
1.89 to 2.81, vs. QRISK2, mean 3.21, 95% confidence interval 2.44 to 3.97). The largest proportion
of health check time was spent discussing causal risk factors (overall mean 37.54%, 95% confidence
interval 32.92% to 42.17%; JBS3 mean 35.33%, 95% confidence interval 27.76% to 42.90%, vs. QRISK2
mean 40.58%, 95% confidence interval 36.20% to 44.96%). At 12 weeks post health check, relevant
activity was recorded in 30.1% (JBS3, 31.0%; QRISK2, 28.8%) of patients’ medical records, most
commonly related to blood pressure measurement/discussion, and 8.7% (JBS3, 6.0%; QRISK2, 12.3%)
of patients had been prescribed medication. Among the 173 patients, there were 10 new diagnoses
(i.e. three pre-diabetes, three diabetes, two hypertension and two hyperlipidaemia).
Deductive thematic analysis of health check (using adapted protection motivation theory)
When applying the protection motivation theory to analyse cardiovascular disease risk communication
in recorded health checks, we found that cognitive appraisal (threat appraisal and coping appraisal)
and coping modes (adaptive and maladaptive) were most relevant. Again, there was little evidence of
cardiovascular disease risk communication, particularly in consultations using QRISK2. Practitioners in
both groups often missed opportunities to check patient understanding and encourage risk-reducing
behaviour, confirming practitioner verbal dominance. JBS3 appeared better for initiating risk factor
discussion. Heart age and visual representation of risk were more easily understood and had a greater
impact on patients than 10-year risk (QRISK2). However, a lack of effective cardiovascular disease risk
discussion in both risk calculator groups increased the likelihood of a maladaptive coping response
(i.e. no risk-reducing behaviour change).
Video-stimulated recall interviews with patients
Inductive thematic analysis of data from video-stimulated recall interviews with patients (QRISK2,
n = 19; JBS3, n = 21) identified four main themes:
1. Relieved about cardiovascular disease risk: misplaced assurance was observed in some patients
who did not understand their CVD risk and, therefore, did not recognise its severity or their
vulnerability to it.
2. Mixed levels of understanding: patients often did not understand cardiovascular disease risk
information, particularly 10-year risk, and had a preference for heart age.
3. Positive impact of health check: attending a health check appeared to have a positive impact on
many patients by increasing their awareness of the benefits of relatively small lifestyle changes.
Heart age appeared to be the most impactful risk score, allowing appraisal of risk.
4. Importance of presentation style and content: patients in both groups struggled to absorb and
retain the volume of information.
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Visual presentation and risk score manipulation with JBS3 appeared to foster patient understanding of
risk and motivated patients to follow recommendations more than 10-year risk did.
Video-stimulated recall interviews with practitioners
The inductive thematic analysis resulted in three main themes:
1. Communicating cardiovascular disease risk: 10-year risk was considered useful for clinical decision-
making, but not for facilitating cardiovascular disease risk discussion, and practitioners lacked
confidence in explaining the score. Heart age was favoured as it was easier to explain and well
received by patients. Event-free survival age was misinterpreted.
2. Understanding of cardiovascular disease risk: practitioners acknowledged gaps in their understanding
of 10-year risk beyond the use of low-, medium- and high-risk thresholds. Practitioners relied on
patient reactions to information to gauge their understanding, rather than asking patients.
3. Risk management: lifestyle advice was most prominent, sometimes with written information.
Referrals to support services were less frequent (e.g. exercise referral).
Case studies
Within-case analysis identified confirmatory and additional themes. When patients were already motivated
to, or had already started to, implement lifestyle changes, health checks had positive outcomes regardless
of how cardiovascular disease risk was communicated. Patients had already appraised a perceived risk
(often a specific risk factor or behaviour) and identified specific and relevant action (e.g. omitting certain
foods or reducing alcohol). Case studies confirmed that relying on the minimal patient responses to gauge
understanding (rather than asking patients) could lead to incorrect assumptions of patient understanding.
Some limitations of the consultation could be addressed through telephone reinforcement.
Conclusions
Communication of cardiovascular disease risk during health checks was brief, particularly in consultations
using QRISK2. Patients’ understanding of, and responses to, cardiovascular disease risk information were
limited. Practitioners missed opportunities to check patient understanding that could allow an appraisal of
risk, which, in turn, could encourage risk-reducing intentions or behaviour. The use of JBS3 appeared to
provide more opportunity for the practitioner to initiate discussion of risk factors and their management;
in particular, the concept of heart age and the visual representation of risk included in JBS3 were more
easily understood by patients, and more impactful, than that for QRISK2. The apparent lack of effective
cardiovascular disease risk discussion in both groups resulted in misunderstandings, practitioner-
dominated discussion and an increased likelihood of a maladaptive coping response. Our data have
highlighted a need for practitioner training and a move towards a more tailored and patient-centred
health check consultation, in which discussion of the concept heart age and risk score manipulation could
improve communication of cardiovascular disease risk.
Trial registration
This trial is registered as ISRCTN10443908.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 50.
See the NIHR Journals Library website for further project information.
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Cardiovascular disease and NHS Health Check
Cardiovascular disease (CVD) accounts for over one-quarter of UK deaths and costs the NHS around
£9B annually.2 Given that CVD mortality has decreased in the UK (68% reduction between 1980 and
2013), the number of people living with CVD remains large.3 Therefore, prevention, for which the NHS
Health Check (NHSHC) programme plays an important part, remains a priority.4,5 NHSHC aims to assess
the CVD risk of adults in England aged 40–74 years who are not known to have certain cardiovascular-
related diseases.6 It is the largest CVD risk identification and management programme of its kind
globally. NHSHCs have been linked to some increases in the detection of risk factors and chronic disease,
and in statin prescriptions,7,8 but there are gaps in the evidence for long-term benefits for CVD risk,
morbidity and mortality,9–14 and mixed predictions of future benefit from microsimulation studies.15,16
Health check consultations typically take place in primary care with a health-care assistant (HCA) or
practice nurse (PN), and comprise (1) assessing patients’ CVD risk and (2) communicating CVD risk,
which should inform (3) the discussion of CVD risk management through lifestyle, or subsequent
medical appointments or referrals. Public Health England (PHE)’s best practice guidance17 specifies that
those attending a health check ‘must be told their BMI, cholesterol level, blood pressure and AUDIT
score as well as their cardiovascular risk score’ (p. 14; contains public sector information licensed under
the Open Government Licence v2.0.). However, this guidance document primarily focuses on legal
requirements for local authorities delivering health checks, processes for risk assessment and clinical
pathways. The associated competence framework for practitioners who deliver health checks, both the
version available at the time of data collection18 and the updated version,19 are more explicit in the role
of CVD risk communication and expectations of practitioners. They make clear that it is important that
practitioners understand CVD risk information and are able to communicate it so that patients
understand, and the need to involve patients in strategies to manage their risk (Box 1).
Despite a growing body of evidence on NHSHC, little is known at present about the nature or content
of health check consultations. What we know about what takes place in the consultations is limited to
qualitative data from retrospective interviews with patients and practitioners, who are asked to recall
and reflect on their experiences.21 Although these data have value, they do not present a complete
understanding of the dynamics and interactions that may influence the outcomes of a health check.
Cardiovascular disease risk communication
Practitioner–patient interactions are complex,22 and communicating risk is challenging.23 For health
checks to promote health-protective behaviours that reduce CVD risk, risk information must be
effectively communicated and understood, such that the patient leaves the consultation with the
knowledge and intention to act.
A review of 70 risk-scoring methods concluded that there is no single ‘correct’ approach. The appropriate
method depends on individual preferences and understanding, which differs with education, numeracy
and personality traits, such as optimism.24 The emotional response to the communication of risk, how
DOI: 10.3310/hta25500 Health Technology Assessment 2021 Vol. 25 No. 50
Copyright © 2021 Gidlow et al. This work was produced by Gidlow et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social
Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution,
reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the
title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
1
and by whom the information is conveyed, presentation of risk and the influence on health behaviour,
differs greatly between patients.25–28 Poor communication of risk can cause patients anxiety and
reduce their confidence in health professionals who use risk communication techniques.29 However,
if risk communication is delivered effectively, it can enhance knowledge, aid decision-making about
treatment, empower and create autonomy.30 Wells et al.31 assessed whether or not an electronic CVD risk
visualisation tool facilitated explanation of CVD risk to primary care patients. They found that watching a
video about the communication of risk increased associated practitioner confidence and understanding,
which led to greater efficiency. Researchers who interviewed general practitioners (GPs) indicated that the
GPs vary their strategy for communicating CVD risk depending on factors such as patient’s perception of
risk, motivation and anxiety, and recommended that clinicians should have alternative ways to explain
absolute risk to improve how the metrics were used in practice.32
Cardiovascular disease risk communication in health checks
For CVD risk assessment in NHSHC, QRISK® (QRISK®2 and, more recently, QRISK®3) is the mandated
CVD risk calculator.17,33 QRISK provides a percentage risk of a CVD event in the next 10 years, and this
must be communicated to patients for the health check to be considered ‘complete’. It is integrated
within the general practice electronic medical record software, so can be calculated from pre-populated
BOX 1 Extracts from the NHSHC competence framework
Interpreting results
The use of a risk engine together with clinical judgement and observations/discussions during the assessment,
to calculate the individual’s risk of developing cardiovascular disease. Thereafter, understanding the results
that must be communicated to them.
Communication of risk
All healthcare professionals involved with delivering the NHS Health Check should be trained in
communicating the risk score and results to the client. It is important to understand that sharing information
about risk with people may not necessarily motivate them to change.
Therefore, the use of behaviour change methods, such as motivational interviewing techniques, should engage
clients in person-centred conversations about their own reasons for change.
Risk should be communicated in everyday, jargon free language, so the client understands their level of risk.
Advice should be tailored to the client’s values and beliefs for better health outcomes, and the impact of the
wider social determinates of health should also be considered.
Brief intervention/signposting/referral
These competences enable the effective and appropriate signposting of clients to the range of locally available
interventions in a supportive manner. It requires more than a simple communication of information; the
person signposting must be able to engage the client in the choice and communicate in a manner that will
maximise the potential that the client will take up the agreed action and sustain it.
Some material has been reproduced from Public Health England,20 which contains public sector information
licensed under the Open Government License v2.0 (www.nationalarchives.gov.uk/doc/open-government-
licence/version/2/).
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and new data. The score is then saved directly to the patient’s record. However, there are limitations to
the QRISK score and how it is used. First, 10-year risk estimates, such as those presented by QRISK,
have been criticised for being heavily influenced by age and sex, thereby underestimating risk in younger
adults and women, and not accounting for risk from other diseases as effectively as long-term (lifetime)
estimates.34,35 Second, qualitative studies indicate limited practitioner and patient understanding of
percentage CVD risk.21 Practitioners report difficulties in explaining percentage CVD risk.26,36–38 In turn,
patients attending health checks have been unable to recall being provided with a risk score or have
found it confusing.21
In 2014, the Joint British Societies (JBS) launched the JBS3 risk calculator. JBS3 has a primary focus
on lifetime risk,34 which can address some of the limitations of short-term risk estimates and identify
raised CVD risk that would not be picked up through conventional 10-year risk estimates.39 JBS3 has a
range of features (Figure 1):
l Heart age. This is the estimated age of someone of the same sex and ethnicity, and with the same
annual risk of an event, but with all other risk factors at ‘optimal’ levels (see Figure 1a); for example,
an individual with a heart age of 67 years has the same CVD risk at someone aged 67 years, of the
same sex and ethnic group, who has optimal levels of risk factors. Those with an ‘old’ heart age
should be motivated towards risk-reducing behaviours to bring their heart age back to their real
chronological age. There is evidence that heart age is more easily communicated to, and understood
and recalled by, patients.41,42 A recent review concluded that randomised controlled trials testing
the effects of CVD risk communication using heart age have reported improvements in some risk
factors (cholesterol and blood pressure) and intentions to improve lifestyle compared with usual
care or alternative risk scores.43
l Event-free survival. This is the age by which an individual might expect, based on their current risk
profile, to sustain their first CVD event. This is presented on a visual analogue scale that indicates
the average expected age of a cardiac event for an individual (based on demographic and risk factor
profile; see Figure 1b).
l Percentage chance of survival free of heart attack or stroke, by age. This is presented as a survival
curve, showing the reduction in the percentage chance of being free of heart attack or stroke as age
increases (see Figure 1c).
l A range of visual displays. Lifetime risk scores are presented using a range of images, including icon
array or Cates’ plots, an image of a heart for heart age, visual analogue scales and a survival curve.
This variety aims to accommodate a range of preferences23 and can be preferable for promoting
risk-reducing behaviour.44
l Risk score manipulation. Risk factors can be modified (e.g. altering smoking status or reducing blood
pressure or cholesterol level) to show the beneficial effect of effective intervention on risk scores
(see Figure 1d). This ability to interact with graphics has the potential benefit of engaging the
individual with the information and promoting their understanding and retention.23,45
Collectively, these attributes of JBS3 might accommodate a range of patients and facilitate practitioner
communication that allows patients to understand and retain their CVD risk, and perhaps foster
intentions towards risk-reducing behaviour.23,31 Yet, to our knowledge, a comparison of the relative
benefits JBS3 and QRISK2 for communicating CVD risk in health checks has not been undertaken.
The most effective way to address CVD risk during health checks is to involve the patient in a
discussion of their risk and allow them to identify strategies that they could adopt to manage that risk.
This is preferable to a didactic consultation, in which practitioners are providers of information and
patients are the passive recipients. Studies of clinician–patient interactions have identified that short,
clinician-dominated (or ‘paternalistic’) consultations are less patient centred and are linked with low
patient and clinician satisfaction,46–49 which, in turn, have been linked with poorer patient outcomes,
such as poor adherence to clinical recommendations and failure to adopt health-promoting behaviour.50
As noted in the competence framework (see Box 1), CVD risk management should be negotiated
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FIGURE 1 Example JBS3 outputs. (a) Heart age; (b) event-free survival age; (c) percentage change of survival free of CVD
event; (d) risk score manipulation (showing the effect on event-free survival of reducing blood pressure and cholesterol).
Source: JBS3 risk Calculator 201440 [reproduced with permission from British Cardiovascular Society for the prevention of
CVD, personal communication, 2020 (Copyright© UoC/BCS. All rights reserved)].
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through a mutual exchange between practitioner and patient (i.e. a person-centred approach) that
places the individual at the centre of their own care, service or treatment, as part of a shared decision-
making process.51 At present, there is no evidence regarding the practitioner–patient balance during
health checks, particularly the extent to which patients are engaged in discussion of their CVD risk and
its management.
Patient outcomes from health checks will depend on patients’ actions, and the support and interventions
available to them following their consultation (e.g. referral to effective lifestyle support programmes or
appropriate specialist referrals). There is evidence that patient outcomes from primary care consultations
are influenced by patients’ experience; hence, there is a need to understand more about the dynamics of
the health check event. If delivery of the health check consultation does not create a positive experience
for patients, their engagement with and effectiveness of the subsequent risk management actions could
be undermined. To optimise the efficacy of health checks in laying the foundations for the management
of identified risks, a better understanding of what is already occurring during health check consultations
and identification of areas requiring improvement are necessary.
In summary, the NHSHC programme aims to assess CVD risk and prompt patients and practitioners
to undertake risk management behaviours. At present, there is insufficient knowledge about how they
are conducted, the nature and adequacy of CVD risk communication, and the potential benefit of using
alternative CVD risk calculators, such as JBS3. Knowing which approach best delivers the information
that patients need to foster intentions for risk-reducing behaviour (or actual behaviour change) could
inform decisions about practitioner training and resource allocation.
Research objectives
RIsk COmmunication in NHS Health Check (RICO) was a qualitative study and quantitative process
evaluation that aimed to explore practitioner and patient perceptions and understanding of CVD risk
when using the JBS3 lifetime risk calculator or the QRISK2 10-year risk calculator, the associated
advice or treatment offered by the practitioner and the response of the patient.
Specific study objectives were to:
l explore how practitioners use QRISK2 and JBS3 to communicate CVD risk during the consultation
l explore how patients respond to the risk information
l explore how QRISK2 and JBS3 promote patient and practitioner understanding and perception of
CVD risk
l explore patient intentions with respect to health-protective behaviours
l explore mechanisms by which intentions for health-protective behaviours are elicited
l make recommendations regarding use of QRISK2 or JBS3 during health checks.
Theoretical basis
Given the complexity of practitioner–patient interactions52,53 and the translation of risk information
into health-protective behaviour,54 we used a theoretical framework based on the revised protection
motivation theory (PMT).55 In PMT, ‘protection motivation’ refers to the intention to undertake
health-protective behaviour resulting from the cognitive appraisals (or internal assessments). CVD
risk communication could be a key source of information feeding into such appraisals (Figure 2).
Protection motivation theory is informed by fear-driven models, which recognise that behaviour change
can be prompted by fear-inducing communications that motivate action to reduce the perceived threat
(or risk).54,56 However, protection motivation is influenced by two cognitive appraisals: appraisals of
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the threat (risk of CVD) and coping (consequences of undertaking positive behaviour change). Threat
appraisal evaluates maladaptive responses (i.e. not initiating positive behaviours in response to recognising
an elevated CVD risk). This considers the source of the threat (i.e. practitioner/health check), intrinsic
rewards (e.g. enjoyment associated with health risk behaviour) and extrinsic rewards (e.g. social approval),
and the perception of the threat (i.e. perceived severity and personal vulnerability). Coping appraisal
evaluates the adaptive response to cope with the threat (i.e. CVD risk), and considers the likelihood that
positive behaviour change (adaptive response) will reduce the patient’s risk (response efficacy), the
patient’s own ability to make the necessary changes (self-efficacy), and the burdens of, or barriers to,
making the change (response costs).54,55,57,58 Threat and coping appraisals are influenced by both environmental
aspects (e.g. persuasive communication and observational learning) and intrapersonal variables [e.g.
personality and feedback from prior experience of both positive (adaptive) and negative (maladaptive)
behaviours].54 In the context of this study, PMT emphasises the key role of practitioners in providing
information on CVD risk (severity and vulnerability) and incorporating a patient’s beliefs, priorities and
experiences into strategies to reduce this risk so that patients feel they can achieve adaptive behaviours55
and subsequent health outcomes.
Protection motivation theory is particularly pertinent to the study of the relative merits of different
CVD risk calculators and the mechanisms by which they might promote positive behaviour change
for several reasons. First, it was initially developed to examine intention to adopt behaviours relating
to disease prevention.59 Second, it does not assume rationality in behaviour choices,54,60 that is people
will undertake unhealthy behaviours because they serve other purposes, for example enjoyment or
social integration. Third, its components have been associated with (intention for) behaviour change in
relevant contexts (e.g. smoking cessation and exercise).55,57 Finally, it provides an understanding of why
attitudes and behaviour can change when people are confronted with threats (i.e. the mechanisms).54
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Design and setting
This qualitative study, with quantitative process evaluation, was undertaken in 12 general practices
in the West Midlands of England that were already delivering NHSHCs. Six practice pairs, which were
approximately matched on level of deprivation,61 were randomly assigned to one of two groups: the
QRISK2 (usual practice) group, in which practitioners continue to use QRISK2 to communicate CVD risk,
or the JBS3 (intervention) group, in which practitioners use the JBS3 CVD risk calculator to communicate
CVD risk following brief introductory training about the platform. Participating practices were asked
to video-record NHSHCs using the allocated CVD risk calculator until 20 useable consultations were
recorded. Data collection took place from January 2017 to February 2019 and comprised (1) video-
recording NHSHC consultations; (2) post-consultation video-stimulated recall (VSR) interviews with
patients within 4 weeks of their health check, using excerpts from recorded health checks to facilitate
recall and reflection; (3) VSR interviews with practitioners after their final recorded health check;
and (4) patient medical record reviews 12 weeks post health check to determine subsequent action
(e.g. GP appointment, lifestyle referrals, lifestyle referral and statin prescription).
Sample
General practices
General practices were recruited if they met the following criteria:
l were delivering NHSHCs
l were already using the QRISK2 percentage risk score during health checks
l were already delivering (or were willing to deliver) health checks in specific clinics to facilitate
data collection
l had signed up to the ‘incentive scheme’ implemented by the Clinical Research Network (CRN) to
ensure that the practice is ‘research ready’
l were willing to participate.
Postcodes were used to stratify general practices into the bottom or top 50% based on national
deprivation rankings,62 as a proxy for the typical socioeconomic status of the local population (Table 1).




40–54 4 (3 white British/1 ethnic minority) 4 (3 white British/1 ethnic minority)
55–64 3 (2 white British/1 ethnic minority) 3 (2 white British/1 ethnic minority)
65–74 3 (2 white British/1 ethnic minority) 3 (2 white British/1 ethnic minority)
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Patients
The patient population were those eligible for NHSHCs based on national criteria. These criteria excluded
people who:
l were outside the target age range of 40–74 years
l had existing diagnoses for certain cardiovascular-related chronic conditions
l were taking statins
l had attended an NHSHC in the last 5 years
l were known to be at high risk of CVD (i.e. had a 10-year CVD risk score of ≥ 20%).17
Practitioners
Participating practitioners were health-care professionals who usually delivered health checks in participating
practices and who were willing to participate (usually one or two PNs or HCAs per practice).
Recruitment
Practice sampling
The CRN facilitated practice sampling. Briefly, this involved an initial e-mail inviting expressions of
interest, followed up with telephone calls and subsequent practice visits. Practice participation was
incentivised through financial reimbursement of service support costs and additional remuneration for
completing all parts of the study. Following practice-level consent, practice pairs that were matched
on level of deprivation (bottom vs. top 50% of national deprivation rankings), were randomly assigned
to the QRISK2 or the JBS3 group using a random number generator in Microsoft Excel® (Microsoft
Corporation, Redmond, WA, USA). After randomisation, the research team completed initiation
meetings at practices to provide further information and basic training for staff involved.
Patient and practitioner sampling
There were three levels of patient sampling:
1. Total sample (target, n = 240) – to achieve the 144 recorded consultations suitable for qualitative
analysis (12 recorded consultations per practice allowing for non-attendances and consultations
with no/minimal discussion of CVD risk), the aim was that health check clinics were recorded
until 20 recordings per practice (240 total) were complete. In each practice, the patient database
was searched to identify eligible patients, who were then stratified by age, sex and ethnicity to
ensure that there was representation from different demographic groups (see Table 1).
Invitation letters, information sheets and consent forms were sent out to eligible patients (up to
400 per practice depending on the size of the eligible cohort), asking them to contact the CRN for
more information or to arrange their video-recorded health check. Those who did not respond were
contacted by telephone by the general practice staff.
2. Qualitative analysis (target, n = 144) – video-recordings were quantitatively coded soon after the
health check to identify those for qualitative analysis (target of 12 video-recordings per practice)
and VSR interview (target of four VSR interviews per practice). Where risk was not discussed by
patient or practitioner, the patient’s data were not used for either.
3. VSR interviews (target, n = 48) – VSR interviews were conducted with patients (target, n = 24 VSR
interviews per group) sampled from the 144 recorded health checks. The aim was to stratify by sex,
age and CVD risk (Table 2), although issues with recruitment meant that this could not be strictly
adhered to and, in some under-recruiting practices, all those who consented were asked to take part.
The target of 144 recorded consultations (12 per practice) was comparable to other studies using
audio-recordings of similar consultations to explore CVD risk communication in patients with psoriasis
(e.g. n = 130 in 10 practices),63 while the targets of 48 patient VSR interviews and 18 practitioner VSR
interviews were in alignment with the number of interviews carried out in other VSR studies (n= 9–39).52,64
METHODOLOGY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
10
All practitioners who delivered the video-recorded health check were asked to participate in
VSR interviews.
Groups
General practices were randomly assigned to one of two groups:
1. QRISK2 group (usual practice) – practitioners delivered health checks using the QRISK2 risk
calculator as per usual practice.
2. JBS3 group (intervention) – practitioners delivered health checks using the JBS3 risk calculator.40
An introductory session with practitioners established the minimum requirements to use:
¢ the first two output screens, which show heart age and healthy years (event-free survival age)
¢ risk score manipulation to show the effects of intervention through modifying one of those risk
factors (e.g. lowering blood pressure, smoking cessation) (see Figure 1).
Practitioners were also asked to practise using JBS3 in at least two health checks prior to the video-
recorded clinics and could seek further clarification from the research team should they wish. During
these introductory sessions, practitioners were provided with a verbal explanation of the tool, given
written materials to support data entry and given a digital versatile disc (DVD) and link to an online
training video (www.youtube.com/watch?v=idecGzlwIc4%26feature=youtu.be; accessed June 2021),
which was also played to them during the introductory session. As a requirement of the NHSHC
programme, patients in the JBS3 group were also told their QRISK2 10-year risk.
Data collection procedures
Video-recorded health checks
Digital camcorders were positioned in health check clinic rooms to provide an audio-visual record of
consultations. Informed by patient and public involvement (PPI) and pilot work, cameras were positioned
to capture both the patient and the practitioner, but prioritising the view of the patient. Video-recordings
were screened soon after the health check. If there was no discussion of CVD risk, this was noted and
the file retained. In the case of consultations that involved discussion of CVD risk and were eligible for
qualitative analysis, the audio-recording was separated from the visual recording [using Adobe® Premiere
Pro (Adobe Systems Incorporated, San Jose, CA, USA)] for transcription and qualitative analysis.
Semistructured video-stimulated recall interviews with patients and practitioners
Semistructured one-to-one VSR interviews with patients were conducted at the patients’ home or
their general practice (depending on patient preference) within 4 weeks of their health check. VSR
interviews with practitioners were conducted at the general practice within 2 weeks of their final
recorded health check. No others (i.e. non-participants) were present in the room during interviews.
After each clinic, the recorded heath checks were watched to identify sections of the consultation
to use in VSR interviews that related to discussion of the CVD risk score, modification of the risk
TABLE 2 Example of intended stratified sampling of VSR patient interviews per group based on age,
CVD risk and sex
Age (years)
CVD riska (n)
Low (< 10%) Medium–high (≥ 10%)
40–54 2 males/2 females 2 males/2 females
55–64 2 males /2 females 2 males/2 females
65–74 2 males/2 females 2 males/2 females
a QRISK percentage 10-year risk used for stratification for consistency across both groups.
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score (in the JBS3 group) and practitioner advice, recommendations and interventions. During their
VSR interviews, practitioners were shown excerpts of video consultations with some of their patients
who had subsequently been selected for VSR interview. Semistructured VSR interviews followed
a pre-piloted process and topic guide, with variation depending on whether the patient/practitioner
was in the QRISK2 group or the JBS3 group. All VSR interviews were audio-recorded and transcribed
verbatim for analysis.
Patient medical record review
Data from the 12 weeks following the health check were extracted from patient medical records. Data
were processed by the principal investigator (CJG), with verification by a GP co-investigator (EC), to
identify any relevant recorded activity or prescriptions that occurred as a result of the health check.
Classifications were data driven, as detailed in Appendix 1, Tables 11 and 12. Where possible, these
were based on Read codes/terms, but also included uncoded additional text.
Patient and public involvement
Patient and public involvement activities informed study development and were used throughout.
There were three PPI strategies. First, we engaged with Patient Participation Groups (PPGs) by attending
meetings at three general practices on two occasions to gather opinion on the study concept and overall
design and, subsequently, the methods and protocols. This initial engagement had an impact through
validating the study as being important and the acceptability of video-recording methods, while making
important links for ongoing PPI. One PPG facilitated the completion of four mock health checks (with
the PN and four PPG members) to allow testing of protocols including camera placement, video-recording
quality, participant consent and debrief processes, development of the quantitative and qualitative coding
frameworks, post processing of the video for VSR excerpts and development of the VSR topic guide and
protocols. This had an important impact on all of our data collection processes, and the mock health check
data allowed development of coding processes. Second, two patient representatives sat on the Programme
Advisory Board, which was important to ensure that the patient voice was considered at the level of
project management, as well as at the operational and process levels. Third, a virtual study patient group
was established using a closed Facebook (Facebook, Inc., Menlo Park, CA, USA; www.facebook.com)
group. This novel approach had an impact throughout data collection by allowing engagement with a
large number of patients and members of the public (membership reached over 270), who provided
rapid feedback that further informed study processes (e.g. consent forms, participant information
sheets, camera placement) and how we responded to problems with recruitment.
Data processing and analysis
Qualitative and quantitative data were analysed to inform the quantitative process evaluation,
qualitative outcomes and case studies. The processes are summarised by data source.
Qualitative data: recorded health check consultations
Qualitative data were analysed using deductive thematic analysis,65 following the six-stage process
described by Braun and Clarke66 (Table 3). A coding template was developed around PMT.56 Use of
this framework (see Figure 2) was considered appropriate to investigate the use of the two CVD risk
assessment tools given the complexity of patient–practitioner interactions52,53 and the translation of
risk information into health-protective behaviour.54
Each transcript was uploaded to NVivo version 12 (QSR International, Warrington, UK) qualitative data
analysis software.67 This allowed the interpretation of how QRISK2 and JBS3 were used to communicate
risk in the context of PMT components (e.g. verbal persuasion, influencing patient prior beliefs and
priorities, and how patients respond, which will reflect the nature of their appraisal within the consultation).
METHODOLOGY
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Initially, 14 transcripts were inductively coded independently by Lisa Cowap and Victoria Riley. This was
to check the application of PMT to health check consultations and agree coding between the researchers.
Following inductive coding, 13 new codes were added to the framework (e.g. medical history, clarification
of results). The final version of the coding template, including examples for each code from health check
consultations, is provided in Appendices 3 and 4. The remaining 114 transcripts were individually coded
by Lisa Cowap and Victoria Riley; 2 out of every 20 transcripts were independently dual coded to check
their reliability using kappa coefficients for each node in the PMT framework. Reliability ranged from
0.48 to 0.71 over the five reliability checks conducted, indicating fair to good reliability.68 Data saturation
was considered to have been reached at the point of completion of coding.
Subsequent analysis of codes was led by Sophia Fedorowicz (qualitative researcher and doctoral student,
Staffordshire University) (supported by SG, CJG, NE and VR) to identify codes for key elements of the
PMT model, splitting health checks into two groups (QRISK2 and JBS3). Specific parts of transcripts that
illustrated the practitioner communicating CVD risk to the patient, and the patient responses, were
identified. These related to cognitive appraisal (threat appraisal and coping appraisal) and coping modes
(adaptive and maladaptive).
Qualitative data: semistructured video-stimulated recall interviews with patients and practitioners
Patient VSR interview transcripts were analysed using inductive thematic analysis, with codes and
themes generated from data based on individual reflections, perceptions and experiences. In the case
of patient VSR interviews, line-by-line coding and preliminary theme development were undertaken
by Lisa Cowap. Themes were discussed with Victoria Riley and Sarah Grogan, before reviewing and
agreeing final themes.
Practitioner VSR interviews were line-by-line coded by Naomi J Ellis and Sarah Grogan (see
Acknowledgements). Sian Calvert led theme development and was supported by Victoria Riley and
Christopher J Gidlow, who reviewed and agreed the final themes.
Quantitative: content of health check consultations (process evaluation)
Recorded health checks were viewed by two authors (LC and VR) and the content of the consultations
was characterised using a second-by-second coding framework developed specifically for this study.
TABLE 3 Process of thematic analysis (adapted from Braun and Clarke66)
Phase Summary
1. Familiarisation Analysis started with a period of familiarisation involving watching and re-watching the
video-recorded consultation (or listening to audio-records in the cases of interviews),
noting initial thoughts in the transcript
2. Initial coding For deductive analysis, codes from the PMT template were applied to the transcript
independently by two researchers (where possible); for inductive analysis, codes were generated
based on interesting features and recurrent patterns in the data. For both inductive and
deductive analysis, the researchers checked their own codes, before discussion to verify and
agree final codes
3. Searching for themes Agreed codes were collated into potential themes, gathering all data relevant to each
potential theme
4. Reviewing themes Constant comparison was used to check themes by revisiting data to ensure that they
were representative
5. Defining and naming
themes
Ongoing analysis was used to refine the specifics of each theme, and the overall story,
generating clear definitions and names for each theme
6. Reporting Illustrative extracts were selected to include in a narrative that tells the overall story
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The framework comprised 36 items grouped into six categories: patient–practitioner communication,
health check general (e.g. collecting and inputting data), risk dialogue (e.g. overall discussion of risk,
10-year risk reference, heart age, patient question on CVD risk), causal CVD risk factors (e.g. medical,
lifestyle), risk management (lifestyle intervention or medical intervention) (see Appendix 2). This allowed
derivation of aggregate indicators for each consultation to allow between-group comparisons of:
l length of health check
l time (absolute and proportion of consultation) discussing CVD risk, CVD risk factors (overall,
lifestyle, medical) and risk management (lifestyle, medical)
l practitioner–patient communication balance (proportion of health check time for which practitioners
and patients spoke, ratio of practitioner to patient speaking time)
l number and proportion of patients asking questions about CVD risk
l use of heart age, healthy years (event-free survival age) and risk score manipulation (as fidelity
check in the JBS3 group).
As noted in a previous paper,1 the coding process and framework development was iterative, using
four mock health checks that were video-recorded as part of PPI. To reach consistency in approach,
Naomi J Ellis and Lisa Cowap coded mock health checks by consensus. Victoria Riley then coded the
same four consultations independently and intraclass correlation coefficients (ICCs) demonstrated
excellent inter-rater reliability (ICCs from 0.968 to 0.995). Once data collection had started, health
checks were coded by authors Lisa Cowap and Victoria Riley, with verification of 10% (2 out of every
20 independently coded) to mitigate the risk of coder drift. ICCs ranged from 0.992 to 0.999,
indicating excellent inter-rater reliability.
Data on patient sex, age, ethnic background (classified as white British or ethnic minority) and lower-
layer super output area (which was used to derive deprivation decile)62 were also extracted from
patient medical records.
Following checks for normal distributions, QRISK2 and JBS3 groups were compared using key
variables. To take into account the nature of the sampling, which was in clusters, 95% confidence
intervals (CIs) were calculated; as usual, where the CIs of the two groups do not overlap then the
groups can be considered to differ significantly. Data processing and analysis were performed in SPSS
version 26 (IBM Corporation, Armonk, NY, USA).
Quantitative: patient medical record review (process evaluation)
Activities extracted from the patient medical records were classified as relating to further assessment of
CVD risk (or QRISK), weight, blood pressure, cholesterol level, diabetes, other tests (e.g. liver function
test, kidney function test, echocardiography), lifestyle, lifestyle referral and new diagnoses. Relevant
medications that were prescribed following the health check were grouped as statin/lipid lowering,
anticoagulants, cardiovascular or diabetes. The specific composition of each category is shown in
Appendix 1, Tables 11 and 12.
Between-group comparisons were explored, but were somewhat limited by the relatively small number
of patients with relevant recorded activity or prescriptions in their medical records.
Case studies
A subsample of 10 patients were selected for within-case analysis. Selection was on the basis of evidence
of positive patient intentions and/or behaviours to reduce their CVD risk following the health check, and
to provide coverage across general practices. The aim was to further explore apparent mechanisms by
which the risk calculators may lead to changes in patient or practitioner behaviour. A data extraction
template was created to bring together data from all sources (see Appendix 6, Table 13).
METHODOLOGY
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Quantitative data
l Patient medical records: age, sex, ethnicity, deprivation level of home neighbourhood and 10-year
CVD risk recorded in the health check, and relevant activities, diagnoses and prescriptions recorded
in the 12 weeks following the health check.
l Quantitative coding of health checks: total duration (in minutes), practitioner–patient communication
balance (ratio of practitioner to patient minutes), practitioner speaking (as percentage of total health
check), patient speaking (as percentage of total health check), no speaking (as percentage of total
health check) and total minutes discussing CVD risk.
l Non-verbal patient engagement: non-verbal communication during sections of the health checks in
which CVD was discussed, was assessed independently by two researchers. As detailed in Appendix 6,
a Likert scale was derived and piloted, informed by existing measures of non-verbal communication.
Results for each case study patient are presented in Appendix 7.
Qualitative data
Transcripts of recorded health checks and VSR interviews with the patients and the corresponding
practitioners were revisited, and excerpts were extracted to provide information on:
l the patient (e.g. current lifestyle, awareness and perceptions of NHSHC)
l the practitioner (e.g. role, experience, training)
l how the NHSHC was conducted
l the use, understanding and perceptions of QRISK2, heart age, event-free survival age and risk
score manipulation
l risk management (recommendations and subsequent intentions or action)
Christopher J Gidlow, Victoria Riley and Naomi J Ellis extracted all data and drafted case studies,
with support from a GP co-investigator, Elizabeth Cottrell.
Sample size
A priori determination of sample sizes for qualitative research is a point of contention.69,70 In the
present study, it was necessary to estimate requirements for the patient VSR interviews and use this
to inform the total number of recorded health checks required per practice. The target of 48 VSR
patient interviews (24 per group, four per practice) was chosen to allow patient sampling stratified
by sex, age and CVD risk (see Table 2), and to compare favourably with studies using VSR or audio-
recordings of primary care consultations (ranging from 9 to 44).63,64 These 48 recorded health checks
were to be selected (with stratification) from 144 (72 per group, 12 per practice) recorded health
checks that were subject to deductive qualitative analysis (i.e. 12 per practice was deemed sufficient
to allow stratified sampling of four patients per practice). To obtain the 144 recorded health checks
suitable for qualitative analysis, we aimed to record 240 health checks (120 per group, 20 per practice).
This oversampling aimed to serve two purposes. First, it would allow for exclusions owing to non-
attendance, technical issues and health checks that contained little or no discussion of CVD risk.
Second, a sample size calculation undertaken for the target between-group quantitative comparison
estimated that 120 consultations per group, six clusters (practices) per group with a two-tailed
probability and an alpha of 0.05, would provide statistical power of 0.8 to detect an effect size (r)
of 0.24 (small to medium effect). The overall number of eligible practices from which the clusters
were chosen was 625 (in the absence of a definitive estimate of how many West Midlands general
practices conducted health checks, the total number of general practices in the region was used).71
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Chapter 3 Results 1: quantitative analysis of
NHS Health Check consultations and medical
record reviews (process evaluation)
Parts of this chapter have been reproduced with permission from Gidlow et al.72 This is an OpenAccess article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: https://creativecommons.org/
licenses/by/4.0/. The text below includes minor additions and formatting changes to the original text.
General practice characteristics
General practices were recruited in matched pairs, based on the level of deprivation [Index of Multiple
Deprivation (IMD) deciles 1–5 vs. deciles 6–10],62 and randomly assigned to the QRISK2 group or the
JBS3 group (Table 4). Practices were located across eight CCG areas in the West Midlands. Variation in
practice size was not used for stratification. Many large modern practices are aggregations of smaller
practices, such that the total list size is large but the operation of individual surgeries within them
would be more aligned to ‘small’ practices. The proportion of ethnic minority patients averaged 13.5%,
but this figure ranged from 1.5% to 63.7%.
Half of the practices used point-of-care (PoC) testing to measure cholesterol levels during the health check
and half required patients to have blood tests in advance. Four practices (two in each group) routinely used
Informatica74 during health checks, an additional software embedded into the health check template that
has some JBS functionalities, such as heart age and risk manipulation. The two practices (2 and 12) that
were assigned to the QRISK2 group were asked to continue with their usual practice (i.e. QRISK2 plus
Informatica). For those assigned to JBS3 (practices 1 and 7), JBS3 was used instead.
As proxies for practice quality, data from the Quality and Outcomes Framework (QOF) were retrieved for
overall QOF achievement and patients reporting positive experiences. These showed some variation, with
three practices scoring markedly lower on patient experience (practices 4, 6 and 11; two JBS3, one QRISK2).
There was marked variation in the success of patient recruitment. Each practice was asked to continue with
recruitment until 20 useable recorded health checks had been completed. This was achieved in only four
practices, but each practice exhausted its list of eligible patients. When recruitment was more successful,
there was some over-recruitment of patients to boost the overall sample size. The varied success of
recruitment across practices created an imbalance of patients across the QRISK2 and the JBS3 groups.
There was a trend towards practices in the most deprived 50% of areas (based on the IMD), on
average, recruiting fewer patients and allocating shorter appointment slots to health checks than
those in the least deprived 50% of areas (mean recruitment 11.0 ± 9.6 vs. 17.8 ± 5.1 patients; mean
appointment allocation 23.3.0 ± 6.1 vs. 29.2 ± 2.0 minutes). This vindicated sampling of practices
stratified by level of deprivation.
Practitioner characteristics
Practitioners (n = 15) all worked within primary care (nine HCAs, six PNs; Table 5) and all were female.
Thirteen were classified as white British and two were of Asian British ethnic background. On average,
the practitioners had been delivering health checks for 4.7 ± 2.4 years, ranging from 9 months to 9 years.
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1 JBS3f 6 13,000 1 HCA, 1 PN PoC 30 98.4 96.2 2.0 12
2 QRISK®2+f 6 9000 1 HCA PoC 25 98.4 90.2 1.9 22
3 QRISK2 1 4000 1 HCA Prior 20 78.1 88.9 31.6 14
4 JBS3 4 45,000 1 HCA PoC 20 98.5 67.4 6.4 29
5 JBS3 2 5000 1PN Prior 30 99.6 75.9 3.9 7
6 QRISK2 9 4000 2 PN Prior 30 98.6 74.8 2.5 17
7 JBS3f 10 8000 1 HCA PoC 30 99.6 95.0 2.4 20
8 JBS3 6 4000 1 HCA, 1 PN Prior 30 98.7 95.5 2.5 24
9 QRISK2 4 7000 1 HCA PoC 30 82.4 95.3 16.5 5
10 QRISK2 2 3000 1 PN Prior 15 100.0 85.8 26.6 3
11 JBS3 2 5000 1 HCA Prior 25 99.4 49.9 63.7 8
12 QRISK2+f 6 8000 1 PN PoC 30 100.0 83.0 1.5 12
ID, identifier; PoC, point-of-care testing; prior, patients required to have blood tests in advance of health check; QOF, Quality and Outcomes Framework.
a IMD 2015 was used for practice stratification.62
b QOF achievement: overall as a percentage of maximum 559 (2018/19).
c Percentage of patients reporting a positive experience (2019).
d Proportion of registered patients classified as ethnic minority (from ‘Ethnicity Estimates’).
e Patients per practice who participated in the RICO study and included in analysis (total, n = 173).
f Used Informatica (denoted as QRISK2 +).






































































Where training in health checks was reported (n = 9), it tended to be focused on general delivery and
health check processes. Six practitioners had received no training.
Patient characteristics
A total of 175 video-recorded health checks were completed, of which 173 were included in
the analysis (QRISK, n = 73; JBS3, n = 100). Two were excluded because practitioner process error
invalidated the consultation. The sample comprised approximately equivalent proportions of males
and females (Table 6). The proportion of patients who were white British or from ethnic minorities
was approximately representative of the general practice populations from which they were drawn
(see Table 4). There was a spread of deprivation levels in both study groups, with a trend towards
more participants from the JBS3 group residing in more deprived areas (but with a relatively small
effect size; see Table 6). The average age was higher in the JBS3 group (mean 60.87 years, 95% CI
58.91 to 62.83 years) than in the QRISK2 group (mean 54.70 years, 95% CI 51.66 to 57.70 years),
while 10-year CVD risk was slightly higher in the JBS3 group (mean 9.71, 95% CI 7.85 to 11.57) than
in the QRISK2 group (mean 8.69, 95% CI 5.56 to 11.81).











1 JBS3 1.1 PN Female WBRI 9 years No formal training 7
1.2 HCA Female WBR 6 years Generic training, PoC
training
5
2 QRISK2 2.1 HCA Female WBRI 2.5 years Generic training 22
3 QRISK2 3.1 HCA Female WBRI 2.5 years No formal training
(at time of study)
14
4 JBS3 4.1 HCA Female EM 2 years No formal training 29
5 JBS3 5.1 PN Female WBRI 8 years Generic training × 2 7
6 QRISK2 6.1 PN Female WBRI 2 years No formal training 6
6.2 PN Female WBRI 6 years Generic training, lifestyle
advice and referrals
11




8 JBS3 8.1 HCA Female WBRI 5 years Generic training 11
8.2 PN Female WBRI 9 months No formal training 13
9 QRISK2 9.1 HCA Female WBRI 6 years Generic training (could
not recall details)
5
10 QRISK2 10.1 PN Female WBRI 3 years No formal training 3
11 JBS3 11.1 HCA Female EM 8 years Generic training × 2
(8 and 1 years earlier)
8
12 QRISK2 12.1 PN Female WBRI 4 years Generic training
(4 years earlier)
12
EM, ethnic minority; PoC training, trained to use the PoC testing machine; WBRI, white British.
Reproduced with permission from Gidlow et al.75 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.
org/licenses/by/4.0/. The table includes minor additions and formatting changes to the original table.
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Headline findings from the process evaluation
l Health check duration varied greatly, but most lasted < 20 minutes.
l Health checks were often verbally dominated by practitioners.
l There was little discussion of CVD risk overall (< 2 minutes per health check, on average).
l Compared with health checks using QRISK2, in those using JBS3:
¢ there was more discussion of CVD risk
¢ consultations were less verbally dominated by practitioners
¢ more patients asked questions about CVD risk.





n % n % n % ra
Age (years)
40–54 60 34.68 24 24.00 36 49.32 0.32
55–64 54 31.21 30 30.00 24 32.88
65–74 59 34.10 46 46.00 13 17.81
Total 173 100 73
Sex
Male 86 49.71 49 49.00 37 50.68 0.05
Female 87 50.29 51 51.00 36 49.32
Total 173 100 73
Ethnicity
White British 144 83.24 81 81.00 63 86.30 0.07
Ethnic minority 29 16.76 19 19.00 10 13.70
Total 173 100 73
Deprivation quintileb
1 32 18.50 16 16.00 16 21.92 0.13
2 33 19.08 16 16.00 17 23.29
3 37 21.39 22 22.00 15 20.55
4 34 19.65 22 22.00 12 16.44
5 37 21.39 24 24.00 13 17.81
Total 173 100 73
CVD risk categoryc
Low 104 60.12 57 57.00 47 64.38 0.06
Medium–high 67 38.73 41 41.00 26 35.62
Total 171 98 73
a Effect size (r) in which 0.1 is small, 0.3 is medium and 0.5 is large.
b Deprivation quintile, based on the IMD 2015,62 where 1 is the most deprived.
c CVD risk categories: low is < 10%, medium–high is ≥ 10%.
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l At 12 weeks post health check, relevant follow-up activity was recorded for fewer than one-third of
patients, < 9% had received prescriptions as a result and there were 10 new diagnoses. There were
no corresponding statistical differences between the QRISK2 group and the JBS3 group.
Quantitatively coded health checks
Length of NHS Health Check consultations
Table 7 summarises the characteristics of health check consultations by study group and overall.
Consultation duration varied widely (range 6.8 to > 38 minutes), but the majority of consultations
lasted between 15 and 20 minutes, with most consultations (60%) lasting < 20 minutes (Figure 3).
Consultations were only slightly shorter, on average, in the QRISK2 group than in the JBS3 group
(with a relatively small effect size of 0.13).
Discussion of cardiovascular disease risk
Overall, < 10% (9.1% ± 4.3%) of consultation time was devoted to CVD risk discussion, which equated to
1.7 ± 0.83 minutes. A higher proportion of consultation time was spent discussing CVD risk when using
JBS3 (equivalent to 2.1 ± 0.82 minutes) than when using QRISK2 (equivalent to 1.31 ± 0.63 minutes),
with a medium effect size. Nearly all health checks in both groups included reference to the 10-year
percentage CVD risk score (94% vs. 94.5%; r = 0.01). The proportion of patients asking questions about
CVD risk was higher in the JBS3 group than in the QRISK2 group (32.0% vs. 12.3%; r = 0.23).
In the JBS3 group, nearly all health checks included discussion of heart age (100%) and event-free
survival age (97%), and manipulation of the risk score(s) to show the potential effect of intervention on
risk (92%). This showed fidelity to the requested minimum use of JBS3 outputs. Use of heart age and
risk manipulation was also evident in 52.1% and 21.9% of QRISK2 consultations, respectively. This is a
result of two general practices in the QRISK2 group using Informatica (a software addition that offers
some JBS3 functionalities), and because heart age and risk manipulation are possible (but not main
features) in QRISK2.
Discussion of cardiovascular disease risk factors and risk management
Over one-third of total health check time was spent discussing causal CVD risk factors. This was
slightly higher in health checks using QRISK2 than in those using JBS3 (small to medium effect size),
but with wide variation within groups (see Table 7).
Interventions to manage risk were discussed for approximately one-fifth of total consultation time and
predominantly related to lifestyle rather than medical intervention, which was not discussed at all in
over 30% of QRISK2-informed and 42% of JBS3-informed health checks (r = –0.12).
Verbal dominance
Practitioners spoke for just over half of the total time in QRISK2 consultations and just under half in
JBS3 consultations (compared with ≈ 23% for patients) (Figure 4). There was an indication of higher
practitioner verbal dominance in health checks using QRISK2 than in those using JBS3 (r = 0.27).
Patient medical records: activity and prescriptions 12 weeks post health check
Fewer than one-third of all patients had resulting activity (30.1%) and 8.7% had prescriptions logged in
their medical records in the 12 weeks following their health check. Figures 5 and 6 show the between-
group comparisons. Chi-squared tests confirmed that there were no statistical differences between risk
calculator groups (all had p-values > 0.05).
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(QRISK2 vs. JBS3)JBS3 QRISK2
Mean (95% CI) SD Mean (95% CI) SD Mean (95% CI) SD r
Duration (minutes) 20.06 (18.87 to 21.24) 6.21 20.66 (18.89 to 22.42) 5.65 19.24 (15.28 to 23.19) 6.84 0.13
Verbal dominance
Percentage of total time
practitioner speaking
50.07 (45.90 to 54.24) 9.55 46.60 (41.36 to 51.84) 8.79 54.82 (50.00 to 59.64) 8.48 0.42
Percentage of total time
patient speaking
23.37 (19.87 to 26.87) 10.62 24.67 (20.47 to 28.87) 10.53 21.6 (15.71 to 27.43) 10.56 0.15
Verbal dominance ratiob 2.70 (2.23 to 3.19) 1.50 2.35 (1.89 to 2.81) 1.31 3.21 (2.44 to 3.97) 1.62 0.27
Percentage of total health check time
Discussing CVD risk 9.06 (7.36 to 10.76) 4.30 10.24 (8.01 to 12.48) 4.07 7.44 (5.29 to 9.58) 4.08 –0.32
Discussing risk factors
Total 37.54 (32.92 to 42.17) 12.96 35.33 (27.76 to 42.90) 13.29 40.58 (36.20 to 44.96) 11.91 0.22
Medicalc 21.34 (18.35 to 24.33) 9.41 20.13 (15.33 to 24.94) 9.38 22.98 (19.96 to 26.31) 9.26 0.16
Lifestyled 16.11 (13.79 to 18.44) 7.03 15.08 (11.87 to 18.30) 6.49 17.52 (14.16 to 20.88) 7.53 0.16
Discussing risk management
Total 19.64 (16.48 to 22.81) 11.37 18.82 (13.92 to 23.73) 11.12 20.77 (16.59 to 24.94) 11.69 0.08
Lifestyle 16.59 (13.44 to 19.74) 10.2 15.94 (11.27 to 20.62) 10.04 17.48 (12.95 to 22.01) 10.41 0.08
Medicale 63% 58% 69.9% –0.12
a Effect size (r), where 0.1 is small, 0.3 is medium and 0.5 is large.
b Ratio of practitioner to patient talking (where higher value indicates greater practitioner verbal dominance).
c Includes medical history, family history, weight, blood pressure, cholesterol, diabetes, and mental health and well-being.
d Includes diet, alcohol, physical activity and smoking.
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FIGURE 4 Mean percentage of total health check time with speaking by practitioner or patient. Error bars: 95% CI.
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The most common follow-up activities were related to blood pressure measurement or discussion (20.2%),
followed by lifestyle discussion (9.8%), CVD risk assessment or discussion (9.2%) and cholesterol measurement
or discussion (8.7%). Among the 173 patients, there were 10 new diagnoses (three pre-diabetes, three
diabetes, two hypertension and two hyperlipidaemia).
Just 5% of all patients received prescriptions for lipid-lowering or cardiovascular medication, with 1%
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FIGURE 5 Proportion of patients in each risk calculator group with relevant activity within 12 weeks of their health































FIGURE 6 Proportion of patients in each risk calculator group with relevant prescriptions within 12 weeks of their
health check. Data from all patients (n = 173).
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Figures 7 and 8 show that, as expected, the proportion of patients in whom relevant follow-up activity
or prescriptions were recorded was higher among those at medium risk (with a QRISK2 score of
10–19.9%) or high risk of CVD (with a QRISK2 score of ≥ 20%) than among those at low risk (with a
QRISK2 score of < 10%). Despite the relatively small numbers, differences between low- and medium-/
high-risk groups reached significance for any medication (Fisher’s exact test, p = 0.028) and statin/lipid-
lowering medication (Fisher’s exact test, p = 0.006), and for a number of relevant follow-up activities
(Fisher’s exact tests: any activity, p = 0.004; weight related, p = 0.029; blood pressure related,
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FIGURE 7 Proportion of patients at low or medium/high risk of CVD with relevant activity within 12 weeks of their
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FIGURE 8 Proportion of patients at low or medium/high risk of CVD with relevant prescriptions within 12 weeks of their
health check. Data from 171 patients (CVD risk missing for two patients in JBS3 group).
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Summary
Second-by-second quantitative coding of 173 video-recorded health checks (JBS3, n = 100; QRISK2,
n = 73) and a review of patient medical records 12 weeks after their health check revealed a number
of key findings.
1. Health check duration varied greatly (6.8–38.0 minutes), with most consultations lasting < 20 minutes.
During this time, practitioners are expected to complete a range of clinical and administrative tasks,
such as CVD risk assessment, involving measurement of (and data entry for) weight, blood pressure
and, sometimes, cholesterol level through PoC testing; assessment of lifestyle (physical activity,
alcohol, diet); explaining to patients their CVD risk score(s) and what it means; and patient-centred
discussion of risk management to prompt risk-reducing behaviours.
2. There was evidence of practitioner verbal dominance because, on average, practitioners spoke for
half of the total consultation time. This suggests more information provision than patient-centred,
two-way interaction (see Chapter 4).
3. On average, CVD risk was discussed for < 2 minutes (9.1% ± 4.3% of the consultation time).
Discussion of causal risk factors accounted for the largest proportion of total health check time.
4. There were indications that, compared with health checks using QRISK2, those using JBS3 involved
more CVD risk discussion and were less verbally dominated by practitioners.
5. One in three patients (32%) in JBS3 consultations asked questions about their CVD risk, compared
with one in eight patients (12%) in QRISK2 consultations, suggesting that there is better engagement
with JBS3 than with QRISK2.
6. Fewer than one-third of all patients (30.1%) had relevant activity logged in their medical records
in the 12 weeks following their health check, and just 8.7% received prescriptions as a result.
Among the 173 patients, there were 10 new diagnoses. There was a trend for follow-up activities
and prescriptions to be more frequent in patients at medium/high risk of CVD than among those
at low risk, and for the number of prescriptions issued to be higher following health checks using
QRISK2 than those using JBS3.
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Chapter 4 Results 2: qualitative analysis
of NHS Health Check consultations
Parts of this chapter have been reproduced with permission from Riley et al.76 This is an OpenAccess article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: https://creativecommons.org/
licenses/by/4.0/. The text below includes minor additions and formatting changes to the original text.
Headline findings from deductive thematic analysis of recorded health checks
l There was little discussion of CVD risk, particularly in health checks using QRISK2.
l Practitioners often relayed the risk score without discussing the implications or risk management.
l Patients offered minimal responses to the risk information (e.g. single-word acknowledgement).
l Practitioners frequently missed cues from patients who were unclear about their risk score.
l For QRISK2, it was unclear whether or not the patient understood 10-year percentage risk, or
trusted its credibility or relevance.
l JBS3’s visual presentations of risk and heart age appeared more impactful and better understood
(than 10-year risk in QRISK2).
l JBS3’s event-free survival age lifetime risk was often misunderstood (patients and practitioners).
l JBS3 may provide more opportunities to initiate risk factor and management discussion
than QRISK2.
l Positive responses were more evident when practitioners checked patient understanding, made risk
meaningful to the patient, and asked for patient feedback around the CVD risk score.
Participant characteristics
To define the sample for the qualitative analysis, a further 19 of the 173 recorded health checks
(included in the quantitative analysis) were excluded for reasons including communication of projected
(not actual) risk score (n = 7), no discussion of risk (n = 2), no communication of lifetime risk (n = 4),
incorrect use of JBS3 (n = 4) and insufficient use of the English language (n = 2). Of the remaining
sample (n = 154), 64 health checks included communication of CVD risk using QRISK2. Therefore,
64 health checks using JBS3 were identified, matched on patients’ sex, CVD risk score and ethnicity,
giving a sample of 128 for analysis (Table 8).
The results of deductive thematic analysis demonstrate how practitioners communicated risk using
either QRISK2 or JBS3, and patient responses, to explore similarities and differences between the
two calculators. The analysis, therefore, focused on parts of the health checks in which CVD risk
was discussed. As noted in Chapter 3, this accounted for < 10% of consultation time, on average,
and most patients said little in response to CVD risk information. Therefore, where there was evidence
of two-way dialogue around CVD risk, we present quotations that best illustrate risk communication
and subsequent patient response. Each quotation is labelled to denote which risk calculator was used
(using QRISK®2+ where Informatica was used), the consultation identifier, patient sex and age. Where
dialogue is reported, ‘P’ denotes the patient’s contribution and ‘HP’ denotes the health professional’s
contribution (i.e. the practitioner).
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Theme 1: cognitive appraisal
Threat appraisal
Threat appraisal focuses on the source of a threat (CVD risk) and factors that increase or decrease
the probability of maladaptive responses (i.e. behaviours that inhibit patients’ ability to adjust to the
threat). This theme is central to the health check. It focuses on the discussion of risk as it relates
to patients’ perceived severity of CVD risk, the consequences of CVD, the perceived vulnerability
to future CVD, and the intrinsic and extrinsic rewards for not addressing CVD risk [i.e. perceived
benefits of not acting to manage or reduce risk (maladaptive response)]. Threat appraisal was the
most commonly identified element of the PMT model. It was observed in all health checks, although
less frequently in those using JBS3 (coded 584 times; average 9 times per consultation) than those
using QRISK2 (coded 634 times; average 10 times per consultation).
Patients, when presented with their 10-year risk, generally acknowledged it, but the extent of their
understanding was often unclear. For example, one asked ‘Is that percentage of risk alright?’. Most
often, the risk score was acknowledged with a single-word response, such as ‘yeah’ or ‘OK’, limiting
practitioners’ ability to gauge the patient’s understanding and classification of response for this
analysis. Heart age in JBS3 aided patient understanding of CVD risk, resulting in questions such
as ‘. . . so really what can I do about that? I mean I know it is all estimated’. Such questions reflected
a level of understanding of the score and intention towards risk-reducing behaviour. Several patients
expressed surprise at their risk. The patient in the extract below appeared to question how the score
was calculated because he perceived himself to be healthier than the outcome suggested, leading to
some mistrust. They also made two references to being ‘fitter’ than the risk score indicated, which was
not addressed by the practitioner:
P: I thought I was fitter than that though.





n % n % n %
Total 128 64 64
Sex
Female 64 50.00 32 50.00 32 50.00
Male 64 50.00 32 50.00 32 50.00
Age (years)
40–54 55 42.97 21 32.81 34 53.13
55–64 37 28.91 20 31.25 17 26.56
65–74 36 28.13 23 35.94 13 20.31
Ethnicity
White British 114 89.06 56 87.50 58 90.63
Ethnic minority 14 10.94 8 12.50 6 9.38
CVD risk categorya
Low 86 67.19 43 67.19 43 67.19
Medium–high 42 32.81 21 32.81 21 32.81
a CVD risk categories: low % is < 10%, medium–high % is ≥ 10%.
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HP: [Laughter] You are doing good exercises.
P: But I was fitter than that though . . .
HP: OK, so the health years, so on average expect to survive is 80 for yourself without a heart attack or a
stroke, yeah? And then your risk of a heart attack or stroke in the next 10 years is 15%, so you do need
to look after yourself, because we would say that is a medium risk.
P: Yes.
HP: So wouldn’t say it is too high or low, but a medium to high.
P: OK.
HP: OK, and then that’s what it looks like so from now until there, that’s the last one the chance of
surviving without a heart attack.
P: That’s estimated?
HP: This is estimated, we don’t know what’s going to happen you might be even longer.
P: So about 94 I might snuff it?
JBS3, 11_028, male, 58
Because the practitioner appeared to ignore the patient’s surprise, continuing to focus on the
process of the health check, the patient switched off briefly, until presented with his event-free
survival age. Moreover, there was evidence of misunderstanding among some patients and practitioners
who interpreted event-free survival age as estimated age of survival (i.e. age of death).
Practitioners provided little follow-up explanation of risk scores when using QRISK2 or JBS3:
HP: Right, this is the screening I was telling you about. I will just print that out for you. So your risk of
any heart disease is 15%.
P: Yeah, which is not very high.
HP: It does increase with age. If it is above 10% we then pass it on for them to have a look at it and
they will be able to decide when to have your next health check, which should be 3 years or 1 year.
Obviously next time you come in any results you’ve got in the red tend to up your risk and they tend to
up your heart age as well. So when you come in next time if your blood pressure is back down, and
obviously it could be less so . . . Your heart age has come up as 66.
P: Well I am 66 this year.
HP: Yes, yes, so it is quite near isn’t it? Yes. So, for example, if you were a smoker and that was in the red
that would put your heart age at 75. So the only one we have got in the red really is that one cholesterol . . .
P: It’s only marginal though isn’t it?
QRISK2+, 2_016, male, 65
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The patient quoted above was identified as medium–high risk, but the practitioner did not elaborate
on the severity or implications, leaving the patient’s interpretation of his risk score as ‘not very high’.
This was compounded when the patient received his heart age. The practitioner did not address the
patient’s misinterpretation of the severity of his risk nor explain why his results were conflicting
(i.e. percentage risk score is age and sex dependent, heart age is not), again perhaps focusing on the
consultation process more than the patient. This led the patient to dismiss his elevated cholesterol
as ‘only marginal’. The absence of active listening skills was recurrent across both groups, making it
difficult to gauge patient understanding, and lends support to the apparent imbalance between patient
and practitioner contributions (see Chapter 3).
There was evidence, albeit still limited, that patient engagement in conversations about the threat of
CVD was greater in the JBS3 group, prompted by risk score manipulation (e.g. practitioners visually
showed patients that a reduction in blood pressure could lower their heart age):
HP: . . . so obviously your blood pressure is not too bad, that is fine where it is at 128, but your
cholesterol, so ideally we like that to be below 5. So if you could get it below 5, so let’s put it down to
4.8, you can see that automatically that it brings your risk down to 1.8%.
P: Oh, I see, yes.
HP: . . . improves your life expectancy slightly, and probably brings your heart age down a year. So it
is just, you know, showing that it can and, obviously, the lower you can keep these factors that you
influence, for longer, the better quality of life and life expectancy there is . . . your risk is going to
increase slightly with age. So it is about trying to moderate those other factors.
P: So what impact does exercise have on that?
HP: It has quite a significant impact on your cholesterol, it does help your cholesterol a lot. We know that
it helps because that increases your good cholesterol, which can help increase the balance so, that can
help with it as well.
P: So what’s the normal range that is seen for HDL cholesterol?
HP: HDL can be anything from sort of 1.1 to about 2.5, you don’t get much over, I can’t say I have seen
many, I have seen a few. But your cholesterol could be anything down to you know 3.5.
P: OK and really bad would be?
HP: 6 or 7s, so would be sort of . . .
P: Oh, OK – so 5.6 is yeah it is edging up, isn’t it?
JBS3, 7_020, male, 45
The patient evaluated the threat and sought information to facilitate their appraisal. Although positive,
this exchange again demonstrated misunderstanding of CVD event-free survival age as expected
survival age, this time on the part of the practitioner. The visual impact of demonstrating how CVD
risk can be reduced through risk factor modification (e.g. cholesterol, smoking status) appeared to aid
patient understanding and realistic threat appraisal. There were fewer examples of active engagement
during discussion of the CVD risk score during QRISK2 consultations, which may be because of the
inability to show risk factor modification when using the calculator.
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Coping appraisal
Coping appraisal focuses on the coping responses available to the individual to deal with a health
threat (i.e. evaluation of ways to reduce CVD risk). This included patients’ perceptions of self-efficacy
to engage in adaptive coping, practitioners’ promotion of self-efficacy through individualisation, the
perceived response efficacy of adaptive coping and the response cost of adaptive coping (see Figure 2).
References to coping appraisal were more common in JBS3 (n = 60, 94%) than QRISK2 health checks
(n = 55, 86%). The communication of risk in JBS3 consultations was not observed in the same way
as in those using QRISK2; most such consultations focused on facilitators of adaptive coping
(i.e. risk-reducing changes that patients could make):
HP: Erm and then this gives you your healthy years outlook [event-free survival age]. So based on your
current lifestyle your risk of a heart attack or a stroke in the next 10 years is coming out at 2.4%.
We aim for people’s risk to be below 10% so that’s . . .
P: Yeah.
HP: . . . absolutely fine and on average you expected to survive to an age of 84 without a heart attack or
stroke, so brilliant. So as I say, your blood pressure pretty good as it is, you not going get that much lower.
P: No.
HP: Diet-wise would you say you got a pretty good diet do you know the sorts of . . .
P: We sort of grow our own vegetables and fruit and stuff like that . . .
HP: Yeah.
P: . . . so, erm, I mean we eat reasonably healthy.
JBS3, 7_044, female, 54
Following communication of the risk score, the practitioner moved on to ways that the patient could
maintain a low risk through dietary behaviours. This suggested that, although practitioners (from both
groups) spent little time talking about the CVD risk score, the additional risk information in JBS3
may have helped to facilitate more risk factor discussion between the patient and the practitioner
(than if using QRISK2).
Discussions around response costs for adaptive coping (i.e. perceived costs associated with a
recommended behaviour) related to the use of statins or blood pressure medication, and were only
observed in seven JBS3 consultations (11%) and none of the QRISK2 consultations. Data are limited,
but may offer some evidence to suggest that JBS3 was more likely than QRISK2 to promote discussion
around adaptive coping:
HP: Obviously we’ve tried them, and they haven’t agreed with you.
P: I tried the [medication name] statin.
HP: Yeah, and there are other statins we can discuss and obviously benefits of those they can reduce
your cholesterol obviously and we can reduce your risk of cardiovascular disease so it might be worth
having a think about and if you want to just discuss that further or a different type of statin . . .
P: All they did was it affected my reflux and it made the reflux worse.
HP: Yeah.
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P: I was on that and an aspirin – I did the aspirin first and then . . .
HP: Yeah, but it was affecting you. I mean it might be worth a having another . . . err you know a think
about whether you wanted to erm take that, because obviously it would lower your cholesterol, obviously
add to a healthier heart erm and reduce that risk of cardiovascular disease, but then obviously we’ll not
gonna push that onto you, err it is something you can talk to myself, one of the doctor’s once you have
had time to think erm and they can advise or [name] the prescribing nurse, because they can prescribe,
you know talk about you know what’s best, which statin would be best, and not all statins agree with
everybody but there might be one out there that actually has a better erm compatibility with yourself OK?
P: Yeah.
HP: How do you feel about what I have told you today?
P: I would consider it.
JBS3, 8_177, male, 71
Here, the patient’s prior engagement with statins as a response cost was discussed, leading to a
re-evaluation of the medical intervention by the patient. However, rather than addressing the patient’s
concern regarding their previous experience of statins, the practitioner appeared to interrupt them
to repeat the benefits of statins. There were examples where the perceived cost of taking statins
provided motivation to adopt risk-reducing lifestyle behaviours:
HP: But well done!
P: I am pleased about that, yes.
HP: That’s really good, no I am very pleased with you because that’s really good. And where you were at
10% just before, it is now 5%, so you have halved the risk in that time. So that’s really good. So it shows
it can be done.
P: Yeah, yeah, and that’s what I would rather do than taking tablets.
HP: Of course.
P: I would rather think, no I know what’s wrong, I will deal with it in time.
QRISK2+, 12_055, female, 64
However, opportunities to discuss facilitators of adaptive coping were sometimes missed by
practitioners who communicated risk using QRISK2:
HP: I look at your [total : HDL cholesterol] ratio and your ratio is good. But just to keep a little eye on it,
maybe they will test it again in a year’s time. You probably won’t be due this Health Check, because your
risk is only 3%, which is low. It will increase as you age, so your Health Check wouldn’t be due again for
5 years, but you could probably have your cholesterol done in about a year, with you know normal bloods
taken out of your arm. Erm your heart age, because you got such results in the green, your heart age has
come up less than your actual age, but that’s with the 2 years added on from being an ex-smoker.
P: So is it possible that I could get that even lower? If my cholesterol came down a lot.
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HP: Well we will have a look now, I will play about with it. So if you had never smoked at all, your heart
age would be 45. If you were still smoking, it could be 51. So being an ex-smoker tends to add 2 years,
so with your cholesterol, it could be brought down to 46.
P: Massively, yeah.
QRISK2+, 2_077, male, 48
The patient above attempted to understand how their risk could be reduced. The practitioner did not
engage with this to encourage the risk-reducing behaviour or discuss ways to reduce cholesterol.
Rather, they proceeded to talk about the impact of previous smoking status (which is unmodifiable)
on CVD risk. Although references to coping appraisal were more common in JBS3 consultations,
practitioners in both groups appeared to focus on the consultation process more than the patient.
Theme 2: coping modes
Maladaptive coping
Maladaptive coping is classified as the patient negatively engaging in risk management discussion and
being dismissive of suggestions (e.g. the patient believes that they have a sufficiently healthy lifestyle
and dismisses discussion about change). As noted, patient responses to risk information were often
limited to a single word.Where context allowed, apparent lack of engagement and minimal verbal responses
from patients were also interpreted as a maladaptive coping response if the risk information communicated
by the practitioner did not provoke a response by the patient. Risk management interventions were classified
as medical [appointment referral, medication (e.g. blood pressure or cholesterol lowering), re-testing and
managing blood pressure or retesting cholesterol] or lifestyle (weight reduction and management,
increasing physical activity, diet modification, smoking cessation and reducing alcohol consumption).
Maladaptive coping was identified in 49 (77%) QRISK2 consultations (coded 139 times; average 2.8 times
per consultation), compared with 40 (62.5%) JBS3 consultations (coded 110 times; average 2.8 times per
consultation). The practitioner in the exchange below briefly communicates QRISK2 before moving on to
heart age (using Informatica):
HP: Yeah this is the screening I was telling you about. So, your risk is 9%.
P: Right.
HP: Which is your key risk for you over the heart disease and diabetes and stroke risk.
P: And heart disease.
HP: As you, as you age your risk does seem to increase, erm any results that you’ve got in the red tend to
push up your heart age slightly.
P: Aha.
HP: So if we can get the results out of the red and back into the green, that can reduce that one down.
P: Right, OK.
HP: So, for example, being an ex-smoker actually puts 2 years onto your heart age there.
P: Yeah.
HP: So would be its 66 and it would be 66 if you never smoked at all.
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P: Right.
HP: Erm, if you were still smoking it would be 73.
P: Oh my gosh!
HP: Your heart age has come up as 71 – you are 66. Any results you have got in the red do tend to
increase your heart age. It is just that one cholesterol one that was in the red.
QRISK2+, 2_001, female, 66
Sometimes, maladaptive responses to the 10-year percentage risk score could be shifted towards a more
positive response through communication of heart age. The brief exchange prior to the communication of
heart age (above) may have also suggested that the practitioner was less confident discussing QRISK2,
a recurrent observation (see Chapter 6). If practitioners cannot clearly explain the meaning of a patient’s
percentage risk score to confer understanding, subsequent discussion/actions regarding risk management
may be undermined, and the link between CVD risk and lifestyle may be unclear.
Minimal engagement following communication of the risk score was also identified in JBS3
consultations:
HP: OK. And your blood pressure being under 82 but that’s fine everything is OK with that. Now, on
average what they’re saying is that your risk of a heart attack or stroke in the next 10 years is 15%,




HP: And to expect to survive till the age of 78 without a heart attack or a stroke OK. And if we have a
look at the next, this one, just reiterates its this, but if I changed it to . . . say if you didn’t smoke OK and
we went to the next your heart age would then become equal with your age.
P: Hm hm.
HP: And your risks in . . . of a heart attack or stroke in the next 10 years comes down to 9.6% and your
actual survival to the age of 83 without a heart attack or a stroke OK and that reiterates it in that
as well.
P: Hm hm.
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HP: So it gives you food for thought.
P: Hmm hmm. You haven’t told me anything I didn’t already know.
JBS3, 1_181, male, 65
The patient’s dismissal of discussion around smoking cessation may reflect the influence of environmental
and social factors on their smoking behaviour (and related intentions), preventing a meaningful exchange.
The practitioner did not encourage the patient to quit smoking or explore previous experience of attempted
smoking cessation and, therefore, was unlikely to promote intentions to change behaviour. There is an
added pressure of time during health check consultations. Appointment times allocated to health checks
ranged from 15 to 30 minutes (see Table 4), during which time practitioners need to assess CVD risk,
communicate the risk score(s) and discuss risk management. Adherence to the process of completing
the health check may result in patients being passive recipients of information. As shown above (and
throughout), the practitioner delivered the information presented on the screen without asking questions
to check understanding or provide context. This prompted little response from the patient, which may be
indicative of deference to the practitioner’s health knowledge, which would indicate a power imbalance.
Negative engagement in discussion of risk factor management was also evident following the
suggestion of statin use:
HP: What we do tend to say if you risk is above 10%, obviously I don’t know whether the doctors have
ever discussed a statin with you?
P: I don’t see the point, I mean if I am going to live to 83, I am quite happy to live to 83.
HP: So it’s just about being aware that we know that taking a statin can help reduce your overall risk,
so it’s one that sort of we usually advise that . . .
P: If we do this next time and I don’t know, it was ’04 [last cholesterol check], and we are now in 2018,
so what does that mean, it could be another 12 to 14 years [for the next health check]?
HP: Well I do normally try and do these every 5 years, so yeah.
P: So yes, if it is hugely worse.
HP: Yeah.
P: . . . in 5 years, I will consider it.
JBS3, 7_012, male, 70
Again, the patient misinterpreted event-free survival age and suggested that their risk was not severe
enough to consider medical intervention in the short term, only if it was ‘hugely worse’ at the next
health check. This was another example of a missed opportunity for the practitioner to question
the patient’s understanding of their risk and potential false reassurance provided by the 10-year
percentage risk score (which was 15%).
Adaptive coping
Adaptive coping focused on the patient’s positive engagement with discussion of interventions to
manage CVD risk, apparently listening and engaging in the consultation and accepting what is being
said/suggested. Adaptive coping was identified in 58 QRISK2 (91%) consultations (coded 310 times;
average 5 times per consultation) and 55 JBS3 (86%) consultations (coded 328 times; average 6 times
per consultation). The frequency of occurrences overall and per consultation was similar between the
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two groups for adaptive coping in medical interventions [39 QRISK2 (61%) consultations and coded
116 times (average 2.9 per consultation); 42 JBS3 (66%) consultations and coded 142 times (average
3.4 per consultation)] and lifestyle change [11 QRISK2 (17%) consultations and coded 15 times (average
1.4 per consultation); 20 JBS3 (31%) consultations and coded 32 times (average 1.6 per consultation)].
A number of patients showed intentions to change their behaviour as a result of their CVD risk:
HP: So your ratio is 3.5. So this is the screening I was telling you about. So your risk is 3%. That will
increase as you age.
P: Yeah.
HP: And obviously if we can, perhaps with your smoking, it has pushed your heart age up to 48, and your
age is 41. Because that is the only result you have got in the red. Because all your other results are really
good, they are in the green.
P: They are really good, so I need to . . .
HP: Yeah, so if you had never smoked at all, your heart age would be aged 40.
P: I think I need to do something about that don’t I?
QRISK2+, 2_122, male, 41
This was another example of how heart age changed the way that the patient responded to the
information presented. Although a positive response was evident, the practitioner did not allow much
time before moving on. By giving the patient time to confirm his understanding, the practitioner gave
the patient the opportunity to increase his confidence in engaging in coping behaviours. Another
example of positive engagement during the discussion of risk was identified from another practice:
HP: OK that’s good. Err let’s see your key risk.
P: If I know what weight so I can just try to change my life.
HP: Yeah, yeah, it would be good if you can cut down and, and lose a bit of the weight err what was it
13.8. So it’s only a little higher, it should ideally be below 10% is what we want so 13.8 is a bit high but
it is because of, because of your weight. OK, you don’t smoke, you don’t drink alcohol, so that’ all good,
but your waist is a bit big as well.
P: Yeah
HP: Your waist is erm it’s 112, let’s have a look.
P: Around my tummy around here.
HP: Yeah let’s have a look. So your waist is 44 inches.
P: And that’s this bit here.
QRISK2, 3_259, male, 57
The patient above engaged with the information presented about their risk and suggested a need for
weight management, somewhat reinforced by the practitioner. However, the interaction was disjointed,
possibly because the practitioner needed to complete all other elements of the health check and
created a barrier for adaptive coping through not truly attending to what the patient was saying.
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Although scarce, a successful strategy for supporting adaptive coping used by one practitioner was to
ask the patient to reflect on the risk information that they had received, prompting consideration of
action needed:
HP: So average survival free of heart attack or stroke is 84.1 years OK? So how do you feel about that?
P: Oh I will make more of an effort to lose some weight.
JBS3, 1_154, female, 70
The approach adopted by the practitioner encouraged the patient to express their immediate reaction
to their CVD risk, which gave the patient an opportunity to evaluate their action and show intention
to change their behaviour. This was a rare example of PMT in action, showing connection between the
risk information and the patient’s intention to change her behaviour, helping to redress the power
imbalance evident in most consultations across both groups. It also demonstrated the significant role
that the practitioner plays in ensuring that risk communication is delivered effectively regardless of
the risk calculator.
Summary
Deductive thematic analysis of the 128 video-recorded health checks highlighted a number of
key findings:
1. Components of PMT coded most frequently in consultations using JBS3 (compared with QRISK2)
included threat appraisal, facilitators of and response costs to adaptive coping. This suggests that
JBS3 may provide more opportunities than QRISK2 to initiate discussion of risk factors and
their management.
2. Lifetime risk communicated using JBS3’s event-free survival age was misunderstood by both
patients and practitioners, who confused estimated age of survival free of a cardiovascular event
with estimated age of survival.
3. Patients presented with a QRISK2 score acknowledged their risk level, but it was unclear whether or
not they understood 10-year percentage risk (or trusted its credibility or relevance to them). Visual
presentations of risk and heart age, such as those provided in JBS3, and those which are not typically
communicated within standard practice systems (although they can be generated in QRISK2/3)
appeared to be more impactful and better understood by patients than the QRISK2 score.
4. Regardless of the risk calculator used, and despite the recognised importance of risk communication
in the health check best practice guidance17 and competence framework,19 there was little discussion
of CVD risk. This was particularly marked in QRISK2 consultations. Often, practitioners simply
relayed the risk score without discussing the implications of the risk for the patient or what they
could do about it. Equally, most patients offered minimal responses to the risk information, which
was often acknowledged with a single word.
There was an apparent absence of active listening by practitioners who frequently missed cues from
patients who were unclear about their risk score. Positive outcomes were identified when practitioners
checked patient understanding, relayed information in a way that was meaningful to the patient
(e.g. heart age) and asked for patient feedback around the CVD risk score.
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Chapter 5 Results 3: video-stimulated
recall interviews – patients
Headline findings from inductive thematic analysis of video-stimulated
recall patient interviews
l Most patients reported some impact of attending their health check (through intentions or modest
behaviour change).
l Patients often did not understand CVD risk information, especially 10-year risk (QRISK2) and
event-free survival age (JBS3).
l JBS3’s heart age and risk score manipulation were liked by patients and can confer patient
understanding and appraisal of the risk severity and vulnerability that the score conveys.
l JBS3’s visual presentation and risk score manipulation were liked by most patients and made the
important link between lifestyle change and overall CVD risk.
l A CVD risk score alone is insufficient to enable patients to understand or recognise their
personal risk.
l Practitioners should check patients’ understanding of CVD risk, tailor the information and make
clear the implications for their health.
Participant characteristics
As detailed in Chapter 2, patients were recruited for VSR interviews to give approximately equal
numbers across risk calculator groups, sexes and age categories (Table 9). However, the subsample
of patients who took part in VSR interviews, compared with the overall sample, included a higher
proportion of patients with low CVD risk (70% vs. 60%) and a higher proportion of patients of white
British ethnicity (90% vs. 83%).
Analysis of the data resulted in four main themes: (1) relief regarding CVD risk, (2) mixed levels of
understanding, (3) positive impact of health checks and (4) importance of presentation style and
content. These are discussed in turn using illustrative quotations, including some interviewer–patient
exchanges. Quotations are labelled to show CVD risk calculator (QRISK2+ where Informatica was
used), consultation identifier, patient sex and age. Where dialogue is reported, ‘I’ denotes the
interviewer’s contribution and ‘P’ denotes the patient’s contribution.
Relieved about cardiovascular disease risk
In general, many patients felt relieved about their CVD risk, perceived their CVD risk to be low, and
were unconcerned. For many patients, expectations of their CVD risk did not match up to the reality,
especially for 10-year risk and heart age. It appeared that 10-year risk was often anticipated to be
higher, and heart age anticipated to be lower. Yet there was also some consensus that, if CVD risk
were higher, patients would be concerned and consider risk-reducing behaviour change.
Not concerned by cardiovascular disease risk
For most patients, perceptions were largely focused on a lack of concern, regardless of the way in
which CVD risk information was delivered. One patient described how being told her 10-year risk
‘didn’t alarm me . . . I thought 6% wasn’t too bad at all really . . . I thought that was a pretty good,
average’ (QRISK2+, 12_131, female, 57). Other patients described how they were ‘quite relaxed about
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that really’ (JBS3, 7_117, male, 49) after being told their heart age. A small number of patients spoke
of their worries after finding out their CVD risk information. For example, on learning that his heart
age was 6 years older than his chronological age, one patient explained: ‘that shocked me. No, it
concerned me’ (JBS3, 7_105, male, 59).
Receiving CVD risk results also appeared to reassure patients, regardless of the way in which risk was
presented. For example, one patient talked about the relief of being given a 10-year risk that she
perceived to be low:
So saying to be 6.0 – well under 10, so yeah, yeah, yeah, it is reassuring. Which when she said it was
under 10 that’s why I forgot the number, but I was just relieved.
QRISK2, 3_125, female, 56
This was also observed for heart age: ‘I was quite pleased because it came out with my heart age at
being my age, so I thought phew [laughter]’ (JBS3, 4_263, female, 61).
It is possible that patients’ lack of concern about their level of CVD risk was related to a widespread
perception in the sample of a low level of personal CVD risk (as 70% of the 128 were classified as low
risk). However, this perception that personal CVD risk was ‘small’, ‘low’ or ‘quite low’ or ‘wasn’t that
high’ was observed among patients with different levels of risk. For example, one patient whose
10-year risk was estimated at just 1% (which was heavily influenced by his relatively young age):
I: . . . so do you remember what you were told by the practitioner about your level of developing
cardiovascular disease, or your risk?





n % n % n %
Total 40 21 19
Age (years)
40–54 14 35.00 6 28.57 8 42.11
55–64 14 35.00 7 33.33 7 36.84
65–74 12 30.00 8 38.10 4 21.05
Sex
Male 21 52.50 13 61.90 8 42.11
Female 19 47.50 8 38.10 11 57.89
Ethnicity
White British 36 90.00 18 85.71 18 94.74
Ethnic minority 4 10.00 3 14.29 1 5.26
CVD risk categorya
Low 28 70.00 13 61.90 15 78.95
Medium–high 12 30.00 8 38.10 4 21.05
a CVD risk categories: low is 10%, medium–high is ≥ 10%.
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P: I was very low 1% something like that.
QRISK2+, 12_064, male, 40
And another patient who had a 10-year risk just under the 10% threshold at which intervention might
be recommended:
I: OK so she said that your risk of heart attack or stroke was 8.1%.
P: Yes so quite low.
JBS3, 8_162, female, 67
However, a patient considered at high risk (≥ 20%) described how they felt when informed of their
10-year risk score, indicating that even those with a high risk of developing CVD did not perceive or
understand the severity of this information:
Err, well it didn’t really err, how can I put it, well err, err, well it . . . I thought about it but, 25% that’s yeah
I thought well err most people walking round now are at, what is it 25%? . . . You know erm, I, I thought
the odds were pretty good myself to be honest with you [laughter].
JBS3, 5_132, male, 74
Patients who were told that they had a low risk of CVD were understandably reassured (see Positive
impact of Health Checks). However, there is evidence of false reassurance for those with a high risk
of developing CVD who do not recognise the risk severity from the information provided or the
related discussion. This can be linked to a lack of understanding (see Mixed levels of understanding),
particularly surrounding the notion of percentage risk.
In addition, several patients commented on CVD risk being an estimate or a prediction, and this
appeared to influence the perceived severity of threat to their health:
I: So getting your actual cholesterol result, so rather than having kind of your 10-year risk or your heart
age, or your survival age, it would be your cholesterol . . . ?
P: Yeah very much so because that is the now, you know all those other things are projections.
I: OK, that’s interesting.
P: Like a forecast as such. This is the forecast, but that forecast is only determined by the here and now.
If there is a lifestyle change tomorrow that information that was given yesterday is null and void to
a degree.
JBS3, 4_080, male, 57
This appeared quite prominent in relation to event-free survival age, which this patient considered less
credible than heart age:
Cause, yes that [lifetime risk] . . . I think I’d take that as a pinch of salt, to be honest . . . You can’t predict
that . . . You know, that’s pretty ridiculous . . . I can listen to myself and think err . . . I’ve got a 51-year
heart or you know . . . they’re gonna know that . . . But to predict how long I’m gonna, live really that’s
errr . . . science fiction ain’t it really?
QRISK2, 9_087, male, 48
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Patients viewing their CVD risk results as a prediction or estimate might facilitate beliefs that CVD
risk can be reduced, in turn, enhancing self-efficacy towards positive behaviour change (see Facilitating
change). However, for other patients this could be detrimental to the appraisal of their risk and lead to
a fatalistic view, rather than considering their CVD risk as being in their control.
I would be more worried if cardiovascular disease risk was higher
Patients dismissed their CVD risk if they perceived it to be low (regardless of risk level). For example,
one woman, whose heart age was 5 years older than her chronological age, said:
No I just thinking well it doesn’t bother me ’cos, 5 years OK 5 years, 5 years, but it’s not you know about
20 years, 20 years be thinking ‘Oh my God’, you know . . . horrified, but I think 5 years is not too bad and
there’s things that I can work on to try and reduce that really so I wasn’t horrified by it, no.
QRISK2+, 12_131, female, 57
This suggests that this patient, because her heart age was similar to their actual age, regarded the
threat as not severe, and perceived that she had self-efficacy over the changes needed to reduce it.
Similar thinking was observed in relation to 10-year risk. In the example below, the practitioner had
suggested that a 10-year risk of 1.6% was slightly raised:
You tend to look at it and then tend to be kind of, I don’t know, kind of brush it away . . . although she
said it was quite high, I think because I think it is such a low percent, it’s kind of not at the front of my
mind and I am not concentrating on it.
QRISK2, 9_083, female, 39
Therefore, it appeared that patients’ perceptions of the severity of their CVD risk and vulnerability to
it are important in fostering intentions towards risk-reducing behaviour (in line with PMT).
It was common for patients to explain that, if their CVD risk had been higher (whether this was higher
10-year risk, older heart age, or older event-free survival age), they would have been more concerned,
and this would have been more likely to prompt change. For example, one patient believed that if he
had been given a 10-year risk that was double his current risk (15%), it would have prompted more
concern and increased steps to lower it:
P: You know, I mean if you’d said to me it was 30% . . .
I: Hm.
P: . . . a risk . . .
I: Yeah.
P: . . . obviously I’d be concerned about it.
I: Yeah, cos it would have been high . . .
P: High, it’d be double really, and higher, and obviously I’d have to take erm . . . or listened more, or look
at taking steps, to . . .
I: Hm.
P: . . . to rectify it or do something about it.
JBS3, 11_028, male, 58
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Similarly, patients frequently noted, that if their heart age had been a lot higher than their actual age,
it would have been perceived as a more severe threat, prompting behavioural action (in this example,
heart age was 51 years vs. chronological age of 55 years):
If it [heart age] had of been a lot higher then I would have thought ‘oh I will definitely go and get a bike
and I will go swimming as well’ [laughs].
QRISK2+, 12_083, female, 55
This suggests that an increased understanding surrounding CVD risk level is required for patients to
appraise how their individual risk may affect them. If patients do not perceive their CVD risk as a
threat, then they are perhaps less likely to make positive behaviour changes and follow practitioner
recommendations.
Feedback on cardiovascular disease risk was unexpected
Throughout patient accounts, it became apparent that there were mismatches between expectation
and reality of CVD risk. Some patients expected to be told that their overall CVD risk was higher than
it was based on known risk factors:
I thought they [10-year risk] were going to be higher, because of saying with my blood pressure and the
cholesterol, and so I thought ‘oh I am in trouble here’, yeah and I thought . . . I really did think it was going
to be high.
QRISK2, 3_125, female, 56
This was particularly true for 10-year risk. One patient, for example, explains that he was expecting the
score to be higher than it was, despite it placing him in a medium–high risk category: ‘I think it was a
case of [name] understood that I understood the 17% . . . As I say, I expected it to be higher but thankfully it
wasn’t’ (QRISK2 +, 2_084, male, 64).
Many patients had expectations of their heart age that did not match the estimates from the health
check and expected a low heart age based on a perception of being in relatively good health:
P: That is a bit of a surprise really for that, because I don’t feel that you know, and I don’t know I still feel
quite energetic and still play you know the sports I do, I am never tired, or feeling like I can’t go on any . . .
you know, in fact I do the complete opposite. Yeah, if I feel oh right I am feeling a little bit – like if I am
playing badminton for example, I can always push and push and push yeah, to you know go a little bit
harder and that so you know I was a bit shocked at that to tell the truth. Not shocked, as in disappointed,
but I thought you know . . .
I: You thought it would be lower rather than higher.
P: Lower than that yeah, because I don’t feel like I physically can’t do anything.
JBS3, 4_311, male, 57
This suggests that patient awareness or perceptions of their own health status are important. If a
patient perceives themselves to be physically fit, they may underestimate their personal level of CVD
risk, which might be elevated. This could stem from a lack of understanding of the CVD risk score itself
and the information on which it is based, which is important if patients are to understand how lifestyle
changes can be used to manage and reduce their risk.
Theme summary
It is likely to be insufficient to provide patients with their 10-year risk, or a heart age, in the absence
of supporting information. Putting these results into context or presenting them in a different way to
ensure that the severity of patient’s risk is understood is important to engage patients in discussion to
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address misunderstandings or misperceptions about what the score means, why it might be higher/
lower than expected and the implications for their health.
Mixed levels of understanding
Perceived understanding of CVD risk varied. Some patients thought that they understood the information
provided to them, but others felt confused, particularly in relation to percentage 10-year risk. In addition,
there was confusion around the concept of event-free survival age. Providing context around CVD risk
appeared important to facilitate understanding.
Understanding versus lack of understanding
Throughout patient accounts, there was a distinct division between patients who seemed to understand
the CVD risk information provided and those who did not. This was particularly true for 10-year risk
and event-free survival age and, to a lesser extent, heart age. Some patients demonstrated a level of
understanding of percentage 10-year risk (albeit with some confusion):
I: Yeah, OK, and do you know erm . . . kind of do you understand what [practitioner] meant when she
gave you that percentage score?
P: Yeah that you’ve got 6% risk of, of getting heart disease in life really yeah, out of 100 people you know
1 in 6.
QRISK2+, 12_131, female, 57
For other patients, gaps in knowledge and understanding of the score were observed. Some could not
recall what their score meant. For example, one patient struggled to ‘remember what the significance
of 9.5 was’ (JBS3, 4_233, female, 69), when talking about her 10-year risk. Other patients found it
difficult to put the percentage score into context in terms of a ‘good’ and ‘bad’ outcome. This was
evident across all risk categories (low, medium and high). For example, a patient with a relatively low
percentage demonstrated confusion about her 3% 10-year risk:
It depends, like I said, what it actually means. If 3% is not good, then obviously that information wasn’t
useful to me, because I have gone away thinking that’s fantastic. Even though I am a bit sceptical, erm
but if you are saying 3% actually is good, then yeah it was accurate what she was saying to me. But it
almost seems as if, because she did say like slightly higher, I think if 3% is a high risk of you know heart
disease, then 3% is not good, because 3% makes you think it’s good, because 3 out of 100 is good.
QRISK2, 9_295, female, 51
This lack of clarity was also observed where risk was higher:
I can’t quite understand what like 25% is, what’s, what’s good and what’s bad with 25%?
JBS3, 5_132, male, 74
This suggests that, regardless of the actual score, patients may find it difficult to understand the
implications and severity of a 10-year risk. Despite misunderstanding, some described their experience
of being told 10-year risk positively: ‘I thought that bit of it was very good indeed, obviously I didn’t
recall it, but I did think that was good how that was explained and showed’ (JBS3, 4_080, male, 57).
Yet the potential benefit of such positive perceptions is likely to be undermined by the lack of recall or
understanding of CVD risk information.
Lack of understanding was also common for JBS3 event-free survival age. Instead of viewing lifetime
risk as the expected age of survival free from CVD events, some patients interpreted this as predicted
age of survival. This appeared to be the case not only for patients who were given this lifetime risk
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estimate during the health check, but also for QRISK2 patients when asked their opinion on this
alternative way of presenting CVD risk:
I: So this would be your age to expect to live to without a heart attack, or a stroke . . .
P: Hm.
I: . . . and then after that age, your risk would increase significantly.
P: Hm hm.
I: So it is not necessarily kind of when you are dying.
P: When you are expected to live to? Hm. Hm. Well you see now, what’s interesting about that, because
now that I have read that, I have realised what it says . . .
I: Hm.
P: . . . but initially, what I thought, and I think that’s probably what a lot of people would think. Initially
you read it quickly and it looks like it is saying that we expect you to live until this age.
I: OK, so life expectancy.
P: And when you see that, then you cut off from what that’s saying . . .
I: Right OK.
P: . . . so I think that’s . . . because that is exactly what I have just done.
I: Yeah
P: I have just dismissed that bit there, and only read to there, on average expect to survive to 73.
QRISK2, 9_295, female, 51
This was also the case for one patient on being informed of his event-free survival age in the health
check, which was relatively close to his actual age. The confusion understandably caused a great deal
of concern (until this was identified and resolved):
I: So did you, did it make you feel sort of what emotions was it sparking was it . . . ?
P: Erm deflated me a little bit.
I: Yeah.
P: Erm, because I’ve never, ever thought about it and err it was my fault, that, that was the bit I felt
where it let itself down a little bit.
I: Yeah.
P: Erm, if she’d have said yeah, yeah we can guarantee, well not guarantee, but we can see you’ve got
reasonable amount of having good health until you’re 80 you know 82.
I: Yeah.
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P: And then things might deteriorate a little bit.
I: Yeah.
P: That would have been perfect I’d have . . .
I: Yeah.
P: But then as I say 82.7 mentioned and I thought to myself and I never, that was it, the end of the
interview really, I think.
I: Yeah.
P: As I thought, then, then it gets in your, gets in your head then.
JBS3, 5_132, male, 74
Understanding of heart age was also mixed, but patients seemed to have a better understanding of
this than on other risk scores, and the comparison with chronological age allowed patients to quickly
appraise their individual risk as ‘good’ or ‘bad’:
Where it says ‘your heart age is’ and gives you a heart age, straight away you know whether that is good,
or bad, because if your [chronological] heart age is lower than the reading [heart age estimate], then you
know straight away that is not so good. Whereas if it is higher you know. So I think that one is a bit
more clearer.
QRISK2, 9_295, female, 51
However, some patients found the concept of heart age challenging, and failed to understand the
context or implications of a heart age different to their actual age:
. . . again it, it’s there was this lack of information you know, what do these numbers mean? . . . I can’t
remember ever being told what the numbers actually mean . . . You know what is the, you’ve got a heart
of a 72-year-old, or 73-year-old and you’re, you’re 62. What does that actually mean?
JBS3, 4_143, male, 62
Overall, lack of understanding was evident across all methods, especially QRISK2 and event-free
survival age. This highlights the need for practitioners to check patient understanding during the
consultation and, where necessary, tailor the information to the patient.
Importance of context
One way to improve understanding of CVD risk relates to the context in which the different risks are
presented [i.e. the extent to which practitioners demonstrate the relevance to patients (its severity or
their vulnerability to it)]. This was highlighted by some patients, who believed that the CVD risk
information lacked context, making it difficult to understand or appreciate the severity:
P: . . . walked off and probably thought afterwards, I could have done with actually understanding is the
heart age kind of thing, normal . . .
I: Hm.
P: . . . I was kind of thinking come out probably late 30s mid to late 30s something like that . . .
I: Yeah.
RESULTS 3: VIDEO-STIMULATED RECALL INTERVIEWS – PATIENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
P: . . . but that’s without knowing anything about it . . .
I: Hm and was it useful to be told a heart age?
P: It’ it needs more context think . . .
I: Hm.
P: . . . on reflection as I walked away I don’t, didn’t really ask what that meant, it’s just stuck in me that
it’s like hm . . . it’s not younger than me which, I imagined it should be.
QRISK2+, 12_064, male, 40
This idea was also discussed in relation to 10-year risk, in which additional context helped the patient
to understand (in this example, as noted in Chapter 7, this quotation also reflected understanding
conferred through a follow-up telephone call in which a specialised nurse practitioner provided
further explanation):
I: Erm, and did you understand what she meant when she said a risk of 17%?
P: Erm, yes, I think . . . We did do kind of an analogy of you know like 100 people in a room – 17 can be
expected . . . but you don’t know which of the 17 . . . which I thought was quite a nice graphic analogy to
give you a visual picture.
I: Yes. Was that something that she showed you on a screen or was it . . . ?
P: No we just discussed it.
I: It was conversation?
P: Conversation, yes.
I: Brilliant. So that kind of helped you to put it into context a little bit about sort of the 17%?
P: Yes.
QRISK2+, 2_084, male, 64
Patients who were not given as much detail on the 10-year risk to put it into context appeared to have
less understanding of the implications:
I think with the percentage unless you have been given the range it should be in for your age and for
your, you know, capabilities, then it’s kind of a mismatch of information. I don’t know which to kind of . . .
they are saying it’s high, but I think it’s quite low, but I don’t know what high is because I haven’t been
given anything to compare it against.
QRISK2, 9_083, female, 39
Therefore, the context in which CVD risk information is communicated is important to aid understanding.
Providing patients with more explanation on how to position their score relative to the population might
facilitate understanding of the severity of their personal risk. One method of doing this is to provide
some more information (e.g. use of analogies, relative risk) during the CVD risk discussion. Another
method relates to the presentation of information, particularly given the positive perceptions of the
ability to manipulate a patient’s CVD risk using JBS3 (see Importance of presentation).
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Perceived changeability of cardiovascular disease risk
In addition to varied understanding of CVD risk in general, there were apparent differences in
understanding of whether or not it could be changed by lifestyle factors. A small number of patients
thought that it was fixed:
Yeah, you know, so err and having known the fact that my dad had a heart attack has increased my score
. . . and she said herself on the video you can’t do anything about that. That’s just there you are there’s
10 points on the score.
QRISK2, 6_044, male, 61
In contrast, other patients talked about CVD risk as changeable: ‘Yeah, yeah, I remember thinking
so I could do something about it’ (JBS3, 4_233, female, 69), or even acknowledged their own role
in lowering the score: ‘But obviously it could come down, it could be better I guess if I change . . .’
(QRISK2 +, 2_001, female, 66). There was also an awareness that CVD risk could also increase over
time, an important point for patients to understand from a prevention perspective:
. . . so, but again she did say that it wouldn’t stay the same it would change, so I do know that I,
I do need to start looking after me self . . . a bit better.
QRISK2, 10_539, male, 51
The idea of CVD risk being a prediction or a ‘lottery’ was also evident in relation to discussion about
the patient’s ability to make changes. This highlights an important separation between patient’s
lifestyle or risk-reducing behaviours and what they see as a prediction of future disease risk, which
might lack credibility:
I: Yeah, so was that information in particular helpful, or unhelpful, the 9%?
P: Oh!
I: To you?
P: To me it didn’t mean anything, because to me you know I can change my lifestyle and all that sort of
thing, but at the end of the day it is a bit of a sort of like lottery really isn’t it? [Laughs].
I: Yeah, yeah, I think it is isn’t it really?
P: I would be quite happy if I had 9% chance of winning the lottery! [Laughing].
QRISK2+, 2_001, female, 66
This could be positive because of associations with change and adaptability, but negative in terms of
fatalistic attitudes and not recognising CVD risk as the context or reason for making health-promoting
changes.
Finally, despite the predominant belief that CVD risk (or risk factors) was modifiable, some patients
lacked understanding about how to implement positive changes, for example to reduce cholesterol:
So it then led me to think ‘Well, where am I with it, can I do something about it?’. I don’t think I can do
much more with my standard of living and exercise to be honest. So I think ‘well if there is an issue it
might be genetic’, but I am now in the process of thinking ‘well you know what let’s get this tested again
and see where we are’.
JBS3, 4_080, male, 57
RESULTS 3: VIDEO-STIMULATED RECALL INTERVIEWS – PATIENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
Or in terms of lowering CVD risk itself:
But that part wasn’t . . . I am not clear about, erm I think at that point you are just . . . I am not sure
actually, I am not sure how . . . right now so it’s 4.8% over the next 10 years, but I don’t know how you
would lessen that.
JBS3, 4_263, female, 61
This makes clear the important link between clarity and understanding of CVD risk information,
and patients’ perceptions (and subsequent intentions) regarding their ability to reduce risk through
lifestyle changes.
Theme summary
Patients often do not understand CVD risk information (particularly 10-year risk and event-free
survival age) and the implications of the scores. They are often unable to determine if their CVD risk
is higher than that of others of the same age and, therefore, they may not be sufficiently motivated
to change their behaviour. Patients would benefit from practitioners providing further information to
make clear the relevance of their CVD risk. Visual presentation and risk score manipulation offer tools
that can accommodate the range of patients, and also to make the important link between lifestyle
change and overall CVD risk.
Positive impact of health checks
Despite some of the more problematic parts of the health check, there was evidence that attending
had a positive impact on the majority of patients including increases in awareness, contemplation of
behaviour change and positive intentions, as well as implementation of recommendations made by the
practitioner (albeit with small changes). One aspect of the health check that seemed particularly
positive was providing a heart age to patients.
Facilitating change (risk management)
The extent to which patients reported to have altered their intentions or behaviours as result of the
health check varied. For some, the health check prompted them to contemplate behaviour change:
‘did make me think a bit more . . .’ (JBS3, 7_136, female, 53); ‘put it [CVD risk] on my mind’ (QRISK2 +,
12_083, female, 55). For some, it resulted in a positive change in attitude towards health: ‘Overall . . .
I came out with the attitude I’ve got to be more health focused’ (JBS3, 7_105, male, 59). For others, it
appeared to increase their awareness of lifestyle aspects that might need to be changed, and promoted
contemplation to engage with this:
Erm . . . no, the good thing was like you know get your cholesterol checked I had that, had previously
checked it was still little bit high, but I’d gone up again erm . . . so it’s made me think about changing my
diet and . . . and erm . . . tweaking it a little bit here and there . . .
QRISK2+, 12_131, female, 57
Consequently, a number of patients had not made any changes based on the recommendations
provided, but were considering change. Others had made positive changes to lifestyle and behaviour.
Overall, the health check seemed to facilitate patients to ‘work on that [behaviour] a bit harder’ (JBS3,
4_311, male, 57). Positive changes in several health behaviours were seen, mostly those most discussed
by practitioners (see Chapter 4), such as physical activity, healthy eating and blood pressure monitoring.
Many patients talked about increasing their levels of physical activity following the health check.
Typical examples involved increasing walking ‘I’ve started to go out a few minutes earlier and walking
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up the hill [laughs] . . . it’s just a few minutes a day . . . might make a difference’ (QRISK2 +, 12_055,
female, 65), or other home-based exercise:
P: I have, I mean like I have got my step machine . . . I have got a step machine that was in the garage,
I have brought that inside, so I can do that while I am watching television.
I: How brilliant!
P: So like it does get me out of breath.
QRISK2, 9_202, female, 46
There were also several instances of dietary change. This could involve reducing intake of certain foods:
I’ve cut sugar down no end.
JBS3, 5_132, Male, 74
I: Brilliant. So has being told your level of cardiovascular risk, so either the percentage, the heart age,
the survival age, has that affected you in any way at all, sort of you know how you are approaching kind
of lifestyle and things like that?
P: Well, certainly, over diet really, over the cheese, because I was . . . she actually suggested cutting it
down to a couple of times a week, which I have done already, so that definitely has had an impact.
JBS3, 4_263, female, 61
Others had substituted foods:
I: Do you mind me asking what change you made?
P: . . . erm . . . cut out some dairy . . . so I stopped using milk in porridge, and things like that and using
water . . . got coconut milk as well, erm . . . and cut out bread . . . and erm . . . I’ve actually got a bit more,
I’m not gonna go vegetarian, but I’ve gone a bit more vegetarian . . . I’m eating probably slightly less,
but I’ve cut the crap out . . .
QRISK2+, 12_064, male, 40
When blood pressure was highlighted as a particular issue during the health check, some participants
engaged in positive behaviour change related to further monitoring, either at the general practice or
at home:
But the fact that I went out and ordered a small blood pressure monitor and one thing and another erm
and presented my wife with those sheets and whatever. I’ve never done anything like that before.
JBS3, 7_105, male, 59
Despite the positive contemplation and actual behaviour change taking place, the changes made by
patients were small: ‘I have not made any massive changes’ (JBS3, 7_105, male, 59). This could be
explained by a number of the preceding themes, such as feeling reassured by their CVD risk, thinking
CVD risk was low, considering behaviour change only if CVD risk is perceived to be high, believing that
they were already doing the right thing, and perceived ability to change. For example, one patient
talked about taking a ‘small step’ as a result of attending the health check:
And then erm, I forgot about the heart age, when she said about the heart age yeah. I just went back
with the erm the life expectancy age. Erm, yeah so it has it, it gave me the momentum to do something,
I know it’s only a small step but it’s a step.
JBS3, 5_185, male, 47
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Overall, evidence related to contemplation of change and also the relatively modest changes made by
many patients suggests that something else, in addition to what was included in the health check,
may be needed to facilitate intentions for, and implementation of, more consistent and substantive
behaviour change.
Impact of heart age
When asked about the CVD risk information they could remember, numerous patients could recall
their heart age, more so than 10-year or event-free survival age. As a result, heart age seemed to
stand out to patients as being more impactful:
P: I think, I think the thing that registered with me and that sort of really grabbed my attention, and
I know I said this earlier, all I could see was that 65 on that screen.
I: Yeah.
P: And I couldn’t . . .
I: Yeah so the heart age really kind of . . .
P: . . . that was wallop.
I: Yeah.
P: Yeah. That heart age and I think perhaps I missed some of the, shall we say, the finer detail because
I was focused on that.
I: Yeah.
P: I could see that 65 and I was thinking, bloody hell, I ain’t 65!
JBS3, 7_105, male, 59
Clearly, it would be problematic if patients, in trying to process heart age information, ‘switch off’
and are unable to engage with subsequent recommendations from the practitioner. However, given
the lack of retention of 10-year risk (and confusion over event-free survival age), understanding the
implications and retaining one of the metrics can be interpreted as a positive, as it could provide the
context for a meaningful discussion of risk management.
The concept of heart age was also well received by patients in the QRISK2 group who were interviewed,
who were shown alternative ways of presenting CVD risk information during their VSR interview:
Err I think that one has got the most positive impact really. Even if it wasn’t positive from point of view of
your heart age, if it was higher than what your [chronological] heart age is. I think you would still straight
away understand that more and know what you have got to do.
QRISK2, 9_295, female, 51
Heart age was perceived to increase understanding of CVD risk among patients in both the JBS3
group and the QRISK2 group:
But when it was very clearly written, you know so the model brings it up as your heart age, given the
information that it has got, is 61 years and I thought ‘well that is so clear and understandable’, so I found
that very helpful, because if it had been much higher, then that would have also been very understandable.
JBS3, 4_263, female, 61
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In addition, heart age appeared more relatable and, perhaps, more credible. As reported earlier, one
patient described event-free survival age as ‘science fiction’, but could believe the idea of heart age:
I can, I can listen to myself and think err . . . I’ve got a 51 year heart, or you know . . . they’re gonna
know that . . .
QRISK2, 9_087, male, 48
This links in with the earlier idea that CVD risk is only a prediction. If heart age is perceived as more
relatable and credible, patients may have an increased understanding of how their risk of developing
CVD, be able to appraise its severity and their vulnerability to it and, therefore, be more likely to make
behaviour changes to mitigate the risk. This was illustrated in the patients accounts around heart age
prompting change as ‘it is that swift kick to say: “get out there and do something”’ (QRISK2 +, 2_084,
male, 64):
Don’t get me wrong, it was enough to make me say to my wife ‘I’ve got to do something about what I eat,
and I’ve got to get more exercise and I’ve got to do this, and I’ve got to get that’, and I ordered a blood
pressure monitor and all the other things. I even checked that the bathroom scales worked properly.
JBS3, 7_105, male, 59
The other methods of presenting CVD risk information (10-year risk, event-free survival age) were also
commented on by patients in terms of their strengths, limitations, ability to increase understanding and
also impact on behaviour change. However, conversations around heart age were much more common,
and rarely in a negative context. Some patients were alarmed or even shocked to learn that their heart
age was higher than their actual age and clearly did not expect to receive such information:
Well it made me, what she said is that this is the age group I would be . . . so obviously that’s alarming,
because . . . it’s like adding another 10 years to your life. You know which you don’t want . . . you know
you don’t mind erm . . . being at the level where you are at your age . . .
JBS3, 11_028, male, 58
Clearly, a CVD risk metric, such as heart age, that is understandable and impactful has the benefit of
giving patients a better appreciation of their risk than does 10-year or event-free survival age.
Theme summary
There was evidence that attending a health check had a positive impact on many patients, but these
often related to contemplating change or making relatively small changes to lifestyle. Heart age
appeared to be preferred by patients, and beneficial for facilitating patients’ understanding and
appraisal of CVD risk (compared with 10-year or event-free survival age).
Importance of presentation style and content
Throughout patient accounts there was evidence that the way in which CVD risk is presented can
affect recall, understanding and attempts at risk-reducing behaviour change. Patients commented
that it can be difficult to take in all of the information provided during a health check, particularly
if this is communicated predominantly verbally. Potential ways of enhancing delivery of CVD risk
communication include presenting the information visually and with visual demonstration (or
manipulation) of how making positive changes to lifestyle factors (i.e. ‘interventions’ in JBS3) can
reduce CVD risk. These two factors were perceived positively by patients, and are both related to
functionality within the JBS3 calculator.
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Difficult to absorb information
Patients frequently highlighted the difficulties in absorbing information presented in the health check
and commented that they ‘Didn’t really sort of take in you know what the numbers were’ (QRISK2,
3_125, female, 56). They felt that the volume of information provided to them in a short space of time
limited their capacity to retain and accurately recall it:
As I say, when you are in somewhere like that you can’t take on too much either can you really? Because
it all becomes a bit muddled together.
JBS3, 4_263, female, 61
This appeared particularly problematic when exclusively presenting information verbally, which is
common practice during a health check:
You know what I mean, you, you could take the time to look at it whereas, when, when it’s when it’s
spoken to yer, it’s spoken then it’s gone.
QRISK2, 10_539, male, 51
This supports evidence for the benefit of presenting risk information visually.23,77 Patients who feel
overloaded with information that they cannot effectively process will be limited in the extent to which
they understand their own personal CVD risk and appraise the implications.
Positive impact of presenting cardiovascular disease risk visually
One key feature of the JBS3 risk calculator, aside from the various risk metrics (10-year risk, heart age,
event-free survival age), is the visual presentation of risk information. The interactive nature of the tool
facilitates a more collaborative consultation between patient and health-care practitioner. It was often
observed in the video-recorded health checks that practitioners would share their computer screen
with patients to communicate CVD risk information (see Chapter 4).
Patients in the JBS3 group typically commented on the visual presentation of information, which was
perceived positively and overcame some of the barriers related to verbal communication of information:
It was good that you could see the screen and how she actually . . . how she worked it out as well rather
than somebody just telling you . . . I thought it was a good to see . . .
JBS3, 7_044, female, 54
There was also a common feeling that seeing information written on the screen, and the accompanying
visuals, strengthened the message and aided recall (more than simply hearing it from the practitioner):
. . . because it was on the screen, I think that is such an aid to memory . . . you know it’s just that sort of
interactive ability really to be able to see something, rather than just being told information. Because in
any situation that is new to you, if there’s a lot of things going on and you are not sure what’s going on,
you don’t hear . . . But if you see it, it is actually much, much clearer to you.
JBS3, 4_263, female, 61
Patients also reported that they took more notice of the information when presented graphically, and
that the presentation influenced intentions to engage in positive behaviour change:
I certainly got the gist of what [practitioner] was saying and it’s quite graphic seeing it there on screen
erm, you know heart age 65 and I’m, I’m not quite 60 so you’re thinking yeah I ought to do something
about that and yeah the intention is there.
JBS3, 7_105, male, 59
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This did not appear limited to one type of CVD risk information provided. Rather, visual presentation
appeared to increase understanding and impact of 10-year risk (‘Yeah she did give me a percentage
score, she did something on the computer that showed you erm what it was and that was quite good
actually’; JBS3, 7_044, female, 54) and heart age (‘But the 65 was a big 65 on the screen’; JBS3, 7_105,
male, 59) although was not commented on in terms of event-free survival age.
Positive perception of risk manipulation
The JBS3 calculator function that allows the practitioner to manipulate a patient’s CVD risk by altering
modifiable risk factors was perceived positively by patients, with one describing it as ‘quite impressive
really’ (JBS3, 8_162, female, 67):
Yes I think it helps, rather than somebody talking to you and saying, ‘well it’s like this, it’s like that’, but
actually when you can see it and then by altering it, you know and saying, ‘if we put this information in you
can see how . . . so if you were much heavier say, for example, or if you smoke, or if you do these sorts of
things’, so I found that really helpful. Really clear and understandable from my point of view anyway.
JBS3, 4_263, female, 61
This also appeared to have more of an impact on patients, potentially increasing motivation to engage
in behaviour change:
You can see the differences . . . not just somebody saying or if you do this, you can, you’d be better . . . or
better off . . . shall we say, not better, better off, you know but if you can, if you can read it and you can,
you can compare the two at the same time . . . You can, you can it, it has better more, more of an impact.
QRISK2, 10_539, male, 51
It was also evident that some patients had made positive lifestyle changes and followed practitioner
recommendations based on their risk manipulation in JBS3:
I: Erm do you remember being shown how your risk might change, you kind of mentioned it a little bit
earlier how she said if you reduce your cholesterol erm it could have an effect on your risk.
P: Yes she did yeah bring the percentages down and all this, all the above which is as I say I took on
board . . . Which err you come out, I came out thinking well yes my lifestyle needs to change . . . because
it’s an easy thing to slip into . . . I have made the effort and through that, through this meeting you know
so it . . . the benefits are there it’s definitely done something for me . . . In as much as made me decide
well ‘come on enough pull your finger out get on with this’, you’ve been told, you know.
JBS3, 4_394, male, 65
Theme summary
Patients are given a lot of information in health checks, which they can struggle to absorb and retain.
There appeared to be benefits of visual presentation of CVD risk information and risk score manipulation
within JBS3 to foster patient understanding of CVD risk and motivation to follow recommendations for
behaviour change.
Summary
Data from VSR interviews with 40 patients regarding their perceptions and experiences of CVD risk
communication as part of a health check (delivered using QRISK2 or JBS3), and their subsequent
intentions or actions, highlighted six key findings:
1. Most patients reported that attending a health check had some impact, in terms of contemplating
change or making small changes to lifestyle.
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2. Patients often did not understand CVD risk information. This was true for all metrics, but
particularly for 10-year risk. Event-free survival age was misinterpreted by some as estimated age
of survival. Heart age and risk score manipulation were perceived positively by patients and can be
used to confer patient understanding of the risk and allow appraisal of its severity and vulnerability
(and, therefore, its personal relevance).
3. Providing patients with a CVD risk score alone is insufficient. Further information is needed to put
the results into context, or the results should be presented in a different way, with further
discussion to ensure that the severity of the risk is understood.
4. Visual presentation and risk score manipulation appealed to most patients, and also helped them to
make the important link between lifestyle change and overall CVD risk.
5. Patients are given a lot of information in health checks, which they can struggle to absorb and
retain. The visual presentation of CVD risk information and risk score manipulation offered by JBS3
fosters patient understanding of CVD risk and motivates patients to follow recommendations for
behaviour change.
6. Building on findings from Chapter 4, the range of issues identified highlights the need for
practitioners to check patient understanding during the consultation and, where necessary, tailor
the information and address misunderstandings or misperceptions about what these risk scores
mean, why they might be higher/lower than expected and the implications for their health.
DOI: 10.3310/hta25500 Health Technology Assessment 2021 Vol. 25 No. 50
Copyright © 2021 Gidlow et al. This work was produced by Gidlow et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social
Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution,
reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the
title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
55

Chapter 6 Results 4: video-stimulated
recall interviews – practitioners
Parts of this chapter have been reproduced with permission from Gidlow et al.75 This is an OpenAccess article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: https://creativecommons.org/licenses/
by/4.0/. The text below includes minor additions and formatting changes to the original text.
Headline findings from inductive thematic analysis of video-stimulated call
practitioner interviews
l QRISK2:
¢ The 10-year risk score was used as a tool to guide clinical decisions, rather than for CVD
risk communication.
¢ Practitioners expressed confidence in delivering 10-year risk.
¢ Practitioner understanding of 10-year risk often did not extend beyond applying thresholds for
low, medium and high risk.
l JBS3:
¢ Practitioners perceived that patients were more responsive to heart age and the risk
score manipulation.
¢ There was a perception that patients liked the visual displays in JBS3.
¢ Event-free survival age was misinterpreted by some practitioners.
l Practitioners relied on patient reactions to gauge understanding and intentions.
l Practitioner roles appear to be providers of information, rather than facilitators of change.
l Risk management strategies focused on lifestyle advice, with limited referrals to lifestyle support
programmes (a lack of follow-up regarding attendance or effectiveness).
l Practitioner training is required to increase confidence and understanding in CVD risk communication.
Participant characteristics
Practitioner characteristics were presented in Chapter 3 (see Table 5).
Thematic analysis of data from the 15 practitioner (9 HCAs, 6 PNs) produced three main themes:
(1) communicating CVD risk, (2) understanding of CVD risk and (3) risk management. These are
discussed in turn using illustrative quotations. Each quotation is labelled to show the practitioner
identifier, risk calculator used (QRISK2+ where Informatica was used), and their role (HCA or PN).
Where dialogue is reported, ‘I’ denotes the interviewer contribution and ‘HP’ denotes the health
professional (i.e. practitioner) contribution.
Communicating cardiovascular disease risk
The first theme discusses practitioners’ perceptions and confidence regarding use of the CVD risk
scores and the extent to which they enabled risk communication. Four subthemes were identified:
10-year risk (QRISK2), event-free survival age (JBS3), heart age (JBS3) and risk score manipulation
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and visual displays (JBS3). Overall, 10 (out of the 15) practitioners liked JBS3, of those, nine were in
the JBS3 group and, therefore, had direct experience of using it. The five practitioners who spoke
positively about QRISK2 were mostly from the QRISK2 group, so lacked experience of JBS3 for
comparison. Mixed views of QRISK2 were expressed by practitioners from both groups.
Ten-year percentage risk (QRISK2)
QRISK2 is presented as percentage 10-year risk, and an equivalent score is also presented in JBS3.
Practitioners generally reported feeling confident in communicating to patients their estimated 10-year
risk (QRISK2): ‘I think I’m OK, I think I’m confident . . . I think I deliver it well . . .’ (9.1, QRISK2, HCA);
‘Quite confident’ (11.1, JBS3, HCA); and ‘I feel fairly confident’ (6.1, QRISK2, PN).
However, there was reported variation in its application. Some practitioners stated that they tend to
deliver the CVD risk information to all patients in the same way: ‘I’m like a robot. I think I say the
same thing to every patient . . .’ (6.1, QRISK2, PN). This is problematic given the evidence supporting
tailored risk communication to accommodate varying patient needs and understanding.24 Other
practitioners said that they adapted their delivery of 10-year risk, recognising that ‘the way in which
it’s delivered can sometimes [be] more than the actual QRISK . . .’ (10.1, QRISK2, PN):
I try and explain it for the level of the person that is sitting there and adapt it.
6.2, QRISK2, PN
Despite the communication of QRISK2 (or QRISK3) being mandated in NHSHC,17 there was variation
in whether or not practitioners chose to communicate 10-year risk during the health check:
[If] you think the patient perhaps is not going to pay any attention to you, they are not going to take it in,
then no.
6.2, QRISK2, PN
I personally always do it . . . because the whole point of the health check is that you reach that number
. . . the QRISK is below the percentage that you want and that you know, and that is fine.
1.1, JBS3, PN
Some practitioners suggested that the decision of whether or not to tell patients their 10-year CVD
risk ‘very much depends on the patient’ (6.1, QRISK2, PN) and can be informed by patients’ age, level
of understanding and engagement.
Other factors that appeared to influence the extent to which practitioners used 10-year risk included,
first, the perceived usefulness. Through identifying patients with elevated risk (i.e. ≥ 10%), 10-year risk
was seen to have value in guiding recommendations and clinical decision-making: ‘QRISK is more
the sort the diagnosis and the referrals and things’ (2.1, QRISK2+, HCA). But it was generally not
considered beneficial for the patient:
. . . giving them a percentage, doesn’t inspire them, doesn’t motivate them really . . .
1.2, JBS3, HCA
I suppose when you look at it and you have got that 10%, it is quite clear isn’t it? . . . Because you see it
and you think about it ‘well they are going to need a statin’ . . . So it is quite clear cut then. I don’t always
know how helpful it is to patients.
6.2, QRISK2, PN
Practitioners descriptions of the QRISK2 suggested that it was not used to facilitate discussion of CVD
risk with patients: ‘A quick go-to tool. . . it’s OK. It’s all that we have’ (10.1, QRISK2, PN). In addition,
although practitioners expressed confidence in communicating 10-year risk, there was evidence that
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their understanding of and confidence in explaining the score was, in fact, limited and that this
prevented them from engaging patients in a discussion of their risk:
Several things are taken into account, so age, sex, their BMI [body mass index] . . . which does make it, to
me, very complicated. . . to try and explain it to [patients] is the hardest.
12.1, QRISK2+, HCA
There was also a perception among practitioners that patients’ ability to understand risk information is
limited, and as a result it is challenging for practitioners to communicate information in a way that
patients will understand:
What I find difficult is sort of putting it in a way that the patient will actually understand . . .
10.1, QRISK2, PN
This has implications for practitioner training. There is clearly a need to improve practitioner competency
in communicating CVD risk communication in a way that enables a meaningful discussion around risk
management, in accordance with the competency framework.19
Event-free survival age (JBS3)
Practitioners who used JBS3 discussed issues with communicating lifetime risk to patients. For some,
this was new, and it became easier with experience: ‘. . . it is new for me, it is new for the patients and
yeah it just got easier every clinic that I did’ (11.1, JBS3, HCA). But event-free survival age appeared to
be ‘. . . the hardest one to try and communicate . . .’ (7.1, JBS3, HCA). This difficulty was two-fold. First,
unlike 10-year risk, there are no thresholds for event-free survival age to identify patients as low,
medium or high risk, and, therefore, no prompts to initiate discussion or action (e.g. risk > 10% would
be followed up with further tests and discussions around statins):
. . . That’s there’s no benchmark to give that comparison to be like ‘right you can live till 84 and so-and-so
live till 82’, so that one was harder . . .
7.1, JBS3, HCA
Second, as the above example illustrates, there was some confusion around the meaning of event-free
survival age. Despite providing brief introductory training and a training video in the use of JBS3
and its outputs (see Chapter 2), some practitioners described lifetime risk in terms of expected age of
survival (rather than CVD event-free survival). This is clearly an issue, resulting in the communication
of incorrect or misleading information.
One practitioner also questioned whether event-free survival age would motivate a patient to make a
change if the predicted age the patient is expected to live without a CVD event was high:
HP: Again, because you have told them that they are going [to] live until they’re 82 without any heart attacks
or strokes . . . Is that motivating them, or not motivating them? I would say not really motivating them.
I: Why?
HP: Because . . . they are going get to 82 without anything happening to them.
1.2, JBS3, HCA
Overall, event-free survival age appeared problematic in terms of practitioner understanding and
application. There was a perception that this kind of information could shock patients into changing
their lifestyle to reduce long-term risk: ‘. . . if that’s telling them younger, than they’d expect it to be
then that’s quite a shock tactic isn’t it . . .’ (9.1, QRISK2, HCA). But this did not reflect the majority view
or experience.
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Heart age (JBS3)
The heart age output from JBS3 was perceived positively. Practitioners expressed confidence in
communicating heart age, ‘ ’cos it’s just the easier one to . . . sort of explain’ (8.2, JBS3, PN). Heart age
has inherent benchmarking through comparison with chronological age, which overcomes a perceived
limitation of event-free survival age: ‘. . . they know how old they are and then they are exactly . . .
“oh it’s the same age as me”, so I think they understood that more’ (11.1, JBS3, HCA). Practitioners also
suggested that patients liked and responded strongly to the ‘visual of heart age’:
. . . because it is an actual [heart] when you go onto that screen of heart age. The heart is there, you can’t
escape that and then you have got your age right by it.
8.1, JBS3, HCA
. . . they liked the heart age . . . I don’t know whether it was because there was a picture of the heart . . .
8.2, JBS3, PN
It appeared that practitioners were using heart age as a motivational tool to highlight to patients the
need to make lifestyle changes rather than simply a risk score metric to be relayed to patients, as was
the case for 10-year risk.
Risk score manipulation and visual displays (JBS3)
The risk factor manipulation function and visual displays in JBS3 were discussed positively. Those using
JBS3 reported that visual features provided an alternative method to deliver key messages to patients:
‘. . . [patients] have said it is quite nice to see visually, [as] opposed to me talking’ (8.1, JBS3, PN). Some
practitioners perceived that patients were more engaged when presented with visual information,
based on non-verbal cues:
Because, like I said, it is visualised. They are seeing, they actually are interested. They have come closer to
me, their body language was good, they were looking at that, they did ask questions and they were happy,
because I think it was visualised.
11.1, JBS3, HCA
The visual stimuli in JBS3 were thought to ‘make a far better impact’ by being ‘able to show them
visually, rather than just verbally tell them’ (5.1, JBS3, PN), promoting interaction and discussion
with patients:
So, this is the point [going through JBS3 outputs] then they [are] starting to ask questions, or looking like
they [are] actually wanting to be here . . .
8.2, JBS3, PN
There was some conflicting evidence from the video-recorded health checks that most patients give
limited responses when presented with risk information, even when JBS3 was used; often single-word
acknowledgements, infrequent questions and scant non-verbal cues (see Chapters 4 and 7).
Theme summary
Ten-year risk is viewed as a guide for clinical decision-making, not for facilitating discussion of CVD risk,
and the evidence suggests that practitioners lack the understanding and confidence to explain the score.
Event-free survival age appeared problematic in terms of practitioner understanding and application;
training would be needed before this type of metric was recommended for use in practice (in addition
to general training in discussion of risk with a preventative focus). Heart age was favoured for being
easier to explain and well-received by patients, who were thought to appreciate the visual presentation.
Practitioners thought that patients responded well to the risk manipulation and visual displays in JBS3.
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Understanding of cardiovascular disease risk
The second theme discusses practitioner understanding of CVD risk and potential factors that could
influence perceived patient understanding, and has three subthemes: practitioner understanding,
perceived patient understanding, and barriers to and facilitators of understanding.
Practitioner understanding
There was a strong link between practitioners’ understanding and communication of CVD risk. The
majority described 10-year risk in a similar way, with reference to current lifestyle and risk factors:
. . . so the score that we are giving them is their risk of heart attack or stroke in the next 10 years, based on their
. . . current lifestyle as it is as the moment, so it’s not sort of you know if their lifestyle changes or any risk . . .
7.1. JBS3, HCA
They also referred to the thresholds used to identify those with elevated risk: ‘So, we are looking at
patients over the 10% mark, so their risk factors of developing strokes and heart disease is increased’
(6.2, QRISK2, HCA). Despite apparent confidence in communicating 10-year risk expressed by most, one
practitioner doubted their understanding of what the score meant (and cited a preference for heart age):
I feel confident in the way that I give it . . . but then you are only reading off a piece of paper . . .
I don’t feel that I understand . . . what the percentage is really . . . I prefer the heart age.
1.2, JBS3, HCA
Conversely, some felt that they understood the risk score, but questioned their ability to communicate
it effectively:
Putting it into sentences which they can think well OK, or they might say, ‘well it just doesn’t make sense’
. . . I can probably babble sometimes and think, even I didn’t understand that.
12.1, QRISK2+, HCA
In some cases, watching the video-recordings of themselves delivering health checks (during the VSR
interview) prompted practitioners to appraise their risk communication, with comments such as ‘It was
just sort of abrupt wasn’t it? . . . There didn’t seem to be much of a consultation around it’ (1.2, JBS3, HCA)
and ‘There is definitely room for improvement I can see myself there’ (6.1, QRISK2, PN).
Several practitioners acknowledged a need for additional training to improve risk communication with
health check patients:
No, I think we do need more training in that.
1.1, JBS3, PN
We need more training to understand the risks better to deliver it to the patients.
1.2, JBS3, HCA
When asked about any training they had received, practitioners discussed this in terms of ‘can’t even
really call it on-the-job training, can you, really?’ (1.1, JBS3, PN) and ‘. . . it’s been on how to use the
[PoC testing] machine . . . rather than how to talk . . . and understand the risks’ (6.2, QRISK2, PN).
The latter point offers support to findings from the video-recorded consultations (see Chapter 4),
which suggested that the process often takes precedence over quality; the need to populate all parts
of the NHSHC template might be at the expense of the quality of interaction.
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Perceived patient understanding
It was suggested that patients who understand risk information are more likely to acknowledge their
personal CVD risk and understand the options that could help them modify their risk factors: ‘Because
if they understand that, they make changes to their lifestyle’ (4.1, JBS3, HCA). Perceived barriers to
understanding the risk information conveyed within the health check, included patients’ level of
education and possible ‘language barrier[s]’ (11.1, JBS3, HCA), but also a willingness to engage:
I: Why do you think some don’t understand [% risk score]?
HP: Maybe poor education . . . maybe they do understand, but they don’t care . . . so they don’t want to
know, they don’t want to discuss it . . .
3.1, QRISK2, HCA
Similar to findings from patient VSR interviews (see Chapter 5), there was also the suggestion that the
consultation involved a lot of information for patients to process, which could contribute to lack of
understanding and engagement:
. . . So, it’s alright giving them all the information [10-year risk], but whether they’ve taken any of it in . . .
8.2, JBS3, PN
Practitioners reported using patients’ verbal and non-verbal reaction to risk information to gauge
understanding: ‘Nodding their head, so I think they all understood what I was trying to say’ (11.1,
JBS3, HCA). They also appeared to recognise that this was limited: ‘It was based on their reactions,
but you did wonder sometimes whether they actually fully understood’ (5.1, JBS3, PN). The challenge
of using patient response to judge understanding was evident from analysis of video-recordings
of their health check consultations, which rarely demonstrated clear patient responses, positive or
negative (see Chapter 4). Here, there was a common feeling that even if patients ‘say they understand
the percentage, some will, and some won’t’ (12.1, QRISK2 +, HCA) (i.e. that patients might not tell
practitioners when they do not understand the CVD risk information presented):
Yes, they seemed to be [understanding % risk score], that’s the impression that I had got, and they didn’t
say otherwise, but maybe they wouldn’t, I don’t know.
6.2, QRISK2, PN
Moreover, there was little evidence that practitioners routinely explored patient understanding
through asking them, which again confirms findings from video-recorded consultations that health
checks tend to be practitioner dominated (see Chapter 4).
Heart age and risk manipulation functions of JBS3 were again discussed favourably. Heart age was
considered easier for patients to understand (than 10-year percentage risk): ‘. . . they can get their head
around that concept of their [heart] age a lot better than risk score . . .’ (7.1, JBS3, HCA). This could be
due to the inherent comparison/benchmark for heart age. The visual demonstration of manipulating
risk was thought to promote patient understanding; it provided a tool to help facilitate discussion of
risk-reducing behaviours, not just a risk score. This was discussed in terms of showing patients the
positive effects of their risk-reducing lifestyle choices; this is an example of gain framing (i.e. benefits
of reducing risk), which has been linked with increased self-efficacy to prevent heart disease:78
No, I think they understand more, because then they have an idea how . . . what they need to do to
change to find the results so . . . When you show them that if you bring your blood pressure down, your
cholesterol down, your weight down . . . how that can affect the results . . . And they start to think about
exercise and lifestyle . . . it’s like an eye opener to them . . .
4.1, JBS3, HCA
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There was also a suggestion that this was used to present risk with a loss frame (i.e. consequences of
high CVD risk), which might be more appropriate for those with a family history of CVD:78
So when I was increasing the blood pressure, or the cholesterol, or if they were a smoker, they actually
saw the difference and then they were like, ‘no I won’t, and thank God I am not [a smoker]’, you know so
it was a difference on them as well.
11.1, JBS3, HCA
Theme summary
Practitioners acknowledged gaps in their understanding or communication of 10-year risk, often relying
on the thresholds (low, medium or high risk). There was recognition that understanding of CVD risk
varied between patients, and a perception that heart age was understood more easily. Practitioners
associated patient understanding with lifestyle changes. They relied on patient reactions to information
to gauge understanding, rather than asking patients, although the VSR interviews did prompt a reflection
that they should involve patients more.
Risk-management
The third theme discusses how practitioners reported encouraging patients to reduce their CVD risk
and the associated barriers. This theme has two subthemes: promoting risk management and barriers
to risk reduction.
Promoting risk management
Practitioners described some routine medical follow-up for patients with elevated CVD risk: ‘raised risk
score over 10%, we’d always get them to come back have a complete workup of blood test done and
book in to see a doctor’ (7.1, JBS3, HCA). Practitioners reported that, during the consultation, they
try to promote risk management, primarily through educating and advising patients on how to modify
lifestyle (i.e. improving diet, increasing exercise, reducing alcohol consumption) to lower cholesterol,
blood pressure and body mass index:
I sometimes go into portion sizes and carbohydrates and things like that.
2.1, QRISK2+, HCA
Get a little bit more movement back and to get their heart pumping and use up some of the fats and
calories that they are eating and storing.
12.1, QRISK2+, HCA
Alongside this, some practitioners said that they use written materials, which they felt helped patients
to understand lifestyle and recommended changes: ‘. . . and then when we give that diet sheet, then
they look at it and they read and they go “oh, yeah, this is where I am going wrong” ’ (11.1, JBS3, HCA).
Referral to services to support risk reduction, such as exercise referral, smoking cessation and
weight management, were discussed. Some practitioners suggested that not all those referred to such
services will attend, ‘they don’t very often like to take you up on them’ (12.1, QRISK2+, HCA), and,
for those who do, attendance might not be sustained: ‘we have a big drop-out . . .’ (10.1, QRISK2, PN).
Practitioners suggested that a variety of contributing factors could explain uptake and retention of
intervention services, such as the cost of continued attendance (e.g. gym membership after period
of subsidised exercise referral); the absence of local services; lack of time to attend (working or lack
of childcare); or preferring to make lifestyle changes unaided: ‘Oh well I know what changes I need to
make, I’ll go away and make them’ (7.1, JBS3, HCS).
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There were a small number of reports by practitioners about patients making lifestyle adjustments
following a health check:
I see patients in general around the practice . . . say 6 weeks later and somebody will catch me and say,
‘oh, I really took in what you said, I’ve made some changes and my diet’s changed and this that and
the other’.
9.1, QRISK2, HCA
A lack of communication between the general practice and external services to which patients could be
referred meant that practitioners were uncertain if patients attended such programmes and, therefore,
how effective programmes were. Even when patients are referred to the GP following the health
check, practitioners were sometimes unsure about subsequent actions and outcomes.
Barriers to risk reduction
Practitioners identified several patient factors related to environment and intrapersonal factors in the
PMT (see Figure 2) that could be barriers to patients forming risk-reducing intentions or behaviours.
Some practitioners inferred that patients’ culture and personal beliefs could be barriers to risk reduction.
It was suggested that cultural beliefs may affect current lifestyle choices and patients may not recognise
that current lifestyle choices pose a health risk: ‘Yeah, because if you do say to them, they just say,
“oh, but we have parties, we have this that, and we have a lot of sweet food” ’ (4.1, JBS3, HCA). Further,
personal health beliefs may affect intentions towards behaviour change. Practitioners suggested that
patients who do not feel unwell may have less incentive to make a change: ‘You know think they’re
fine they think they’re invincible and you know nothing wrong, ’cos they don’t feel poorly’ (9.1, QRISK2,
HCA). Practitioners also indicated that some patients believe that their risk of ill health is related to
family history, rather than their lifestyle:
Sometimes, no matter how much you say to patients ‘I think it’s your diet and lifestyle’, they are still
adamant that, because their mum and dad have got it, that that’s why they have got it.
6.2, QRISK2, HCA
Moreover, some practitioners reported finding it difficult to refer patients to an intervention service
because local lifestyle support services were no longer operating or were not considered to be effective:
So, they have taken the lifestyle programme off us haven’t they, so we can’t offer that any more.
6.1, QRISK2, HCA
In addition, some practitioners expressed a lack of confidence in intervention services’ ability to
support patients to change, despite referring patients to such services: ‘I don’t think the Help to Quit
is very useful’ (2.1, QRISK2+, HCA). This experience and perception could explain the relatively low
number of referrals observed in patient medical records following health checks (see Chapter 3).
There was a common inference that patients’ willingness or apparent intentions to make risk-reducing
changes was largely determined by their intrinsic motivation, that although practitioners could provide
information, the impact that it had depended on patient motivation:
You can give them all the options in the world and then I think a lot of it is down to the patient and their
motivation to change.
6.2, QRISK2 HCA
It just depends how important they think it is for themselves, erm we can only do what we can do here.
Once they are out that door we don’t know, yeah, so hopefully some people do take the recommendations
and do what they can do.
11.1, JBS3, HCA
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In support of this idea that patients are recipients of information and advice, rather than active participants
in a discussion of their risk and its management, one practitioner described how they might respond to a
patient who does not understand CVD risk by moving on to risk factors and modification:
HP: That they just might not have understood, like the complexity of how you explain the QRISK and
that maybe where I would then adapt it, and maybe there are times when I might explain it, but not
explain the QRISK and the percentage as much, like I did with those patients you know?
I: So how would you explain it with those types of patients then?
HP: Just basically saying your risks of strokes and heart disease have increased . . . You have got a lot of
risk factors, you know, we need to give you a statin to bring you down. I need you to stop smoking, I need
you to eat better. You know and keep it a bit more basic.
6.2, QRISK2, PN
With this approach, the practitioner would be telling patients what to do, rather than engaging in
patient-centred dialogue. This confirms the indications that many health check consultations are
practitioner dominated (see Chapters 3 and 4) and do not include elements of motivational
interviewing, as recommended in the best practice guidance.17
Finally, even if patients appear to understand and respond positively to the risk information and advice
in the consultation, there can be uncertainty about the sustainability of the changes implemented:
Well I think it will have quite a good impact. Whether it would be sustained is another thing, but initially
it did seem as though ‘oh yeah I will do something about that’, but it is like human nature isn’t it with
things . . .
5.1, JBS3, PN
Theme summary
Most practitioners described risk management as lifestyle advice, routine medical follow-up triggered
by raised 10-year CVD risk (≥ 10%) or risk factors, and referral to support services (e.g. exercise referral).
Lifestyle advice was the most common intervention, sometimes supplemented by written information.
Perceived barriers to risk management included patients feeling healthy and, therefore, not recognising the
need for risk management (risk severity or vulnerability), lack of patient motivation, and limitations of the
services to which patients could be referred.
Summary
Analysis of data from VSR interviews with 15 health check practitioners regarding the perceptions and
experiences of undertaking health checks using QRISK2 or JBS3 highlighted a number of findings.
1. Practitioners were relatively confident about their ability to deliver 10-year risk. However, this metric
was largely used to identify patients with elevated risk, and to trigger routine medical follow-up if a
certain threshold was exceeded. It was generally not seen as a tool to facilitate a discussion of CVD
risk with patients, most likely because practitioners lacked understanding of 10-year risk and were
not confident about explaining it to patients.
2. There was a perception that patients were more responsive to, and therefore more likely to display
intentions for risk-reducing behaviours in response to, heart age and the risk score manipulation
and that patients liked the visual displays in JBS3 (including the heart age image). The limitation of
using patient reactions to gauge understanding and intentions and the lack of routine follow-up to
know what happens post health check were acknowledged.
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3. Event-free survival age was misunderstood by some practitioners, and the lack of thresholds to
indicate when risk was ‘high’ (as with 10-year risk) and lack of inherent comparison (as with heart
age vs. chronological age) limited its application.
4. Risk management strategies largely focused on lifestyle advice during the health check. Again,
the role of practitioners appeared to be as providers of information, rather than as facilitators of
change, the success of which was often discussed in terms of patients’ receptiveness to advice or
motivation to change.
5. Referrals to lifestyle support programmes were discussed, but such programmes did not appear
to be regarded as particularly well attended. The lack of follow-up to or communication between
general practices and referral services limited practitioner knowledge regarding patient attendance
or effectiveness of such services.
6. The need for training to increase practitioner confidence and understanding in CVD risk
communication was evident and was recognised by practitioners.
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Chapter 7 Results 5: case studies
Introduction
A subsample of 10 patients were selected for within-case analysis to further explore mechanisms by
which the risk calculators may lead to changes in patient or practitioner behaviour. Selection was on
the basis of evidence of positive intentions and/or behaviours to reduce CVD risk following the health
check, to provide balance across QRISK2 and JBS3 groups, to cover a range of general practices and
practitioners, and to provide a variety in the type of positive experiences.
Using patient pseudonyms, each case study is presented under the following subheadings:
l Summary – a brief statement to illustrate how the health check led to positive patient intentions,
behaviours or outcomes.
l Patient – patient background such as family history, basic health or lifestyle information and general
attitude towards the health check.
l Practitioner – practitioner background in terms of their role, experience and training. All
practitioners expressed positive perceptions of the NHSHC programme as a means of identifying
unknown issues in patients who otherwise might not visit the practice. These perceptions are not
included in case studies, but can be assumed for all.
l The NHS Health Check – summary of the consultation, including duration, CVD risk communication
and level of patient involvement, and any notable events or perceptions from patient or practitioner.
l What worked well – summary of the reasons that appeared to explain why the patient demonstrated
positive intentions or behaviours relevant to CVD risk reduction following their health check.
l Areas to improve – parts of the consultation that could have been improved.
Two case studies from the QRISK2 group used Informatica and are labelled as QRISK2+.
Case study 1: Abbie (JBS3)
Summary
This case study describes Abbie, who was in relatively good health, with no clear CVD risk factors and
who did not require any post-health check follow-up. CVD risk was communicated using heart age and
risk manipulation prompted Abbie to make dietary changes to address her elevated cholesterol, which
was identified in the health check.
Patient
Abbie is a 61-year-old white British female living in a relatively deprived area (IMD decile 2). She does
not drink alcohol or smoke, walks at least 10,000 steps a day, and regularly undertakes gardening and
housework. She has no family history of CVD and has lost 8 kg since her weight was last recorded
(8 years previously). She feels that having this type of health check is important and expresses gratitude
to the practitioner. Her total cholesterol is slightly elevated, but not enough to warrant follow-up.
Practitioner
This health check is delivered by a British Asian female HCA with 2 years’ experience of delivering
health checks and who has received ‘on the job’ training (no formal training). The HCA is positive about
NHSHCs in general and likes the JBS3 manipulation options. She feels confident in communicating
the risk score as the ‘GP has explained it’ to her and thinks that, in general, patients understand the
information presented to them.
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The NHS Health Check
The health check is shorter than average (just over 17 minutes). However, the HCA talks for a smaller
than average proportion of time (46.0%) and Abbie speaks a little more than average for the sample.
Abbie’s QRISK2 score is calculated as 4.8% and her heart age is estimated as 61 (equal to her actual age).
What worked well
Abbie reacted positively to heart age:
I was pleased to hear that [heart age was 61] and encouraged really . . . I found the whole thing
encouraging, it encourages me to make some changes and to look after myself, because I think
that is my duty.
Abbie liked the visual element of heart age: ‘because it was on the screen, I think that is just such
an aid to memory’ and ‘an understandable way of presenting it’. The HCA also recognised Abbie’s
positive reactions. She felt that being able to show Abbie her heart age on screen had helped Abbie to
understand the concept, and that it was helpful for the two of them to compare Abbie’s heart with her
true age, to see whether it was ‘good or bad’.
During risk score manipulation, there was discussion around good and bad cholesterol, and how to
reduce Abbie’s total cholesterol, which was elevated. Abbie and the HCA appeared to enter into a
mutual discussion, which concluded with Abbie thanking the practitioner. Abbie later reflected:
I thought that was very well done actually, and because the nurse showed me . . . by changing some of
the data . . . that was very clear and understandable to me, so I thought that was quite a good way
of doing it.
This information was remembered by Abbie, who had implemented some changes: ‘[the practitioner]
actually suggested cutting [cheese] down to a couple of times a week, which I have done already, so
that definitely has had an impact’. Abbie said during her VSR interview that when ‘information was
given to me in the recommendation . . . I have implemented that immediately’. The HCA also liked
using the risk manipulation function within JBS3, describing it as an ‘eye opener’ for patients.
Areas to improve
Abbie highlighted the challenge for practitioners in reading patients’ reactions to CVD risk information,
and the need to ask patients if they understand and tailor appropriately. Abbie could not remember
her 10-year risk: ‘I am not sure I fully understood the importance of the cardiovascular part of it’.
However, the HCA perception of Abbie’s response, when she watched the video clip of their consultation
(‘they just nodded and quite calm’), and our ratings of engagement based on non-verbal cues identified
Abbie as being generally positively engaged.
The HCA liked JBS3 and being able to ‘show [patients] on the screen, they can see what is going on’,
but referred to event-free survival age risk as ‘a good way to show patients if you can control things,
your life expectancy will increase’. This showed that the HCA misunderstood the score and, as a result,
did not describe it clearly to Abbie during the health check: ‘So on average it’s [the system] picked
inside 80–85 about a heart attack or stroke’.
In turn, Abbie did not understand or ask for clarification. Comparing it with heart age, she said she
did not understand it ‘as clearly I don’t think . . . I don’t think I took it on board quite in the same
way’. This lack of understanding was not obvious to the HCA, who attributed Abbie’s lack of reaction
to the fact that she was reading the screen and taking in the information, rather than to a lack
of understanding.
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Risk score manipulation was performed using blood pressure, which was normal, rather than cholesterol,
which was elevated. This highlighted the need for tailoring. Abbie left with unmet information needs.
She was keen to learn more about how to implement a change, but did not follow-up:
Until you know what to do you can’t implement it and particularly over blood pressure. I would like to
learn [more about] the blood pressure, but I don’t know how you go about doing that.
Had the HCA asked Abbie if she understood or required further clarification, this could easily have
been addressed.
Case study 2: Barry (JBS3)
Summary
This case study describes Barry, a patient who presented with a number of CVD risk factors including
increased alcohol consumption, poor diet and slightly elevated cholesterol. Barry was recommended to
make a specific lifestyle change that he was already considering. Despite other elements of CVD risk
communication being suboptimal, he made a positive change, demonstrating that the health check can
serve as a prompt to initiate risk-reducing behaviour when patients are on the cusp of acting.
Patient
Barry is a 47-year-old white British male living in a deprived area (IMD decile 1) who drinks 40 units
of alcohol per week, has never smoked and reports doing ‘a bit of running every now and again’. His
diet is the main area of discussion, as he admits to eating ‘a whole pack of chocolate biscuits every
single day’ and excessive consumption of dairy products. Barry has a family history of heart problems
(maternal grandmother) and diabetes ‘runs in my family’.
Practitioner
This health check is delivered by a white British female PN who has 8 years’ experience of delivering
health checks and had previously attended two NHSHC training courses with the last being ‘at least
2 years ago’. The PN felt that she did not ‘have any problems’ with communicating CVD risk to patients
and preferred JBS3 over QRISK2 because ‘you can actually communicate far better, and it’s got visual
. . . everything about it, the patient can actually understand it better than just me talking’.
The NHS Health Check
This health check lasts just over 22 minutes, approximately average for the JBS3 sample, but is
relatively dominated by the practitioner, who speaks for 56% of consultation time, and Barry speaks for
18.4% of the time. Barry’s 10-year risk is 3.1%. Only total cholesterol was considered ‘a little bit high’,
at 5.3 mmol/l (ideally < 5 mmol/l). Barry’s heart age was estimated at 54, which was 7 years older than
his actual age, which the PN attributes to his family history and elevated cholesterol. Based on a
discussion of lifestyle, the main recommendations are to reduce consumption of chocolate biscuits and
increase fruit and vegetable intake.
What worked well
About 3 weeks post health check, Barry had implemented dietary changes and felt that this was
sustainable. Although he had ‘wanted to reduce my biscuit intake anyway’, the health check ‘prompted’
this change, and he had not ‘eaten chocolate biscuits now for over a fortnight’. The discussion around
alcohol had also moved Barry to consider moderating his alcohol, but he saw this as a next step.
A blood test 3 weeks post health check showed that cholesterol had fallen to within the normal
range and, after an appointment with Barry’s GP, no further action was taken.
Areas to improve
Barry said that he was ‘expecting more’ from the health check, ‘something more in depth’, with more tests.
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Although the PN was confident in delivering 10-year CVD risk and believed that ‘the majority of them
[patients]’ understand, when watching the video clips of her interview she ‘did wonder sometimes
whether they [patients] actually fully understood’. Barry could not remember his 10-year risk when
asked by the researcher, even when prompted with a video clip. Although he interpreted the score as
‘quite low’, he said that he ‘didn’t remember it no, I don’t understand it’.
In line with current findings from the VSR patient interviews (see Chapter 5), the PN felt that being
told heart age would be shocking, but Barry did not react in this way. His interview demonstrated that
he had not fully understood how this information had been derived. The consultation would have been
improved by the PN picking up on the trigger of this apparently contradictory result (of old heart age,
but low 10-year risk).
There was misinterpretation of the discussion of event-free survival age, from which Barry took away
that he had survival age of 73 (rather than event-free survival). Barry’s response was to ‘live my life to
the full’, but such misunderstandings could have significant negative consequences including a sense of
futility in relation to lifestyle that negatively affects health behaviour. The practitioner’s VSR interview
revealed that the PN had similarly misinterpreted this risk score.
Finally, the PN altered the blood pressure as an example of how making small changes can be effective,
but this point was missed by Barry, who was confused by the different numbers being entered:
‘I thought my blood pressure was low?’.
Case study 3: Carl (JBS3)
Summary
This case study illustrates a patient, Carl, who presented with a number of CVD risk factors, and in
whom presentation of heart age had a significant impact. This resulted in Carl making a number of
small lifestyle changes following his health check.
Patient
Carl is a 59-year-old white British male who lives in a relatively affluent area (IMD decile 9). He
reports rarely drinking and that he stopped cigarette smoking in 2015, after ‘40 odd years’. He does
little exercise because of ‘spinal problems’ and had a paternal grandfather who ‘had a stroke . . . he was
late 60s, 70s’. Carl reveals that his friends and family ‘think I’ve got type 2 diabetes’, which was one of
the reasons for attending the health check.
Practitioner
This health check is delivered by a white British female HCA with 5 years’ experience of delivering
health checks. She received training in health checks prior to delivering them, but this primarily
focused on PoC testing, and she cannot otherwise recall the training content. The HCA is ‘quite happy
communicating’ CVD risk to patients’ and ‘primarily do[es] it in the same way’ for all patients she sees.
She prefers ‘JBS3 because it has got the heart age on it’.
The NHS Health Check
This health check lasts longer than average (> 27 minutes) and involves more patient speaking than
most (32.9% of total time), and CVD risk is discussed for > 2 minutes. Carl’s QRISK2 is 11% (medium
risk), described as ‘a little bit higher than we’d like it to be’, and his total cholesterol has ‘gone up a
little bit’, to 4.9 mmol/l from 4.5 mmol/l (in 2016). It is suggested that Carl considers improving his
good cholesterol. His blood pressure is ‘just sort of on the higher end of where we’d want it to be’ and
his body mass index (BMI) is 28.4 kg/m2.
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What worked well
Carl said the health check was ‘what I expected and I’m very happy, yeah’ and was ‘now more mindful
of, of what I am or I’m not doing’.
The visual presentation of heart age had the most impact on Carl. He reported that it ‘shocked me,
no it concerned me’, and made him think ‘yeah, I ought to do something about that’. He remembered
‘the picture on that screen, the 65 . . . being in the middle’ and ‘thinking bloody hell I ain’t 65’.
The HCA manipulated Carl’s information within JBS3 to illustrate that reducing his total cholesterol
and increasing HDL cholesterol through simple changes to his diet and physical activity levels would
reduce his CVD risk to 9.3% and lower his heart age to 62. The HCA thought ‘it’s really good having
that option’ because ‘they can actually visually see the changes’. Carl did ‘remember that’, but had
‘already got the message’ by that point.
Carl found a diet sheet provided by the HCA ‘helpful’. He reported several positive behaviour- and
health-related outcomes:
l ‘ordered a small blood pressure monitor’, which he admitted he had ‘never done anything like
that before’
l felt ‘more mindful’, and was trying to ‘do a bit more exercise’ and ‘now looking at certain foods’
l had ‘been researching because of my concerns about diabetes’
l diabetes was later diagnosed following a full blood check at 6 weeks post health check and Carl was
prescribed metformin.
Areas to improve
Ten-year risk was not explained by the HCA and, subsequently, was not recalled or understood by
Carl. On watching the corresponding video clip, he said that it ‘didn’t make a significant impact on me’.
In the absence of an explanation from the HCA, Carl questioned ‘exactly how she arrived at that
percentage’, only remembering that ‘they’d like me to be 10% or less and I’m only 11’.
The HCA did not understand and, therefore, miscommunicated event-free survival age: ‘currently you
can sort of expect to survive the age of 79 based on your lifestyle factors’. The HCA found it ‘the
hardest one to try and communicate’. In this health check, it did not create a serious issue as Carl
reported that seemed ‘a long way off, you’re looking like 20 years in the future’ and recalled thinking
‘well that’s better than what my dad or what my grandparents had’.
Case study 4: Deborah (JBS3)
Summary
This case study presents Deborah, a patient in good health, for whom the health check provided
reassurance. In this example, Deborah attended with a positive attitude to her health. She tried to
lead a healthy lifestyle and was grateful of the health check as an opportunity for reassurance.
Patient
Deborah is a 63-year-old white British female living in a relatively affluent area (IMD decile 10) who
has never smoked, reports modest alcohol consumption (‘7–10 units per week’), ‘excellent . . . varied
diet, nice portion sizes’ and is a ‘Pilates teacher’ who teaches aerobics, and practises yoga for 2 hours
each day. She has no known family history of CVD, but is aware of high cholesterol in the family
(including herself).
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Practitioner
The health check is delivered by a white British, female, newly qualified PN. She has 9 months’
experience of conducting health checks and has ‘had a lot of shadowing’, but no formal health check
training. She felt confident ‘explaining what the QRISK is . . . yeah I’m fine with that’.
The NHS Health Check
This health check is relatively short (17 minutes), but includes > 3 minutes of CVD risk discussion, and
Deborah speaks for > 28% of the health check (above average). Deborah’s 10-year risk is 4.7% and her
heart age is 58 years. Total cholesterol is slightly elevated (5.8 mmol/l) but, in the context of LDL and
HDL figures, her cholesterol level is described as ‘within normal range’.
What worked well
Overall, Deborah reported that the health check ‘was as I expected’ and that it was ‘good to actually have
some reassurance that everything is OK’. She said, ‘I have always been interested in my health, so, erm, for
me it’s a positive thing’ and was ‘grateful that [they] had the opportunity’ to have the health check.
Heart age was the CVD risk information that affected Deborah most positively: ‘when she told me that
my heart age was 5 years less than my actual chronological age’ it served as ‘a positive reinforcement
both for me and within my job’. The PN reported that heart age came ‘more naturally the more I used it’
and felt that patients ‘generally responded really well’.
The PN correctly described event-free survival age and, in turn, Deborah later interpreted it to mean
that ‘I should be alright until I am in my 80s, yeah, before anything might start to develop . . .’. This
emphasises the importance of practitioners having accurate knowledge of CVD risk scores in order to
convey this to patients and mitigate against misinterpretation.
Using JBS3 had led to a change in practice. The PN suggested that they ‘much prefer using [JBS3]’ as they
‘think it gives the patients a better understanding’ and ‘still use it now’ following the conclusion of the study.
Areas to improve
First, information presented without a visual aid was forgotten. Deborah was unable to recall her
10-year risk and, when watching the corresponding video clip, reflected that she ‘understood’ it and
‘wasn’t confused at all’. The PN also thought that ‘they [patients] all understood fully the 10-year risk’,
but that QRISK2 is ‘lacking . . . the visual aids’.
Second, event-free survival age was communicated accurately by the PN in the health check, perhaps
as they read the information from the screen, during the VSR interview, their discussion of this risk
score indicated some misunderstanding: ‘really good you know . . . [patients can think that] “I am going
to survive to 82” ’.
Third, risk manipulation could have been better tailored to Deborah by showing potential CVD risk
reductions through lowering cholesterol (which was raised), rather than how risk would increase
should they start smoking. Deborah had never smoked and confirmed the irrelevance of this scenario:
‘would never happen’. In contrast, the PN thought that manipulating patients’ risk scores ‘had a positive
effect’ and that patients ‘really responded to that’. This highlights a mismatch between practitioner
perceptions of how patients received CVD risk information and the reality.
Fourth, there was some inaccuracy in how the PN relayed patient HbA1c information in relation
to a result in the normal range, which ‘put a big red flag up in my head when I heard that’. Despite
describing it as ‘up at the top end’, the PN did not engage in a discussion around this, but rather
spoke about what would happen if it was in the pre-diabetes range. This resulted in Deborah deciding
to ‘work on that although my solution to that is not to buy [sugar] and not have it in the house’.
This could be an unnecessary burden resulting from inaccurate information.
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Finally, Deborah was positive about the overall experience. However, her body language during CVD risk
discussion was rated as either passive or slightly positively engaged. If picked up by the practitioner, this
could have triggered a discussion to address some of the above issues with how CVD risk information
was provided and received.
Case study 5: Eid (JBS3)
Summary
This case study presents, Eid, a patient with a generally healthy lifestyle in whom the health check
identified mild hypertension. Although this prompted lifestyle changes, follow-up tests and an
appointment, heart age was the only CVD risk information that he could recall and no lifestyle
advice was offered.
Patient
Eid is a 58-year-old Asian British male who lives in a relatively deprived area (IMD decile 2). He has
never smoked, does not drink alcohol and ‘play[s] a bit of sport’ including football and table tennis.
Eid reports ‘eat[ing] a lot of fruit’ and has no known family history of CVD. He felt having a health
check ‘would[n’t] do any harm’ as there is ‘nothing wrong with making sure everything is OK’.
Practitioner
The health check is conducted by an Asian British female HCA who has been delivering health checks
‘ever since the NHS programme started’ and received training ‘when it started’ and ‘. . . last year
as well, and then it’s online as well’. The HCA feels ‘OK’ about communicating risk to patients and
as ‘I know what I am saying, I am more confident and happy to speak to the patient’. She thought
JBS3 was ‘really good, because it tells you the heart age, erm, it tells you the lifespan’ (reflecting a
misunderstanding of event-free survival age observed among other practitioners). The HCA ‘enjoyed
using it [JBS3]’, preferring it to QRISK2 ‘because it’s visualised, the patients you know they are seeing
what their results are. It is not just more score’.
The NHS Health Check
The health check lasts just over 15 minutes. The HCA speaks for only 36% of the time, but Eid’s
contribution is low (20%) and a relatively high proportion of the health check passes without either
participant speaking. Eid’s 10-year risk of 15% is described as ‘medium’ and his heart age is estimated
at 59, approximately 6 months older than his actual age. As Eid’s blood pressure is ‘high’, the HCA tells
him that she will speak with the GP, who will ‘get back to you [Eid]’, and advises Eid that he is likely be
called ‘in for a 24-hour blood pressure’ check.
What worked well
Overall, Eid felt that the health check was ‘helpful for me because, obviously, it gives me an idea of
how things are’, as he rarely attended the surgery. Ultimately, the success of this health check was
in identifying and following up the identified hypertension. Eid remembered that his blood pressure
‘was a bit on the high side’ and was ‘surprised’ as he had not ‘had any issues with it before’.
The most impactful element of CVD risk communication was heart age, with which Eid was ‘quite
happy’ and found it ‘very useful to know’. The result ‘reassured what I already knew, that I was quite
healthy’. The HCA suggested that patients ‘understood [heart age] a lot more . . . because obviously . . .
they know how old they are’ and believed that the visual presentation was helpful (‘them seeing it,
I think it’s a big difference’) compared with relaying the percentage risk score, as is usual practice.
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Areas to improve
Eid did not recall the HCA telling him ‘what I needed to do’. Indeed, the HCA did not offer advice aside
from clinical follow-up (re-test/GP appointment). Consequently, Eid had received ‘a few tips on what to
do’ to reduce his blood pressure from his sister. Eid assumed that this was because the HCA ‘wouldn’t
know until’ she had completed further blood pressure monitoring.
There were several issues with CVD risk communication. First, Eid had a medium–high 10-year risk, yet
could not recall it, nor did he ‘put any importance on it’ (when reminded in his VSR interview) because
he was ‘well within the percentage of being healthy’ and ‘thought the risk out of 100 was minimal’.
The HCA reported using only the risk categories (‘high/medium and low’) because patients ‘don’t really
understand the percentage of the number’. This seemed to be an assumption and was not checked by
enquiring about Eid’s understanding or feelings.
Second, in the health check, the HCA communicated event-free survival age by saying ‘on average
expect to survive is 80 for yourself without a heart attack or a stroke’. The HCA later discussed how
this was a challenging screen and her communication suffered as a result: ‘telling them that your life
expectation, it could be . . . I think I find it a bit hard’. This highlights a mismatch between what the
HCA read from the screen in the consultations (which was correct) and her apparent understanding of
this score as expected survival age. Moreover, the HCA thought that Eid ‘knew exactly what I was
saying’ on watching the video clips. In contrast, Eid could not ‘recall it, I think she said . . . something
about 80 something’, again misinterpreting event-free survival age as expected age of mortality: ‘I’ve
got a few more years to live’.
Finally, Eid had never smoked and presented with mild hypertension. Yet, for risk manipulation in JBS3,
the HCA showed how Eid’s risk would increase if he were a smoker. He appreciated being ‘reassured
. . . that what I’m doing with my health is good and I’ve got to keep it going’, but a more relevant and
tailored manipulation of risk would have been preferable.
Case study 6: Freddie (QRISK2+)
Summary
This case study describes Freddie, a male patient with a range of CVD risk factors, and a medium–high
10-year CVD risk. Freddie was aware of the need to change his lifestyle. He attended with an ‘open
mind’, and received quick and multiple follow-ups after the health check. In this way, the health check
served as a catalyst for change and Freddie subsequently made multiple positive lifestyle changes.
Quickly, his efforts were rewarded with weight loss and a reduction in blood pressure.
Patient
Freddie is a 64-year-old white British male who lives in an area of approximately average affluence
(IMD decile 6) and has not visited his GP for 13 years. He has no family history of CVD, but presents
with a range of risk factors: BMI of 45 kg/m2 (morbidly obese category), moderate hypertension
(167/90 mmHg) and very high alcohol consumption. His main reason for attending is to achieve
weight loss, but he also has concerns about the physical effects of his alcohol intake. Freddie is
positive about the health check, which he recognises as being about ‘prevention rather than cure’.
Practitioner
The health check is delivered by a female white British HCA with 2.5 years’ experience of delivering
health checks and who has attended generic NHSHC training and shadowed a colleague. Despite
positive perceptions of the programme, she feels that it ‘needs tweaking’, and thinks that the primary
purpose of QRISK2 is to identify patients to refer to the GP, rather than to facilitate discussion around
CVD risk.
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The NHS Health Check
This general practice has access to Informatica, which offers some of the JBS3 functionalities, including
heart age and risk score manipulation, which were used in this health check. At 27 minutes, this health
check is considerably longer than most, and Freddie speaks more than the sample average (31% of
total time). Freddie’s 10-year risk is 17% (approaching high risk, 20%), which he interprets as being ‘. . .
lucky that’s quite low really – I was expecting it to be higher’. The HCA is disappointed with her
delivery of 10-year risk information when watching the corresponding video clip (‘like a parrot’;
‘maybe I don’t do enough on that’).
What worked well
Freddie appeared engaged throughout the health check and spoke more than many other patients
in the sample. He was ready to make changes, and the suggestions made by the HCA resonated with
the issues of which he was already aware. This meant that Freddie was later able to recall parts of the
health check conversation with the HCA (e.g. ‘wine has got sugars in them – sugars go to the wrong
places’). This appeared to make Freddie receptive to suggestions and meant that the HCA did not need
to convince him of the importance of CVD risk or lifestyle.
Freddie received a telephone consultation with a specialist nurse practitioner within ‘a couple of hours’
of his health check to reinforce the messages given (telephone reinforcement). This appeared to facilitate
understanding and retention of 10-year risk, as he was able to recall ‘an analogy of you know like
100 people in a room – 17 can be expected . . .’ (words not used in his health check). A barrier to
exercising was identified (could not afford gym membership), and the health check and subsequent
telephone consultation led to a series of outcomes:
l discussion of statins
l exercise referral for 12 weeks of subsidised gym sessions at a local authority leisure centre
l Freddie changed his diet and alcohol intake ‘. . . I have dropped all the things that I know I should
not be eating and it seems to be having an effect . . . I seem to have dropped a few pounds . . . I have
dropped the booze a lot – well totally for the minute, erm, which has helped me sleep a lot better’
l reduction in blood pressure to the normal range.
Areas to improve
Freddie’s 10-year risk put him close to the high risk category, yet he did not recognise the risk severity.
Freddie could not recall being provided with heart age or the HCA manipulating risk scores, which
contrasted with the HCA’s perceptions that ‘heart age is most effective’. Heart age is likely to have
been forgotten because the follow-up telephone consultation focused on 10-year risk. There was scope
to better tailor CVD risk discussion; for risk manipulation, the HCA showed how heart age would
increase if Freddie were a smoker, yet he had never smoked and subsequently forgot his heart age.
It would have been more appropriate to show changes in a risk factor more relevant to Freddie, such
as reducing blood pressure through modifying alcohol and diet: ‘Well that just reaffirms my thinking
about smoking and I did think, erm, the alcohol side might come into it’.
Case study 7: Grace (QRISK2)
Summary
This case study of Grace illustrates that, even when relatively short with minimal discussion of CVD
risk, a health check can be valuable in identifying areas for change, if the patient is already actively
trying to improve their health.
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Patient
Grace is a 56-year-old white British female who lives in a relatively deprived area (IMD decile 2).
Her parents died suddenly of heart failure in their 70s. She stopped smoking 14 months earlier, attends
Slimming World® (Alfreton, UK), has not gained weight since her last visit to the GP, and reports
moderate alcohol intake. Grace is engaged with, and has a positive view of, preventative health care
(‘usually have the well-woman check’) and describes the health check as a way ‘to find out if there’s any
underlying problems which you may have and it’s just really good to keep on top, because you feel fine
but you don’t know what is going on inside’.
Practitioner
The health check is delivered by a white British female HCA with 2.5 years’ experience of delivering health
checks. After participating in the recorded health checks, the HCA completed training in NHSHC, after
which she concluded ‘I don’t think you should give these health checks unless you have had the training’.
The NHS Health Check
The Health Check lasts just 16 minutes and Grace speaks for only 10% of the total time. CVD risk is
discussed for just over 40 seconds. During the health check, Grace’s 10-year risk is calculated at 6.9%
(low). Slightly raised total cholesterol (6.1 mmol/l) and blood pressure are flagged as initial concerns.
What worked well
This health check identified a rise in Grace’s cholesterol, which she attributed to less healthy dietary
habits ‘creeping in’. Risk management discussion focused on this also; the interview data demonstrated
that Grace was clear about her related goals:
I really am going to like get the cholesterol down that’s my main thing . . . So I am really, really saying
right ‘no, we are not even having that in the house, we are not eating this, we are not having that any
more,’ and we are definitely eating better . . .
Two in-clinic blood pressure measurements showed Grace’s blood pressure to be raised, but, at home
readings were found to be normal, no further action was deemed to be necessary.
Areas to improve
The HCA spent very little time discussing 10-year risk:
HP: I’m going to access your QRISK2 score, erm which is, which tells us your likelihood of contracting
cardiovascular disease within the next 10 years . . . So it’s 6.85, which is still OK, it’s below 10.
P: Hmm.
HP: So, erm so it’s not something that we really need to worry about, but getting your cholesterol down.
Grace could not recall her 10-year risk, only that it was ‘low’, and said she ‘just didn’t really absorb it
. . . afterwards I thought “well she said it was under 10”, but what it was, I couldn’t quite put my finger
on it’. Despite that, Grace was motivated to reduce her cholesterol. Encouraging Grace to maintain her
good lifestyle while making small changes, particularly given her positive engagement with the health
check, could prevent further decline.
Case study 8: Harry (QRISK2)
Summary
Harry presented with multiple CVD risk factors and the PN spent > 3 minutes explaining his CVD risk.
This seemed to convince him of the need to go back on to a low-dose statin, despite initial reluctance.
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However, following the apparent success of his health check, Harry could not recall his 10-year CVD
risk, remained reluctant to take statins and had no intention of changing his lifestyle.
Patient
Harry is a 61-year-old white British male, who lives in an area of approximately average affluence
(IMD decile 5). He has a family history of heart attack (father) and has previously taken statins, but
managed to come off them with the support of his GP. His blood sugars have been in the pre-diabetic
range for 3 years, which is Harry’s motivation for attending the health check: ‘for the last couple of
years the doctors been saying I am on the edge of becoming diabetic . . . that was the thing that was
pushing me just to make sure I got the health check’. However, when asked if he had heard of the
NHSHC he commented ‘Yes, but I wasn’t particularly bothered’.
Practitioner
The health check is delivered by a female white British, PN. She has 2 years’ experience of delivering
health checks, but has not received formal training: ‘when I first started, I perhaps would have shadowed
somebody doing them’. Despite feeling ‘fairly confident’ in communicating 10-year risk, she conceded
that ‘all I have ever been told is anything over 10% needs to be started on a statin. Anything below 10%
are fairly low risk, you know, and obviously yeah I discuss that with the patients, but other than that
I don’t know a huge amount about that with the QRISK score at all’.
The NHS Health Check
The health check is one of the longest (> 37 minutes). Harry speaks for 29% of the total time, and
CVD risk is discussed for > 3 minutes. During the health check, Harry’s 10-year risk is calculated
as 14.2%, and blood results showed slightly elevated total cholesterol (5.4 mmol/l) and blood sugars
in the pre-diabetes range. Blood pressure was normal. Both the PN’s assessment and our analysis of
patient engagement from non-verbal cues of the video-recorded consultation suggested that Harry
was positively engaged throughout the CVD risk discussion.
What worked well
The PN explained some factors from which Harry’s 10-year risk was calculated to highlight the need
for him to consider going back on to a low dose statin as a means of lowering risk:
So this is your risk of getting heart disease in the next 10 years . . . that puts it to a calculation of your
weight, your smoking, or lack of smoking . . . and your cholesterol, that sort of thing . . . it’s come out with
a risk score of 14.2%. So ordinarily anything over 10% we would offer a cholesterol-lowering tablet . . .
we would recommend that you start back on your statin.
The PN then went on to explain that Harry’s risk was above average for a man of his age:
. . . let me just go back on to that and I explain in a bit more detail. So like I say, erm ,this is coming out that
your risk score is 14.2% the average 61-year-old male is 10.1%. So you’re slightly above the average . . .
After additional information was given, Harry appeared to recognise the severity of his CVD risk
(‘I don’t like the fact . . . about the risk score’) and moved towards action:
HP: So how do you feel about starting back on it?
P: I didn’t want to.
HP: OK.
P: I will if that what it takes.
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Harry showed confidence and positive engagement in requesting a discussion of his pre-diabetic status,
which was his primary concern, and sought specific details: ‘What does that mean? Does it mean
tablets, does it mean injections?’. This allowed the PN to explain and again highlight the importance
of lifestyle (as well as medication) to prevent progression to diabetes.
Areas to improve
Harry could not recall his 10-year risk and reported that being shown the video clip ‘brought the
disappointment back to me because I was expecting to be better than that’. However, ‘it didn’t make
me feel any different . . . it hasn’t made me change my lifestyle at all’. He revealed that he had not yet
picked up his statins, but ‘I still got my old ones which I had stopped taking. So I have been taking half
of one of them every day’.
Harry’s description of the health check highlighted two issues that prevented more engagement with
the PN’s recommendations. First, the PN’s explanation of his above average 10-year risk did not
empower him:
Mainly to do with the fact that you got family history of cardiovascular disease . . . So although everything
else is pretty good . . . we can’t help what you’re already predisposed to unfortunately, which is your dad.
This left Harry feeling like ‘there was nothing in there that I am not already doing. There was nothing
to do’.
Second, a more tailored approach was needed. Harry expressed a desire for specific lifestyle guidance,
as he left feeling that ‘without any clear direction, I haven’t got anything to change . . . the nurse said
“keep walking the dogs, keep doing the exercise . . . just try and do healthy things, eat your greens and
you know have your five a day”. . . do those things which I am doing anyway’. The lack of specific advice
was acknowledged by the PN on watching the corresponding video clip of this health check:
I did notice when the diet one came up, I did just put a piece of paper in front of them, and I didn’t read
it. So actually in hindsight, perhaps I should have said, ‘you shouldn’t eat this, you shouldn’t eat this, you
shouldn’t eat this’ . . . in hindsight, I could have explained a little bit better. Like the statins, he wasn’t
overly keen on taking the statins was he?
Finally, Harry thought that it would have been useful to have the opportunity to reflect and then ask
further questions ‘In some kind of follow-up, even if it’s a week later on or whatever’. This confirms
the potential role of telephone reinforcement.
Case study 9: Ian (QRISK2)
Summary
This case study describes Ian, a male who was very positive about the overall health check experience,
the practitioner and the advice given, and had implemented some lifestyle changes. Ian had excessive
alcohol intake and had made beneficial changes. The CVD risk discussion was brief and, ultimately,
forgotten; however, in this case it did not matter.
Patient
Ian is a 48-year-old white British male who lives in a relatively affluent area (IMD decile 10) and is
active through his job as a postman. He is an ex-smoker (of 4 years) and has been trying to improve
his diet to manage his cholesterol, but reports excessive alcohol consumption (> 30 units per week).
He has not heard of NHSHC.
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Practitioner
This health check is delivered by a female white British HCA who has 6 years’ experience of delivering
health checks and attended generic training several years earlier, but cannot remember the details.
Although reporting confidence in communicating a 10-year risk, when asked about her understanding
of the score, the HCA focuses only on the thresholds:
. . . anything over 10% is a higher risk, erm . . . so then other risk factors need to be taken in consideration
like family history and things, erm . . . to see, like I say, if it’s worth going on a statin . . . those people are
then would forward onto the doctor for further review or we’ve got a pharmacist.
The NHS Health Check
The health check lasts just under 19 minutes and Ian speaks for just 18% of the consultation. CVD risk
is discussed for just over 1 minute. The HCA collects information on Ian’s lifestyle and offers advice
before his 10-year risk is discussed. Ian’s 10-year risk is 4.5% (low risk), but he is noted to have a slightly
elevated total–HDL cholesterol ratio and excessive alcohol intake. Discussions around dietary changes
to manage cholesterol and reducing alcohol intake account for the majority of the health check.
What worked well
Ian thought it would be longer (‘I’d thought I’d been in there half an hour, at the most I were in there
10 minutes’), yet felt that the HCA ‘was excellent . . . she gave me some great advice’. The way in which
the HCA communicated was clearly appropriate for him:
It weren’t sterile . . . we had a chat . . . it was like visiting a friend.
Ian’s alcohol consumption identified a risk of alcohol-related harm. The impact of the corresponding
discussion was clear during Ian’s VSR interview: ‘I didn’t think it was a problem . . . and maybe it did
become a problem’. Ian made immediate changes, ‘as soon as I talked to her I’d stopped drinking for
a fortnight’. Although he had since had a drink, he had also made dietary changes to address the
elevated cholesterol ratio through eating more fish (albeit tinned tuna, rather than the recommended
oily fish) and vegetables: ‘I actually feel healthier’.
The health check ended with the HCA saying that ‘we are going to set some goals for you’, and Ian had
responded. This was something the HCA specifically mentioned in her VSR: that she tends to set goals
with the patient’s agreement:
I sometimes find if I ask the patient to set a goal they sort of sit there . . . they don’t really know what
goals to set, so I do find that I do, sort of instigate . . . but they agree . . . It’s rare that I’ll instigate a goal
and patients don’t agree with it.
In the light of the low 10-year risk, the HCA tried to emphasise the importance of prevention in general:
As we get older our percentage naturally goes up because we are older, so when we are a young age
because that is a young age, that’s my age, so when we are of that age we have to look after yourselves
and prevent, it’s all about preventative measures OK.
Areas to improve
When 10-year risk was conveyed, it was quickly given as a relative and then absolute percentage risk
score, without much explanation or checking of Ian’s understanding:
OK, so, for your age group, the risk of developing heart disease in the next 10 years is 3.5%. Your risk is
4.5%, so it’s slightly up. Erm, is still a low risk percentage when no major concerns of that but we do need
to say to you is that obviously you just need to make sure you keep active, which you are . . .
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Communication of the risk score was brief, and Ian did not retain anything from the information given.
During the interview he indicated that this information was not important to him and he had made
changes without understanding this: ‘it don’t really bother me to be honest . . . don’t really register
with me’.
The lifestyle goals could have been more tailored. They combined specific behavioural goals and
general outcome goals, covering three lifestyle behaviours, and included an inappropriate exercise-
related goal, which has not been implemented:
‘cos I’m a postman you see, so I was shocked when she says err, cos I walked 10–15 miles a day . . . with
a big bag on me back and everything, and I was surprised when she said . . . ‘do you go home and do any
gardening?’ . . . I just wanna go home and sit and chill.
Finally, Ian thought that it would have ‘helped turning the computer round and showing me the
information . . . ’cos visual has always been better than audio for me for everything’.
Case study 10: Jessica (QRISK2+)
Summary
This case study describes the health check for a patient, Jessica, who had already made lifestyle
changes following an ‘episode . . . they thought might have been a mini stroke’ 12 months prior (this
was not confirmed as this would preclude her from NHSHC). Jessica’s engagement with, and positive
experience of, the health check appeared to result from the reassurance that it provided around the
success of steps she had already implemented.
Patient
Jessica is a 64-year-old white British female who lives in an area of approximately average affluence
(IMD decile 5). She experienced an episode the previous year, which was initially suspected to be a
‘mini stroke’ (but was not confirmed). She was prescribed statins at that time, but ‘thought, “I don’t
want to do this” ’ and consequently made dietary changes, reducing her cholesterol and successfully
losing weight. She had not heard of NHSHC before and assumed it was a general health check, and
wondered why it was focused on CVD: ‘why can’t you go into everything at the same time?’.
Practitioner
The health check is delivered by a white British, female HCA, who has 4 years’ experience of delivering
health checks and received some training when she started, which she describes as: ‘slides and screen
presentations . . . talked through it erm and then it was moving on to how to use the [point-of-care]
machine . . . it was pretty straightforward really’.
The NHS Health Check
This health check lasts < 18 minutes, during which the HCA speaks for over 70% of the time. PoC
testing confirms that Jessica has reduced her total cholesterol (from 6.7 mmol/l to 6.1 mmol/l) and
total–HDL cholesterol ratio (from 3 to 2.8). CVD risk is discussed for about 1 minute, which shows a
reduction from a measurement (recorded several years earlier): ‘you were at 10% just before, it is now
5%, so you have halved the risk in that time’. The HCA congratulates and encourages Jessica to keep
going with changes she has made to lower her cholesterol and recommends that she increase her
activity levels (as she is classified moderately inactive):
The one thing that will help you with that, is being a bit more physical, get doing something that is a little
bit more cardiovascular, even if it’s upping your walking and doing it as a power walk, or doing hills, on
an incline, it gets you out of breath.
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What worked well
Overall, Jessica thought that the HCA was ‘very good’. At the start of the health check, the HCA made
clear to the patient that it was ‘all to do with cardiovascular disease, so what we are looking for is how
at risk you are of developing cardiovascular disease within the next 5 to 10 years’. This provided useful
context for the subsequent discussion of risk factors and management.
Jessica appreciated feedback and reassurance regarding changes already made, and was pleased to see
that ‘the work had been paying off’. She remembered clearly the main point to address and had made
further small changes to her commute to work to incorporate moderate-intensity activity into their
day: ‘I go to [work] on the school bus . . . it picks me up from outside the house, but I’ve started to
go out a few minutes earlier and walking up the hill [laughs] . . . and meeting it up the hill [laughs] . . .
it’s just a few minutes a day . . . might make a difference’.
She also appreciated the written report, as ‘you can’t take everything in straight away, so it’s nice to
have that printout’ to ‘go back and have a look’.
Areas to improve
The 10-year risk score was mentioned briefly, but not explained. Jessica could partially recall the
information as ‘. . . 5% over the next 5 years’. She had retained the correct percentage, but the
timescale was incorrect (reflecting the HCA’s incorrect description, above) and she could not
demonstrate a clear understanding of what it meant for her.
Summary
The 10 patient case studies confirmed many findings from Chapters 3–6 with several strong and
inter-related themes. As noted in Chapters 3 and 4, CVD risk discussion was often brief. Therefore,
these themes are not limited to CVD risk discussion, which might not have been sufficient or necessary
for positive patient outcomes.
Patients attending already motivated to make changes
Health checks with patients who were already motivated to make lifestyle changes or, as in some
cases, had started to implement changes had positive outcomes regardless of how CVD risk was
communicated. These patients attended with a specific focus (e.g. behaviour change in mind), which
provided the practitioner with an obvious focus to tailor risk management.
Cardiovascular disease risk communication
Explaining and checking patient understanding of cardiovascular disease risk
Even in these examples selected on the basis of positive patient intentions or outcomes, practitioners
rarely explained what CVD risk meant for patients, or asked patients if they understood the information
provided. Not knowing how the patient is receiving the information limits practitioners’ opportunities to
tailor risk information.
Practitioner versus patient perceptions
The muted and minimal responses of most patients to risk information led practitioners to assume
understanding (see Chapters 4 and 6); the case studies have highlighted that this was not necessarily
correct. Assessing understanding from patient reactions to information can lead to a mismatch in
perceptions (of practitioner and patient), which could be mitigated through asking patients (see
Explaining and checking patient understanding of cardiovascular disease risk).
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Tailoring of cardiovascular disease risk communication
This is an area of particular importance. Despite positive intentions and actions in some patients following
the health check, there was little evidence of tailoring risk information or discussion to facilitate patient
appraisal of their risk (severity or vulnerability), for example in CVD risk score manipulation. We observed
practitioners demonstrating how non-smoking patients’ risk would increase if they started smoking, rather
than showing them how they could reduce risk by manipulating a more relevant risk factor (e.g. lowering
cholesterol identified as raised during the health check), which could facilitate a discussion around
management through lifestyle.
Visual presentation of cardiovascular disease risk information
Case studies provided further confirmation that patients and practitioners appreciated the ability to
see CVD risk outcomes presented on the screen. Patient heart age, in particular, was often (but not
always) impactful and memorable, and, if used appropriately, the visual representation of risk reduction
through modifying risk factors can be impactful.
Focus on modifiable risk factors
Focusing on non-modifiable risk factors, such as family history, which are outside the patient’s control,
can promote fatalistic views and undermine potential for lifestyle change.
Preventative framing
Patients with low risk appreciated the reassurance provided by their health check and responded
well to explicit discussion of prevention (i.e. changes in specific areas to maintain low risk, which will
increase with age).
Written information
Patients liked having written information to take away and consider in their own time. This allowed
time for reflection and to recall on CVD risk, which might raise questions that could be addressed
through a follow-up call (see Post-health check telephone reinforcement).
Risk management
Tailoring and specificity of recommendations
This was most evident when patients arrived having already considered changes they wished to make
(e.g. stop eating specific foods, reduce alcohol; see Patients attending already motivated to make changes).
Case studies highlighted other examples in which patients were given recommendations to modify several
behaviours, some of which did not resonate with the patient, who either forgot or dismissed them. As
patients tend not to question the advice in the health check, this could be addressed through asking the
patients (see Explaining and checking patient understanding of cardiovascular disease risk) and telephone
reinforcement to confirm and revise agreed actions (see Post-health check telephone reinforcement).
Goal-setting
This was explicitly used in one case study, trying to get patients to agree to the practitioner
recommendations. If these could be co-produced between practitioner and patient, with tailoring,
more positive outcomes would be expected.
Post-health check telephone reinforcement
Telephoning patients soon after their health check seemed to have a range of benefits: allowing
patients time to reflect on the health check discussion and identify questions or areas of uncertainty;
further explaining CVD risk, answering questions and confirming patient understanding; confirming
recommendations for risk management; and making specific plans where appropriate (e.g. referrals,
follow-up appointments, further measurement).
RESULTS 5: CASE STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
82
Chapter 8 Discussion
In this chapter we present our main findings, compare our findings with other research around healthchecks, risk communication in general and specific CVD risk metrics (where available), present
implications for practice and future research, and consider the strengths and limitations. Box 2
summarises the main lessons learned.
BOX 2 Main findings from this research
Communication of cardiovascular disease risk
l Consultations were verbally dominated by practitioners (nine HCAs and six PNs), often with little
patient input or questions, particularly when using the QRISK2 10-year risk calculator.
l Discussion of CVD risk in consultations was minimal (< 2 minutes or < 10% of consultation time on
average), especially when using QRISK2, and was often information provision rather than a tailored
two-way interaction in which patients could ask questions or discuss specific individual risk factors.
l Practitioners rarely explained what CVD risk meant for patients or checked understanding. This limited
opportunities to tailor risk information and to avoid misunderstandings.
l QRISK2’s 10-year risk was commonly seen as a tool to identify those who required referral onto the
GP/to discuss statins, rather than a tool to facilitate discussion of CVD risk and its management.
l JBS3’s heart age was generally preferred (over 10-year and event-free survival age) by practitioners
and patients.
l JBS3’s event-free survival age information was delivered briefly, sometimes with a lack of clarity and
accuracy, and was often misinterpreted.
l JBS3’s visual representations of risk was valued by practitioners and patients.
l JBS3’s risk score manipulation has potential and was generally perceived positively. However, it was
sometimes limited by focusing on risk factors irrelevant to the patient (e.g. demonstrating the impact of
smoking in a non-smoker) or because the patient was not clear about what was happening (e.g. why
different blood pressure values were being entered).
l Further practitioner training would be required to optimise use of lifetime risk and risk manipulation
functions within JBS3.
Practitioner and patient understanding of cardiovascular disease risk
l Our data confirm that providing patients with a CVD risk score alone is insufficient to enable understanding.
l With QRISK2, practitioners felt confident to deliver 10-year risk, but often did not understand it
sufficiently to confidently engage patients in a discussion around what it meant for them (i.e. moving
beyond application of low/medium/high risk thresholds).
l JBS3’s heart age was the preferred CVD risk score overall. Practitioners and patients felt that they
understood it and found it more impactful, and VSR interviews showed that patients could often recall
their own heart age (more so than 10-year or event-free survival age).
l JBS3’s CVD event-free survival age was misinterpreted by some practitioners and patients as expected
survival age. The lack of thresholds (e.g. 10-year risk) or inherent comparison (e.g. heart age) made it
difficult for practitioners and patients to interpret risk as low, medium or high.
l JBS3 can be useful for offering a variety of delivery methods (risk score, visual representations,
analogies, risk manipulation) to accommodate a range of patient preferences. But to make appropriate
use would require that practitioners check patient understanding and tailor information.
l JBS3’s visual presentation and risk score manipulation appealed to a range of patients who vary in preferences
and understanding, and can make the important link between lifestyle change and overall CVD risk.
l Practitioners’ reliance on patient reactions to gauge understanding of risk information was limited by
the general lack of response from patients in health checks.
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Communicating and understanding cardiovascular disease risk using
QRISK2 and JBS3 (objectives 1–3)
Table 10 summarises the relative merits of QRISK2 and JBS3 in health checks, which are discussed in
turn, before considering themes common to health check in both groups.
QRISK2
Communicating CVD risk is central to the NHSHC,17,19 but formed a small part of consultations
(< 2 minutes on average). When using QRISK2, practitioners often perceived 10-year risk as a way
to identify patients for routine medical follow-up (if risk ≥ 10%), rather than to initiate discussion
around patients’ risks and risk management. Consequently, they tended to relay the percentage
10-year risk score and whether it was low (< 10%), medium (10–19%) or high (≥ 20%), without
expanding to make clear the relevance to the patient. Minimal patient responses to risk information,
particularly for 10-year risk, with a single-word response (e.g. ‘yeah’, ‘OK’) made it difficult for practitioners
BOX 2 Main findings from this research (continued)
Facilitating risk-reducing intentions and behaviours
l Patient VSR interviews identified positive changes in most patients following their health check, from
increased patient awareness of lifestyle to implementation of specific recommended lifestyle changes.
l Applying to PMT to analysis of practitioner–patient discussions during health checks (see Chapter 4)
identified more evidence of cognitive appraisal in patients attending health checks delivered using JBS3
(than those using QRISK2); in particular, threat appraisal, facilitators of and response costs to adaptive coping.
l Some patients identified JBS3’s heart age as a trigger for intentions to reduce their CVD risk.
l Being able to understand heart age and recognise the personal relevance (more than other risk scores)
seemed to allow patients to appraise the severity of the risk, their vulnerability to it and evaluate
barriers to/facilitators of risk-reducing behaviour change.
l In some health checks, discussions of patient lifestyle were not in the context of CVD risk; assessment
of lifestyle and associated practitioner recommendations preceded CVD risk discussion.
l The case study examples of health checks that led to risk-reducing intentions and behaviours were
often patients already aware of the need to change, with intentions to change, or who had already
started to implement changes.
Time for consultations
l Length of health check appointment allocated by practices ranged from 15 to 30 minutes, but actual
duration of practitioner–patient interactions ranged from 6.8 to 38 minutes (60% of health checks
lasted < 20 minutes).
l Patients in both groups felt that they were given too much information within a short space of time,
which limited their capacity to absorb or retain it. How time is apportioned within the health check
should be revisited in terms of what practitioners are expected to achieve to ensure that adherence to
process is not at the expense of opportunities for patient-centred discussion and shared decision-making.
l Some patients expressed an appreciation of written information to take away and consider in their own time.
l Telephone reinforcement shortly after the health check was successfully used to confirm patient
understanding and (re-)confirm specific risk management actions.
Training
l There is a clear need for training to support practitioners, who reported having no formal training or
having generic training that focused on health check processes (e.g. completing the template, operating
the PoC testing machine).
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to gauge patient understanding, which would then allow them to address misunderstandings or concerns.
This is important given the evidence that engagement in primary care consultations is linked with patients’
understanding of the consultation and confidence, which has subsequent benefits for recall of information
and adherence to recommended treatments.79
Practitioners reported being confident in communicating 10-year risk, but mainly in application of thresholds
(low/medium/high risk). Understanding and confidence to engage in a discussion with patients around
what risk means for them was less evident. Perhaps as a result, patients often did not understand CVD
TABLE 10 Summary comparison of QRISK2 and JBS3 based on findings from Chapters 3–6
Main finding QRISK2 JBS3 Comment
Overall CVD risk discussion
Amount of CVD risk discussion – + JBS3 – more discussion of CVDa
Both groups – limited overalla
Patient engagement in discussion – + JBS3 – health checks were less practitioner dominateda
JBS3 – more patients asked questionsa
= = Both groups – practitioners missed opportunities to engage
patients in discussion of CVD risk and risk managementb
Both groups – minimal responses to CVD risk information
(e.g. single-word acknowledgement) in many patientsb
Risk score communication and understanding
10-year risk – n/a Seen as guide for clinical decisions, not tool to discuss CVD riskc
Practitioner understanding limited to applying thresholds to relay
risk to patients as low/medium/highb,c
Patients often did not understand the score or its implicationsd
Event-free survival age n/a – Misunderstood and incorrectly communicated by some
practitionersb,c
Misunderstood by patientsb,d
Heart age n/a + Liked by patientsd
Liked by practitionersc
Better perceived understanding and recall of informationb,c,d
More impactfulb,c,d
Some questioned the credibility of heart aged




Causal + – QRISK2 – more discussion of causal risk factorsa
Risk management – + JBS3 – more opportunities to initiate risk factor management
discussionb
+, favourable for the risk calculator; –, unfavourable for the risk calculator; =, no evidence of difference; n/a, ‘not
applicable’ to that risk calculator (used for clarity of comparison, despite JBS3 also giving 10-year risk and some data
relating to perceptions of 10-year risk came from patients and practitioners in the JBS3 group).
a Quantitative analysis of recorded health checks (see Chapter 3).
b Qualitative analysis of health check (see Chapter 4).
c Practitioner VSR interviews (see Chapter 6).
d Patient VSR interviews (see Chapter 5).
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risk information, particularly 10-year risk. Again, this is in line with evidence that practitioners who lack
confidence are less likely to invite patient engagement in primary care consultations.79 Our findings
confirm the findings of qualitative studies, which have also indicated that practitioner and patient
understanding of percentage CVD risk is limited,21 and that practitioners find it difficult to explain CVD
risk,26,36–38 resulting in patients leaving health checks unable to recall or with limited understanding of their
10-year risk.21
JBS3
Practitioners in the JBS3 group were free to use all features of JBS3. However, the minimum
requirements in this study were that practitioners communicate heart age and event-free survival
age (on the Healthy Years Screen), and manipulate at least one of these risk scores to demonstrate
the effect of risk factor changes. QRISK2’s 10-year risk was also delivered as a requirement of the
national programme.
Heart age
Practitioners showed patients the on-screen output for heart age, and this was generally preferred to
other risk scores. Analysis of health checks and practitioner interviews revealed greater confidence
with communicating heart age than with other risk metrics (10-year or event-free survival age). The
finding that patients had better understanding and recollection of heart age (than of 10-year risk or
event-free survival age) is consistent with the findings from studies of online heart age80 and heart age
provided to NHSHC patients (in the form of a risk report).41
Interview data suggested that the comparison inherent in the concept of heart age (chronological age
compared with predicted heart age) allowed patients to quickly appraise whether or not to be concerned
by their level of CVD risk. In turn, we observed more pronounced patient responses than for other risk
scores – some were ‘shocked’, others were ‘pleased’ or ‘reassured’. Mixed responses depending on results
are understandable and have been observed elsewhere.41,81 Moreover, some patients questioned the
credibility of heart age. There is evidence that heart age can prompt consideration of lifestyle change,
regardless of the results (younger or older than chronological age) and its perceived credibility.42,81 This
was not necessarily supported by our data, which suggested a dismissal of heart age where it was not
seen as credible. This would need further exploration. In any case, variation in preference is in line with
the literature24 and highlights the importance of practitioners having different types of risk information
(score, visual, analogies, risk manipulation), which they can tailor to patients’ needs and preferences.
In addition to the heart age score, the visual presentation of heart age appeared important for impact
and recollection. QRISK2 and 3 also generate heart age, but do not offer a similar visual output. Such
visual representations of risk were perceived favourably among our sample, and have been preferred
for promoting risk-reducing behaviour.44
Finally, it is important to be clear about the role of heart age as a form of lifetime risk. The 2014
JBS3 report34 stated that ‘lifetime risk measurement is an adjunct to the estimation of 10-year absolute
risk levels. It is intended not primarily as a guide to decisions about drug initiation, but rather as a way
of allowing an individual to understand the lifetime risk’. Heart age was not designed to guide clinical
decisions,42,82 but our data support its use in health check as a means of promoting patient understanding
of CVD risk and a useful prompt for patients to consider lifestyle changes.42,81
Event-free survival age
Practitioners’ description of the average age to which patients could be expected to survive free from
a CVD event was often unclear and sometimes incorrect, which illustrated a lack of understanding of
event-free survival. There was evidence that this score was misinterpreted by some practitioners and
patients as expected survival age (i.e. age of death). Sometimes the average event-free survival age
was relayed to patients correctly during the health check through reading the score from the screen,
but subsequent VSR interviews (in the same practitioner) revealed a lack of understanding.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
86
There is a lack of evidence exploring this form of lifetime CVD risk score with which to compare
our findings. It appeared from our data that the lack of thresholds (such as those in 10-year risk)
or inherent comparison (such as that in heart age) made it difficult for practitioners and patients to
interpret event-free survival age as low/medium/high or good/bad. In turn, this risk score generally
did not engender much response from patients, who often could not remember it. The graphical
representation of event-free survival age was in the form of a visual analogue scale (see Figure 1)
with text showing the age. This was not the problem. Patients appeared able to read the result from
the display, but often misinterpreted what the figures represented. To be more widely understood,
practitioners need training to enable them to better explain event-free survival and communicate its
significance unambiguously.
The use of, and response to event-free survival age underline the aforementioned importance of clarity
of information such that patients understand and have the confidence to engage in consultations,79
which can then lead to a patient-centred experience.83 Our data suggest that event-free survival age
should not be recommended for use without specific and more substantive training than that provided to
practitioners in the RICO study.We provided a verbal explanation during practice initiation visits, written
materials and a short video tutorial on how to use JBS3, asked practitioners to practise using JBS3 in health
checks in advance of data collection, and were available to answer practitioner questions throughout (in the
practice during data collection or by telephone at any time). The decision not to include more intensive
training was to allow us to understand how practitioners would use this tool if it were made available for
use in NHSHC and has identified an obvious training need.
Cardiovascular disease risk score manipulation
Practitioners liked the risk score manipulation function in JBS3 and thought that it was impactful. Heart
age was often the chosen metric for risk manipulation, reiterating practitioner preference for heart age.
However, often, it was not used to its potential. The importance of user competence with interactive
graphical displays of risk has been noted elsewhere.23 In the RICO study, practitioners tended not to select
the most appropriate risk factor to exemplify the potential risk-reducing benefits of intervention; for
example, in non-smoking patients with raised cholesterol, practitioners defaulted to showing increases in
risk if they did smoke, which lacked relevance to the patient. Therefore, despite the positive perceptions,
it is likely that limited user competence undermined the potential impact of this function in JBS3.
Heart age and risk score manipulation were perceived positively by patients and, if used appropriately,
can be used to confer patient understanding of the risk and its severity/relevance. Visual presentation
and risk score manipulation offer tools that can accommodate the range of patients, and also to make
the important link between lifestyle change and overall CVD risk.
Both groups
Regardless of CVD risk calculator, practitioners rarely asked if patients understood their risk. Patient
questions about CVD risk were also rare, but more commonly observed in the JBS3 group (32.0% vs.
12.3%). CVD risk communication and the consultations overall were practitioner dominated, with
patients speaking for less than one-quarter of health check time. Processes relating to measurement
(CVD risk and lifestyle) and relaying information appeared to take precedence over creating dialogue
with patients, who said little in the majority of health checks.
Practitioners usually relied on patient reactions to risk information to gauge understanding. This was
limited by a general lack of response, which, unless followed up by the practitioner, can lead to patients
failing to understand or recall their risk information. Even in the case studies of patients with positive
intentions or outcomes, practitioners rarely explained what CVD risk meant for patients, or checked
their understanding (but it mattered less for those patients who were already aware of their need
for lifestyle changes, or were motivated to change). Not knowing how the patient is receiving the
information limits practitioners’ opportunities to tailor risk information to instigate change.
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In turn, there was a lack of tailoring in CVD risk information. Some practitioners admitted to delivering
the same information to all patients, recognising that some would understand and some would not.
Others said that they adapted the information to the patient. But as patients were not asked if they
understood the information presented, there was little opportunity for such adaptation. This is an
important limitation. There is no single ‘correct’ way to communicate risk. It depends on individual
preferences and understanding, which differ with education, numeracy and personality traits, such as
optimism.24 Tailoring is therefore critical, but impossible unless practitioners know how patients receive
the information.
Overall, patients in both groups were given too much information within a short space of time, some of
which was irrelevant, limiting their capacity to absorb or retain it. Some expressed an appreciation of
written information to take away and consider in their own time. Hawking et al.41 interviewed patients
who were given a personalised risk report to take away from their health check and found that this
was mostly well received, often for reassurance, but with potential to motivate lifestyle and discussions
and changes with family and friends.
As recognised in the NHSHC competence framework,19 our data confirm that providing patients with a
CVD risk score alone is insufficient. There is a challenge for practitioners to facilitate understanding so
that patients can appraise their CVD risk information in terms of the severity of the risk (patients with
elevated risk recognise it) and the vulnerability to risk (patients not currently at high risk recognise the
need for preventative action).
Intentions with respect to health-protective behaviours
(objectives 4 and 5)
Patient VSR interviews identified positive changes in most patients including increased awareness
or contemplation of risk-reducing behaviour, fostering of positive intentions or implementation of
recommendations from the practitioner by making small lifestyle changes. This activity was largely
self-reported by patients. Medical record data showed relevant follow-up activity in the 12 weeks
post health check in 30% of all patients, most commonly related to blood pressure measurement or
discussion (20.2%), followed by lifestyle discussion (9.8%), CVD risk assessment or discussion (9.2%)
and cholesterol measurement or discussion (8.7%).
Deductive thematic analysis of verbatim speech during health checks (see Chapter 4) showed that, in
consultations using JBS3, there was more evidence of threat appraisal, and facilitators of and response
costs to adaptive coping than during consultations using QRISK2. This suggested that health checks
using JBS3 could provide more opportunities to initiate risk factor and management discussion than
those using QRISK2. The visual presentation (of heart age in particular) and risk manipulation tools
in JBS3 did appeal to a range of patients and could help to make the important link between lifestyle
change and overall CVD risk. As noted by others,81 some patients identified heart age as a trigger for
intentions to reduce their CVD risk; it was understandable and personally relevant, which allowed
consideration of lifestyle to reduce their risk, more so than 10-year or lifetime risk.
For risk manipulation, practitioners tended to use heart age to show how changing risk factors can
affect the patient’s risk. In some cases, patients referred to this favourably. But as noted above,
practitioners defaulting to demonstrating the impact of smoking, regardless of the patient risk factors
and smoking status, is likely to limit the potential impact on risk-reducing behavioural intentions.
Practitioners were advised that they could use this JBS3 function for preventative messages if patients
were low risk; showing how a worsening of lifestyle could increase risk. But relevance to the patients
should still be a central consideration of how this is performed.
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As CVD risk generally was not explained in detail or discussed with patients, the subsequent or preceding
discussion of behaviour change/lifestyle was often not contextualised in terms of reducing CVD risk nor
tailored to their preferences or lifestyle. In some health checks, there was a clear separation – patient
lifestyle was measured and discussed, with advice for changes, before CVD risk was relayed to patients
and without confirming their understanding to make clear the implications (i.e. severity, vulnerability) and
link to lifestyle [i.e. to foster discussion of how patients could manage their risk (see Figure 2)].
The most positive examples of health checks fostering risk-reducing intentions and behaviours were
patients who were already aware of the need to change, had intentions to change, or had already
started to implement changes. In these cases, it was not necessary for practitioners to foster the
appraisal of severity of, or vulnerability to CVD risk, and the tailoring of risk management discussion
and recommendations was effectively resolved by the patient in advance (e.g. they had identified
specific changes, such as excluding certain foods or reducing alcohol consumption). These patients
tended to be focused on a specific behaviour (often dietary change) or risk factor (e.g. cholesterol),
rather than seeing these as a means of reducing overall CVD risk.
Implications for practice (objective 6)
The NHSHC programme is currently the largest CVD prevention initiative in England. It has come under
scrutiny in the absence of evidence for long-term benefits for CVD risk, morbidity and mortality,9–14
but with some favourable predictions for avoidance of disease and premature mortality from a
microsimulation study.15 While an evidence-based review of NHSHC is ongoing5 and changes to the
programme will probably follow, face-to-face consultations are necessary to deliver key elements of
health check.
Our data gathered from a range of patients attending health checks in general practices that ranged
in size and deprivation of the local area have identified a number of ways in which the programme
could be improved. Several of the points below (see Table 10) make a case for use of JBS, or certain
functions within it, to improve CVD risk communication in NHSHC. Specifically, use of heart age, visual
presentations of risk and risk score manipulation appear more beneficial than QRISK2 10-year risk
score for engaging patients in CVD risk discussion and conferring understanding of personal risk that
might lead to risk-reducing intentions and actions. Other important areas for improvement are
common to health checks conducted with either tool.
JBS3’s visual risk presentation and heart age
The visual presentations of risk, such as those in JBS3, are recommended for use in health check.
In particular, the heart age output was widely liked and considered impactful. But having a range is
useful to accommodate patient preference.
If applied appropriately, manipulation of CVD risk should also be considered as a way to demonstrate
to patients the link between their behaviour (and any related recommendations) and their overall CVD
risk, but this would need further practitioner training, and observation of application in practice, before
effectiveness testing.
Ask patients and tailor
When delivering CVD risk information, practitioners should ask patients about their understanding
and how they feel about the information. Knowing how the information is being received would enable
the practitioner to provide follow-up information or present risk in different ways to foster patient
understanding and appraisal of risk and coping responses (i.e. risk management). This, in turn, can lead
to risk-reducing intentions.
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One practical approach to operationalise such a change would be for practitioners to record that
they have checked patient understanding within the NHSHC template (within the practice system).
However, adding to the already substantial list of administrative and clinical tasks could lead to this
becoming another process for which there is insufficient time (see Time). Rather, this should be
fundamental to the consultation approach, moving away from information provision, and towards
shared decision-making.51 We can consider this in terms of the characteristics of shared decision-
making identified by Cipher et al.:83 (1) ‘accurate, objective and comprehensible information’ (i.e. CVD
risk); (2) ‘a practitioner who is present and proficient in communication and able to individualise
data to a particular situation’; and (3) that the ‘individual’s values, goals, informed preferences, and
concerns are incorporated into the communications’. These recommendations identify the need for
understandable and tailored CVD risk information and a practitioner who engages the patient in
dialogue, which can then lead to discussion of risk management, as part of a two-way interaction.
Time
As discussed in Chapter 3, the time allocated to health checks and how that time is spent should be
revisited in the context of what practitioners are expected to achieve.
Patients in our sample reported being provided with too much information, in too short a time.
The length of appointments that practices allocated to health checks ranged from 15 to 30 minutes,
yet the actual duration of practitioner–patient interaction ranged from 6.8 to 38 minutes (60% lasted
< 20 minutes). Health check practitioners have a range of administrative and clinical tasks to complete
within this appointment time: CVD risk assessment involving measurement of (and entry of data for)
weight, blood pressure and, sometimes, cholesterol through PoC testing; lifestyle assessment (physical
activity, alcohol, diet); explaining to patients their CVD risk score(s) and what it means; and patient-
centred discussion of risk management to prompt risk-reducing behaviours.
Our data indicated that the health checks were process driven, rather than content focused, and some
of the observed features of delivery reflected practitioners working through a series of administrative
or clinical processes (e.g. interrupting the conversation, presenting information too quickly, or using
inappropriate language).84,85 Such behaviours reduce the likelihood that information will be understood
and retained.85 This suggests a need to revisit the health check to focus on content and the quality
of interactions.
Consultations that involve shared decision-making take time.85 NICE has endorsed ‘brief’ behaviour
change interventions that take several minutes. The NHSHC practitioner competence framework19
refers to the ‘Brief intervention/signposting/referral’ part of the health check (i.e. risk management)
as ‘more than a simple communication of information; the person signposting must be able to engage
the client in the choice and communicate in a manner that will maximise the potential that the client
will take up the agreed action and sustain’ (p. 23; contains public sector information licensed under the
Open Government Licence v3.0). Therefore, even if the risk management discussion is brief, it should
be delivered by practitioners with appropriate training, who are able to engage patients in designing
their own risk management plan, thus tailoring it to patient needs.86 However, NICE also recommends
‘extended brief interventions’, lasting ≥ 30 minutes, and potentially lasting several sessions;86 and
motivational interviewing, which also features in the NHSHC competence framework, can require
≥ 15 minutes to be effective.
A short, practitioner-dominated health check might be sufficient when patients attend with motivation
and ideas/actions about changes they need or want to make. If this appraisal has not taken place in
advance, it is the role of, and challenge for, the practitioner to present CVD risk information that
facilitates this patient appraisal, helping them towards risk-reducing intentions and behaviour. In this
case, a short, practitioner-dominated health check in which CVD was risk neither well explained nor
understood, is unlikely to be effective.
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Therefore, our data suggest that:
l some health checks appear too short to accommodate all health check tasks in a patient-centred manner
l more time should be allocated to explaining CVD risk, allowing practitioners to check patient
understanding and to tailor risk information using the appropriate tool for that patient
l sufficient time should be allowed for practitioners and patients to co-produce a specific, relevant
and meaningful risk management strategy.
This could be achieved through increasing the overall time available to health check or by reducing the
number of administrative and clinical tasks required, and practitioners should be supported with
appropriate training (see below).
Telephone reinforcement
Follow-up telephone calls to patients soon after the health check, by the practitioners who delivered the
health check or other clinical staff with the required knowledge and skills, should confer a range of benefits:
l patients have time to reflect on the health check and identify questions or areas of uncertainty
l practitioners can provide further explanation of CVD risk, answer questions and reaffirm
patient understanding
l practitioners can confirm recommendations for risk management, making specific plans where
appropriate (e.g. referrals, follow-up appointments, further measurement).
Such telephone reinforcement has been used in physical activity interventions to improve participant
perceptions of the target behaviour87 and promote maintenance of that behaviour if used as part of an
ongoing negotiated follow-up.88 This has resource implications that are likely to be justified, but would need
to be explored. For patients who do not require it, the call could be short and the resource implications
modest. Others will need more time to revisit health check content and agree risk management.
Practitioner training
An overarching theme that cuts across all of the above implications for practice is the need to support
practitioners (HCAs and PNs) with appropriate and specific training to ensure that practitioners know
what they need to do in health checks, that they are confident and have the necessary knowledge and
skills, and that they are supported with ongoing training to promote continued improvements in delivery.
The Best Practice Guidance17 and practitioner competence framework19 set out high expectations. As
the aim is to have consultations that are patient centred, for which shared decision-making has been
described as the ‘pinnacle’,89 patients should be involved in the co-design of practitioner training.90
Therefore, findings from this study highlight two training needs. First, there is a need for training to
address the apparent knowledge deficit around different types of CVD risk. Here and elsewhere,21,91
it is clear that those delivering health checks either do not receive any training specific to conduct CVD
risk measurement and how to communicate risk scores to patients or receive generic training that is
focused on health check processes (e.g. completing the template, operating the PoC testing machine).
Second, PNs and HCAs do not receive training in communication skills, such as those included in medical
training. Our data have uncovered a previous ‘unknown unknown’ about a lack of communication skills
in the context of real-world patient-centred risk communication and risk management discussion. The
communication skills content of undergraduate and postgraduate nurse training and training of HCAs
should, therefore, be evaluated in relation to this need.
Reflexivity
In qualitative research, it is important to consider the interpretive role of researchers in both data
collection and analysis.92 Willig93 notes that ‘Reflexivity is important in qualitative research because it
encourages us to foreground, and reflect upon, the ways in which the person of the researchers is
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implicated in the research ad its findings’ (p. 18). Subsequently, the researchers engaged in reflexive
practice throughout the study to ensure that they engaged with, and articulated, their positions as
researchers and were aware of how their backgrounds, viewpoints, and experiences may have
impacted on their interpretations of data.94
All data collection and the majority of data analysis were conducted by two white female researchers: a
qualified Health Psychologist and Lecturer in Health Psychology (LC; DPsych) and a Research Associate
(VR; MSc). Lisa Cowap had wide-ranging prior research experience (e.g. children’s healthy eating, smoking),
which included some research into uptake in NHSHC (in 2014). Victoria Riley had previous research
experience in pregnancy and body image, and was completing a doctorate around NHSHC uptake and
risk communication (including training practitioners to improve risk communication). Victoria Riley’s
specific, relevant experience and knowledge could have meant that she approached the data collection
and analysis differently to Lisa Cowap (who was less knowledgeable of NHSHC at the outset). However,
prior knowledge of the programme was beneficial in overcoming the many challenges that arose during
recruitment and data collection.
In relation toVSR interviews, both researchers had experience in relevant data collection methods (i.e.
semistructured interviews, focus groups), interview techniques (i.e. face-to-face, telephone interviews) and
qualitative methodologies (i.e. thematic analysis, grounded theory, interpretative phenomenological analysis),
and with a variety of participant samples [i.e. children, students, adults (LC), adults, patients, practitioners,
commissioners (VR); individuals from ethnically diverse backgrounds and various levels of social deprivation
(LC and VR)]. In the RICO study, male and female participants were recruited from different localities across
theWest Midlands, resulting in a diverse sample from different socioeconomic and ethnic backgrounds,
sometimes differing from the sex and background of the researchers, which may have influenced participant
responses during data collection.95 Barrett et al.94 note the importance of challenging and articulating social
and cultural influences and dynamics, and we reflected on how social context may have affected what
participants shared with us. To maximise disclosure and to enable participants to feel as comfortable as
possible, interviews were conducted in locations of the patients’ choosing (the general practice or their home),
ensuring that they were comfortable and felt able to speak freely.
Data analysis was initially conducted by both researchers (both together and independently by LC
following VR’s commencement of maternity leave) before verification by another member of the
research team to check that themes were clear and comprehensive.96 Two additional researchers and
doctoral students, Sophia Fedorowicz (MSc) and Sian Calvert (MSc), were brought in to help with
analysis of the deductively coded health checks and the VSR practitioner interviews, respectively.
Both were young, white, female doctoral students without prior knowledge of the NHSHC programme
who had substantial qualitative research experience in their respective areas of health psychology.
Finally, all themes were discussed and agreed over the telephone and over e-mail with other members
of the multidisciplinary team of principal and co-investigators. This drew on a variety of backgrounds,
including psychology, public health, health services research and general practice, to ensure that a
range of perspectives on the data were taken into account to validate the themes throughout analysis.
Strengths and limitations
This study has 10 key strengths:
1. Video-recording of health checks provided the first objective account of health checks for detailed
quantitative and qualitative analysis.
2. Data were collected across a diverse range of practices stratified by deprivation, with patient
recruitment stratified by age, sex and ethnicity.
3. The comprehensive coding framework with excellent inter-rater reliability offers a methodological
contribution for quantitatively describing health checks.
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4. The sample sizes for the qualitative analyses were large (128 for deductive qualitative analysis of
health checks, 40 for inductive thematic analysis of VSR patient interviews, 15 for inductive
analysis of VSR practitioner interviews).
5. Deductive analysis of video-recorded health check was guided by the theoretically strong PMT
framework, which was augmented through initial inductive coding.
6. VSR interviews were a novel way to allow participants to recall and reflect on the health checks,
how they felt at that time, and their perceptions subsequently.
7. Case studies drew on six sources of data to explore in detail why some health checks appeared to
lead to positive patient intentions or actions.
8. Our multifaceted PPI approach, including a virtual group that reached over 270 members of the public,
allowed patient/public input on specific issues throughout at both operational and management levels.
9. Our multidisciplinary team of health psychologists, primary care researchers, applied health
researchers and clinicians provided the necessary range of expertise.
10. Collecting data using a range of methods highlighted some strong, consistent findings on which to
base recommendations.
A number of limitations were recognised:
1. Challenges with practice and patient recruitment meant that we did not achieve our target sample
size of 240 (120 per group) and had an imbalance between groups. Changes to the recruitment
processes requested by the Health Research Authority (HRA) resulted in a reliance on general
practice teams (rather than CRN) to contact patients who did not respond to initial postal invitations.
To mitigate the poor response, the size of initial mail-outs was increased and practice staff were
offered support when telephoning potential participants, but this was unsuccessful in a number
of practices that under-recruited. The poor response rate could have introduced bias through
self-selection of patients who were not representative of the wider NHSHC patient population.
A larger sample size might have identified more marked between-group differences through
increasing the precision of our estimates for quantitative comparisons (i.e. narrowing CIs).
2. There was a between-group difference in mean age. Given the importance of age in determining
10-year risk scores, there was a potential that this age difference would create statistical differences
in the CVD risk profiles of each group, but this was not evident.
3. Uptake of VSR interviews among patients did not permit stratification by age, sex and CVD risk as
planned (see Table 2). In practices where overall recruitment was low, all patients who consented to
VSR interviews were recruited. The resulting sample did, however, provide representation across
age groups, males/females and CVD risk, but was less balanced than intended. For example,
compared with the overall sample, there were smaller proportions of medium-high CVD risk
patients and those from ethnic minority groups (see Table 9).
4. The lack of specific discussion around the risk scores and subsequent patient responses made it
difficult to apply the PMT framework effectively (the framework required researchers to classify the
response as positive or negative). Thus, a third ‘neutral’ classification was added to the framework
and applied where appropriate. To mitigate the risk of misclassifying, the video-recordings could be
consulted to determine the level of engagement, which might not be evident from transcripts alone.
5. Through observations of recorded health checks and VSR interviews, it is difficult to distinguish between
patient understanding of the risk itself (i.e. what the score meant) and the risk in context (i.e. risk relative
to others of similar age), and the ability of the information to motivate change (based on interview
transcripts available). Related inferences were made from drawing on the multiple data sources.
6. After commencing data collection, we discovered that two QRISK2 practices used Informatica, an
addition to practice software that has some of the JBS3 functionalities. The researchers were unaware
of this addition and were not informed of its use throughout the numerous calls and practice visits
during the recruitment and initiation stages with each practice. Use of QRISK2 + Informatica may
have enhanced these consultations. To maintain the ecological validity of a ‘usual-care’ group, the
34 patients from these practices were retained and corresponding quotations were labelled to reflect
use of Informatica in the reporting (‘QRISK2+’).
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7. We cannot claim that our results are generalisable to the rest of England. However, through our
stratified recruitment (where possible), we obtained a good balance of males and females, a good
age range, representation across socioeconomic groups (based on deprivation) and proportions of
white British and ethnic minority groups that were appropriate for the region.
8. It is possible that being video-recorded affected practitioner behaviour (Hawthorne effect).97
To mitigate this, our PPI explored camera position to best capture patient response and minimise
practitioner awareness of the camera. Practitioners in mock health checks reported forgetting about
the camera during consultations. The Hawthorne effect tends to improve performance,97 which would
mean that any effect would lead to an underestimate of challenges with health check delivery.
9. Most patient and practitioner VSR interviews were conducted in the general practices. It is possible
that this context introduced some social desirability bias.
Implications for further research
Areas for further research include the following:
1. There is a clear need to explore specific practitioner competencies and patient needs to inform
development of training, ideally co-designed with patients and practitioners. This could include
a review of practitioner competencies covered in their basic training (e.g. undergraduate and
postgraduate nursing), the fit with health check requirements and working with practitioners
and patients to develop and test training.
2. Research should explore the reallocation of time during health checks, perhaps revisiting the
processes currently mandated within consultations. As the national programme is under review,
this could extend to exploring alternative types of consultations (e.g. online) in addition to
evidence-based redesign of face-to-face health check consultations.
3. Qualitative methods and effectiveness trials could further explore use of heart age in health checks.
Qualitative work could also be used to understand and help to overcome the challenges that
practitioners clearly faced in understanding and communicating other lifetime risk metrics
(e.g. event-free survival age), with quantitative assessment of benefits for patient outcomes.
4. Explore the benefits of telephone reinforcement of health checks in terms of patient understanding
and retention of information, and subsequent intentions and implementation of recommendations.
A health economic evaluation could be used to explore the benefits for patient outcomes versus the
additional resource implications of making telephone calls.
Summary
Communication of CVD risk in health checks was brief, particularly in consultations supported by QRISK2.
Patient understanding of, and responses to, CVD risk information were limited. Practitioners often missed
opportunities to check patient understanding that could allow an appraisal of risk to encourage risk-
reducing intentions and behaviour. Some aspects of JBS3 appeared to better promote opportunities to
initiate discussion of risk factors and particularly their heart age, visual representation of risk and risk
score manipulation, which were more easily understood and impactful than QRISK2. The apparent lack of
effective CVD risk discussion in both groups resulted in misunderstandings, practitioner-dominated
discussion and increased likelihood of a maladaptive coping response.
Data from the RICO study have brought to light some fundamental issues with delivery, regardless of
which risk calculator was used. Addressing these issues could be expected to have considerable benefit
for patient understanding of their CVD risk, the personal relevance of the information (vulnerability
and severity), the link between overall risk and lifestyle, and what specific changes they could personally
make to manage that risk.
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Appendix 1 Classification of activities and
prescriptions from patient medical records
TABLE 11 Classification of activities from patient medical records
Activity type Codea Term
QRISK (assessment, discussion, IHD prevention) 38DP QRISK2 cardiovascular disease 10-year risk score
6C0 Primary prevention of ischaemic heart disease
Weight (measurement of weight, BMI,
waist circumference; discussion of weight)
22A O/E – weight
22K Body mass index
Blood pressure related (measurement, discussion) 246 O/E – blood pressure reading
315B Ambulatory blood pressure recording
662L 24-hour blood pressure monitoring
242 O/E – pulse rate
2431 O/E – pulse rhythm regular
Cholesterol related (tests for lipids, cholesterol) 44lF Serum cholesterol/HDL ratio
44P Serum cholesterol
44P5 Serum HDL cholesterol level
44PL Non-HDL cholesterol level
44Q Serum triglycerides
Diabetes related (tests, discussion) 42W5 HbA1c level – IFCC standardised
Other tests (kidney, liver, thyroid, ECG) EMISNQAW1 Test request: liver function test
321 ECG – general
EMISNQAW1 Test request: urea and electrolytes
EMISNQAW1 Test request: thyroid function test
Lifestyle discussion (smoking, exercise,
diet, alcohol, general lifestyle)
8CAL Smoking cessation advice
137P Cigarette smoker
137S Ex-smoker
1371 Never smoked tobacco
8CA4 Patient advised regarding diet
8CA47 Patient advised regarding low-cholesterol diet
66At Diabetic dietary review
1F4 Dietary calorie intake
RF020 UHNM nutrition and dietetics V3
8CA5 Patient advised regarding exercise
136 Alcohol consumption
38D3 Alcohol use disorders identification test
67H Lifestyle counselling
67H9 Education about lifestyle for risk of diabetes
continued
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TABLE 11 Classification of activities from patient medical records (continued )
Activity type Codea Term
Lifestyle referral (smoking, exercise,
diet, diabetes prevention)
679m4 Referral to NHS diabetes prevention programme
RF020 UHNM nutrition and dietetics V3
8H7q Referral for exercise therapy






a Where activities were coded, read codes are listed. Additional activities recorded as free text were also classified
under the activity types.
TABLE 12 Classification of prescribed medications from patient medical records
Classification of medication Medications included
Statin/lipid lowering Atorvastatin, simvastatin, ezetimibe
Anticoagulant Apixaban, rivaroxaban
Cardiovascular Propranolol, ramipril, verapamil, amlodopine
Diabetes Metformin, ivabradine
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Appendix 2 Coding framework data variables
Category Code Code title
Patient–practitioner communication PrDT Practitioner dominated talk
PtDT Patient dominated talk
NT No talking
Health check general I2HC Introduction to health check
HCSUM Health check summary
C&ID Collecting and inputting data
TRG Test result/recording given
Risk dialogue DoR Discussion of risk
RSRef Risk score reference
HARef Heart age reference
SARef Survival age free of cardiac event reference
RSM Risk score manipulation using either QRISK2 or JBS3
CVDRQ Patient question about CVD risk
CVD risk factors FH-MHIS Risk factor discussion – medical history
RF-FH Risk factor discussion – family history
RF-W Risk factor discussion – weight
RF-C Risk factor discussion – cholesterol
RF-BP Risk factor discussion – blood pressure
RF-D Risk factor discussion – diabetes
RF-MH&W Risk factor discussion – mental health and well-being
RF-PA Risk factor discussion – physical activity/inactivity
RF-DIET Risk factor discussion – diet
RF-A Risk factor discussion – alcohol consumption
RF-S Risk factor discussion – smoking
Lifestyle interventions I-W Intervention discussion – weight
I-C Intervention discussion – cholesterol
I-BP Intervention discussion – blood pressure
I-D Intervention discussion – diabetes
I-MW&W Intervention discussion – mental health and well-being
I-PA Intervention discussion – physical activity
I-DIET Intervention discussion – diet
I-A Intervention discussion – alcohol
IL-S Intervention discussion – smoking
Medical interventions I-GP Intervention discussion – GP appointment
I-PR Intervention discussion – practitioner appointment (PN or HCA)
I-M Intervention discussion – medication
Comments and recommendations
This table has been reproduced from Gidlow et al.72 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.org/
licenses/by/4.0/. The table includes minor additions and formatting changes to the original table.
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Appendix 3 Coding table based on




of PMT Example codes
Sources of
information
Environmental Family history of CVD






















Health locus of control/fatalism










Attempts to reduce weight
Attempts to undertake physical activity
Attempts to modify diet
DOI: 10.3310/hta25500 Health Technology Assessment 2021 Vol. 25 No. 50
Copyright © 2021 Gidlow et al. This work was produced by Gidlow et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social
Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution,
reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the




of PMT Example codes
Cognitive appraisal Threat appraisal Discussion of risk
Perceived severity of CVD risk (high/low/neutral level of severity)
Consequences of CVD
Perceived vulnerability to future CVD/CVD-related events
(high/low/neutral personal relevance)
Intrinsic and extrinsic rewards for not addressing CVD risk
Coping appraisal Discussion of risk
Self-efficacy to engage in adaptive coping
Promotion of self-efficacy through individualisation
Response efficacy of adaptive coping
Response cost of adaptive coping
Biomedical intervention/lifestyle intervention subcategories for each
category and positive/negative/neutral subcategories
Coping modes Adaptive coping Biomedical intervention
GP appointment referral
Medications (for blood pressure/lipids)
Lifestyle intervention




Increase fruit and vegetable intake








Positively engaged with biomedical/lifestyle/psychosocial intervention
discussion – apparently listening and engaged in the conversation;
accepting of what is being said/suggested
Maladaptive coping Negatively engaged with biomedical/lifestyle/psychosocial intervention
discussion – apparently listening and engaged in the conversation, but
dismissive of what is being said/suggested [already doing all I can (e.g.
already feels that they are very active and eat well)]; not interested in
making changes suggested (e.g. like smoking; hate physical activity)
Passive/disengaged with biomedical/lifestyle/psychosocial intervention
discussion – not engaged in the conversation (e.g. passively takes
information, but no clear plans for further contact)
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Appendix 4 Coding table based on protection
motivation theory for deductive thematic
analysis – including example quotations
Codes Example quotation (if available)
Sources of
information
Environmental Family history of CVD and/or
CVD-related factors
HP: Is there any family history,
is there mum, dad, any brothers
or sisters that were diagnosed
with any form of blood pressure
problems, strokes, heart problems,
under the age of 60?
P: No. Mum and dad are both 88,
still living. They are now on heart
sort of tablets and things though
Experience of family members





P: That’s alright. My Dad did




The patient discusses motivating
or demotivating factors for
attending the Health Check in
relation to their experiences of
going to the GP and how they
usually approach health care
HP: So have you ever had your
cholesterol and that done?
P: No I’ve never no I’m one of
the ones that tries to avoid the
doctors at all costs so . . .
HP: Thanks for coming in
P: Oh no, I always say yes to
these things [laughter]
Environmental influences
External influences that may have
an impact on CVD risk factors
(e.g. impact of work on exercise
levels)
P: Well I’m ex-army so a big part
of my . . .
HP: Yeah so you are used to it
P: I joined the army when I was
15, so a big part of my life was in
the army
HP: Ah oh yeah, the
marching yeah
Influence of significant others
This category relates to discussion
surrounding the positive or
negative effect that significant
others may have on their CVD
risk factors or adaptive/
maladaptive coping
HP: And its that’s how you know
how you feed your farmers up
isn’t it?
P: But you know he’s out in
horrific weather, he needs
good food
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Codes Example quotation (if available)
Intrapersonal
personality variables
Biomedical risk factors Evidence related to discussion of

















Taking of legal/illegal drugs
Psychosocial risk factors Evidence related to discussion of







Health locus of control/fatalism
The belief that health
outcomes are contingent
on (a) personal behaviour
(internal HLC), (b) other
powerful people (powerful
others HLC) and (c) forces
such as fate or chance
(chance HLC)
Mental health and well-being Evidence related to discussion of
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Codes Example quotation (if available)
HP: Have you ever received
treatment for blood
pressure problems?
P: Low blood pressure, not
treatment for it, I have had a test
for it, because it was very low at
one time, but I think it goes up
and down. I have just run a
marathon not so long ago, so
that might have had an effect
P: Yeah, I’m due to have another
one . . . I didn’t have cholesterol
done I just had sugar
HP: Your cholesterol’s in date
actually it’s come up as blue
on here
P: Oh has it what does that mean
HP: Which means it was done
last year, it was done in August
last year
Patient discusses intrapersonal
variables relating to their
medical history (e.g. previous
blood pressure measurements,
previous weight measurements,
etc.) This information would
also be coded under the
relevant medical risk factor
Intrapersonal prior
experience
Prior experience of CVD risk
reduction (positive/negative/
neutral experience)
Positive experience (smoking cessation)
P: And the only you know, and in
fact I saw the Help to Quit nurse
about 10 years ago when I
stopped erm I mean she was . . .
very, very unhealthy . . . she was
. . . obese
HP: Oh right








P: Slimming World I could
never acceptAttempts to undertake physical
activity
Attempts to modify or maintain
diet




HP: Yeah, so do you ever manage
to go to the gym, or swimming, or
any exercise classes?
P: I used to go for the gym
Attempts to reduce blood
pressure
Attempts to make or maintain
lifestyle changes
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Codes Example quotation (if available)





P: Some people just pour it in,
don’t they?
HP: Aye they do, they do.
P: I am aware, and if I think I
have perhaps have had more than
I should in the week, then I stop
and don’t drink at all
Use of statins
Smoking cessation




No example availableAttempts to undertake physical
activity
Attempts to modify or maintain
diet




P: I think I probably eat more
meat than veg
HP: Right
P: If in the whole scheme
of things
HP: Yeah
P: Which is something I’ve
thought about lately
Attempts to reduce blood
pressure
Attempts to make or maintain
lifestyle changes
Cognitive appraisal Threat appraisal Perceived severity of CVD risk Low severity
HP: OK so your Heart Age is 68,
how old are you at the moment?
P: 66
HP: 66, so it’s a couple of
years older
P: How did you make that out?
The degree to which people
think a particular condition is a
severe risk – high/low/neutral
level of severity, e.g.:
Neutral severity
HP: Your Heart Age is 60
alright, erm
P: But that’s what I am but I’m
supposed, supposed to be better
than I am is that what
you’re saying?
HP: Yeah because you’re
very slim
P: Yeah OK
‘Bowel cancer is a serious
illness’
High severity
HP: Right on average you should
expect to survive until the age of
84 without a heart attack, or
a stroke
P: Oh my
‘Oh 17% is not a very high
number is it, so I’ll be fine’
APPENDIX 4
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Codes Example quotation (if available)
Consequences of CVD No example available
Discussion about consequences
of developing CVD, e.g.:
‘I know developing CVD will
reduce my quality of life’
Perceived vulnerability to future
CVD/CVD-related events
Low personal relevance
HP: OK so your Heart Age is 68,
how old are you at the moment?
P: 66
HP: 66, so it’s a couple of
years older
P: How did you make that out?
HP: [Laugh] alright, because of
the info of the stats that I have
put in here
Perception of personal
likelihood to develop a








‘Does that mean I’m likely to
have a heart attack?’
Intrinsic (e.g. pleasure) and
extrinsic (e.g. social approval)
rewards for not addressing
CVD risk
Extrinsic rewards
P: You see the thing is I’m trying
to get my wife to stop
HP: Oh she smokes as well?
P: Yeah, but she won’t, she will
not and she’s got COPD
HP: Oh honestly
P: Yep, yep, yep
HP: Gosh
P: Yep
HP: Oh yeah that’s very naughty
isn’t it?
P: Yep
‘Being a curvaceous woman
makes me happy so it doesn’t
bother me that I am overweight’
‘I don’t want to give up smoking
because my wife smokes too,
it’s something we enjoy
together’
Neutral response to discussion
of risk
HP: So, this is telling me
today that your heart age is 71
P: Right
HP: A lot of that is to do with
your smoking
P: Hm
Patient responds in a neutral
manner to the risk discussion.
For example, the patient could
respond with ‘hmm’, ‘right’, ‘OK’.
Generally very short, one-word
responses
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Codes Example quotation (if available)
Not enough information is
present in the patient response
to classify as either positively
or negatively engaged in the
discussion
Consequences of CVD risk
factors
Split into two categories:
l Acceptance/awareness of
health implications to engage/
not engage in adaptive
behaviour
Here the patient acknowledges or
demonstrates awareness of the
related health implications to





health implications to engage/
not engage related to
maladaptive behaviour
Here the patient acknowledges or
demonstrates awareness of the
related health implications to
engagement with a maladaptive
behaviour (e.g. smoking)
Acceptance/awareness of health
implications to engage/not engage in
adaptive behaviour
HP: OK and when you’re walking
are you slow, steady or brisk
would you say?
P: Brisk
HP: Brisk. Which is brilliant
because it’s put you down into
that active category
P: Gets the heart rate up, yeah
HP: Yeah gets your heart
rate upwards
Acceptance/awareness of health
implications to engage/not engage
related to maladaptive behaviour
HP: So it gives you food
for thought
P: Hmm hmm. You haven’t told
me anything I didn’t already know
HP: I know, I know, I know I
didn’t . . .
P: So yeah
Perceived severity of CVD risk
factors
Low severity
HP: I mean, you might find that
when you are doing it at home
your readings are absolutely fine
P: They are what they are
Similar to perceived
severity of CVD risk yet
this category is related
to patient-practitioner






HP: Erm the other one in the red
is that one cholesterol one which
we were talking about there
P: Oh my God that’s well up
isn’t it?
Clarification of results HP: Your HDL, this figure, that’s
your good cholesterol and we
want to get this one higher
P: Right so what is it, it’s on 1.5
at the moment?
Related to when a patient
asked questions and sought
clarification about their test
results from the practitioner
APPENDIX 4
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Codes Example quotation (if available)
HP: Yeah 1.5 which is a good
figure erm . . .
P: So what what’s a good one?
HP: Its above 1 that is that is a
good figure
P: Oh that’s a . . . yeah OK
Perceived vulnerability of CVD
risk factors
Low personal relevance (in relation
to smoking)
P: I wouldn’t have thought that it
would count now
HP: Well no because it seems a
lot of time to regenerate
P: Eighties, Nineties, 2000 –




HP: So let’s just have a look,
we haven’t done a waist
circumference it’s just. . .
if you’d like me to do one
I can do so we’ve got one
for future reference?
P: Yeah, we can do it but I’m sure
it’s too big [laughter], no that’s
fine I don’t mind
HP: Are you happy with, yeah
yeah, I’ll em, it’s not the most
flattering because it’s just below
your tummy button so I’m sorry




yet this category is related
to patient perceived
vulnerability to related CVD
risk factors specifically (e.g.
cholesterol, blood pressure)
Perceived vulnerability to other
medical conditions
P: I have gone through a bit of a
stage last year thinking . . . I was
going to die of everything you
know, just eh oh God you get into





yet this category is related
to patient perceived
vulnerability to other medical
conditions (e.g. cancer)




Similar to perceived severity
of CVD risk yet this category
is related to patient perceived
severity of other medical
conditions (e.g. cancer).
This is sometimes, but not





P: I’m going to. . . my massive fear
factor is cancer
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Codes Example quotation (if available)
HP: Yeah
P: Beyond belief
HP: Because you’ve got that
within the . . .
P: Mum’s died of it, all my aunties
have died of it, my granny died
on Mum’s side, well in fact to
be honest they all did, but of an
age we lost a lot in their 60s
early 60s
HP: Earlies, so that’s your fear
factor as well isn’t it?
P: That massively is yeah, yeah
Coping appraisal Self-efficacy to engage in adaptive
coping
No example available
The belief that one is capable of
performing the behaviour
‘I am confident that I can
change my diet’




will be effective in reducing the
threat
‘Changing my diet would
improve my health and lower
my risk of CVD’
Response cost of adaptive coping (In relation to physical activity)
HP: And you like physical
exercise, don’t you? Do you ever
cycle at all?
P: Yes, in the summer. I am a
bit of a fair-weather cyclist,
so I do yeah
Barriers than inhibit the
performance of the adaptive
behaviour
‘Healthy eating costs more
money so it’s easier for me to
stay as I am’
Response cost of adaptive coping
(previous coping)
P: Well up to a couple of years
ago, I was doing some mountain
ones, I don’t do it on the road
anymore, because of my joints
and things. But I do half-
marathons yes
Similar to response cost of
adaptive coping above yet this
category relates to discussion
of previous coping attempts,
rather than current or future
coping attempts
Facilitators of adaptive coping P: I am a bit of a fitness . . .
HP: Are you? OK
P: If I don’t get my exercise I get
all sort of ratty!
This relates to practitioner –
patient discussion about any
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Codes Example quotation (if available)







and engaged in the
conversation;
accepting of what is
being said/suggested
Biomedical intervention (In relation to weight management):
HP: So average survival free
of heart attack or stroke is
84.1 years OK? So how do you
feel about that?
P: Oh I will make more of an
effort to lose some weight
(In relation to reducing blood
pressure):
P: So do I make the
appointment today
HP: Yes to see me in a month’s

















Increase fruit and vegetable
intake



















and engaged in the
conversation, but
dismissive of what is
being said/suggested
[already doing all I can
(e.g. already feels that
they are very active
and eat well]; not
interested in making
changes suggested
(e.g. like smoking; hate
physical activity)
Biomedical intervention Negative engaged
(In relation to reducing alcohol
consumption)
P: Pretty much says don’t drink
so much doesn’t it?
HP: Yeah well that’s that
other thing
P: Yawn
HP: It is the drink because . . .
(In relation to reducing blood
pressure)
HP: No, no. Healthy body –
healthy mind, so . . . It is just part
of your health check. Would you
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your blood pressure re-check?
I can do it for you now or you
can book at reception when it is
convenient for you
P: Whatever. I would leave it a
month or so
HP: Yes, about 4 weeks?
P: Yes. The reason being is that
I will be back on my normal
exercise and diet. I don’t know
if that makes a blind bit of
difference to blood pressure?
Neutral response
(In relation to blood pressure
re-check)
HP: We will do another reading
towards the end and if it is still
above 140 on the top and
85 there
P: Hm
HP: We will have to get you
back again for another blood
pressure re-check
(In relation to smoking cessation)
HP: Yeah, OK. Right and on
average you could expected to
survive to age 79 without a heart
attack or stroke but, if you gave
up smoking you would increase




Increase fruit and vegetable
intake












(e.g. referral to Healthy Mind)
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Appendix 5 Data extraction template for
case study patients
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Patient information (medical records)
PID Gender (M= 1)
Age (at time of
NHSHC)
Ethnicity






(Pr : Pt minutes)
Health Check quantitative coding
Practitioner
speaking (as % of
total HC)
Patient speaking
(as % of total HC)
No speaking
(as % of total HC)
Total minutes
discussing CD risk














































Appendix 6 Analysis of patient engagement
through non-verbal behaviours
For the case study participant, the purpose was to assess the level of engagement betweenpractitioner and patient using cues from body language from video-recorded health checks.
To categorise non-verbal behaviours (including some verbal cues) in sections of the health check
involving discussion of CVD risk, non-verbal cues were categorised to reflect whether the patient was:
l engaged (positive) – apparently listening and engaged in the conversation, accepting of what is
being said/suggested
l engaged (negative) – apparently listening and engaged in the discussion but dismissive of what is
being said/suggested, not interested in making changes suggested
l passive/disengaged – not engaged in the discussion, passively takes information.
Using non-verbal behaviour categorisation of patient and practitioner engagement used elsewhere,99–101
a list of non-verbal behaviours or cues were derived to allow classification into the above categories.
Through piloting and revising, the Likert scale shown in Table 13 was applied to analyse non-verbal
behaviour during CVD risk discussion.
For each case study participant, two researchers independently watched segments of the recorded
health check in which CVD risk was discussed, and rated them using the Likert scale. The median of
ratings for each segment were calculated, and range of these median values used to illustrate the
approximate level of engagement.
For each case study participant, two researchers independently watched segments of the recorded
health check in which CVD risk was discussed, and rated them using the Likert scale. The median of
ratings for each segment was calculated, and the range of these median values used to illustrate the
approximate level of engagement.
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TABLE 13 Likert scale used to classify non-verbal behaviours (body language analysis)
Passive Negatively engaged Positively engaged
Very passive A little passive Very negative A little negative Slightly positive Very positive
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Passive: disengaged cues Engaged: negative cues Engaged: positive cues
Negative body language – closed Positive body language – open Positive body language – open
No eye contact, looking away (i.e. on the telephone) Facing practitioner Facing practitioner/giving eye contact
Not responding to information Limited chat from patient Nodding/responding to information
Refusing to answer questions Little nodding/response Talking lots to the practitioner
Dismissive of comments or suggestions Answering questions but with little expansion Asking questions
































Appendix 7 Ratings of non-verbal engagement
in case study patients (for each segment of
health check in which cardiovascular disease
risk was discussed)
Pseudonym Segment times





Median1 2 3 4 5 6 7 8 1 2 3
JBS3
Abbie 12:22–13:35 9 26 27 25 24 26 24 23 24.5 10 27 24 25 24.5
14:50–14:56 22 23 22.5 24 24
16:47–16:55 22 22 20 20
Barry 11:16–11:34 3 6 13 10 8 9 9
13:26–13:58 20 19 21 20 13 13
14:26–14:47 20 19 20 20 15 15
15:15–15:52 19 18 18.5 12 12
16:05–16:17 19 20 19.5 15 15
16:36–16:47 19 20 19.5 17 17
20:09–20:14 19 19 20 20
Carl 01:31–01:35 24 24 19 19
17:44–19:08 25 22 23.5 20 20
19:17–19:45 22 22 20 20
22:12–22:17 21 21 19 19
22:39–22:45 22 22 18 18
Deborah 13:49–16:38 17 19 20 19 18 17 18 19 21 19 9 9
16:51–16:59 21 21 11 11
Eid 09:48–09:57 3 3 5 5
10:32–10:37 17 11 14 15 15
10:57–11:06 20 20 19 19
11:23–12:38 19 18 21 18 22 21 19 20 19.5 19 20 19.5
12:46–13:02 20 19 19.5 20 20
QRISK2
Freddie 18:10–18:24 25 25 25 25
22:54–23:53 25 26 25 26 25 25 24 24
Grace 11:50–12:29 16 14 15 12 14.5 10 10
Harry 07:44–08:15 22 20 21 22 22
08:51–09:38 20 21 20 21 22 21 22 22
10:21–10:29 22 21 19 21 23 23
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Pseudonym Segment times





Median1 2 3 4 5 6 7 8 1 2 3
Ian 15:06–16:17 24 23 24 22 20 22 21 22 19 19
Jessica 00:20–00:27 19 19 10 10
14:00–14:09 19 20 19.5 20 20
14:50–15:18 22 22 22 21 21.5
16:17–16:27 19 20 19.5 22 22
a If patient’s engagement changed within a segment of the health check, the new rating was recorded and
reported numerically.
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